var title_f24_25_24976="Laparoscopic vascular stapler";
var content_f24_25_24976=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F76073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F76073&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laparoscopic vascular stapler",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 237px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic vascular stapler applied to splenic artery proximal to splenic artery aneurysm.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jon Gould, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24976=[""].join("\n");
var outline_f24_25_24976=null;
var title_f24_25_24977="Lichenoid drug eruption 2";
var content_f24_25_24977=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83768&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Lichenoid drug eruption (drug-induced lichen planus)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Flat erythematous/violaceous papules on the shoulder and upper arm of a patient with lichenoid drug eruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24977=[""].join("\n");
var outline_f24_25_24977=null;
var title_f24_25_24978="IJ central line mid";
var content_f24_25_24978=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77907&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77907&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Central approach to the internal jugular vein",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 469px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The central approach to cannulation of the internal jugular vein is most common. Insert the needle at the apex of the angle formed by the two heads of the sternocleidomastoid, lateral to the carotid artery pulsation, at an angle approximately 30 degrees from the skin. Direct the needle towards the ipsilateral nipple. Blood is usually aspirated within 2.5 cm of insertion. If blood is not aspirated while advancing, slowly withdraw the needle. Aspiration often occurs as the needle is pulled back.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24978=[""].join("\n");
var outline_f24_25_24978=null;
var title_f24_25_24979="Patient information: Cirrhosis (The Basics)";
var content_f24_25_24979=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15380\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"         Organs inside the abdomen (belly)",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/39/8819\">",
"          Esophageal varices",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/28/39361\">",
"         Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/40/16002\">",
"         Patient information: Fluid in the belly (ascites) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/40/7810\">",
"         Patient information: Hepatic encephalopathy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/41/26258\">",
"         Patient information: Hepatitis B (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/39/32370\">",
"         Patient information: Hepatitis C (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/42/44706\">",
"         Patient information: Liver cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?24/34/25122\">",
"         Patient information: Liver transplant (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?43/21/44371\">",
"         Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?43/3/44084\">",
"         Patient information: Cirrhosis (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/45/31447\">",
"         Patient information: Hepatitis B (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/4/17478\">",
"         Patient information: Hepatitis C (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/39/4721\">",
"         Patient information: Liver biopsy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/47/12018\">",
"         Patient information: Nonalcoholic steatohepatitis (NASH) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Cirrhosis (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/cirrhosis-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H459780469\">",
"      <span class=\"h1\">",
"       What is cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Cirrhosis is a disease that scars the liver. The liver is a big organ in the upper right side of the belly (",
"      <a class=\"graphic graphic_figure graphicRef64960 \" href=\"UTD.htm?39/54/40804\">",
"       figure 1",
"      </a>",
"      ). Damage to the liver can cause heavy bleeding, swelling, and breathing problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780476\">",
"      <span class=\"h1\">",
"       What are the symptoms of cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Some people with cirrhosis have no symptoms. When symptoms do occur, they can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Swelling in the belly and legs, and fluid buildup in the lungs",
"       </li>",
"       <li>",
"        Heavy bleeding from blood vessels in the esophagus, the tube that connects the mouth to the stomach",
"       </li>",
"       <li>",
"        Bruising or bleeding easily",
"       </li>",
"       <li>",
"        Trouble breathing",
"       </li>",
"       <li>",
"        Feeling full",
"       </li>",
"       <li>",
"        Feeling tired",
"       </li>",
"       <li>",
"        Trouble getting enough sleep or sleeping too much",
"       </li>",
"       <li>",
"        Yellowing of the skin or whites of the eyes, called jaundice",
"       </li>",
"       <li>",
"        Confusion that can come on suddenly",
"       </li>",
"       <li>",
"        Coma",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Cirrhosis also makes it more likely that you will get infections, and it can increase your risk of liver cancer.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780483\">",
"      <span class=\"h1\">",
"       What causes cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;When something harms the liver, the organ tries to fix itself. In the process, scars form. Causes of liver damage include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Heavy alcohol use &ndash; People who abuse alcohol or who are addicted to it are most at risk for cirrhosis.",
"       </li>",
"       <li>",
"        Hepatitis B or Hepatitis C &ndash; Viruses cause these liver diseases. People can catch the viruses by sharing needles or having sex with people who are infected.",
"       </li>",
"       <li>",
"        Nonalcoholic steatohepatitis (NASH) &ndash; People with this condition often don&rsquo;t drink alcohol. Doctors aren&rsquo;t sure what causes NASH, but many people who have it are obese and have diabetes.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780490\">",
"      <span class=\"h1\">",
"       Is there a test for cirrhosis?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Biopsy &ndash; In this test, a doctor puts a needle into your liver and takes out a small sample of tissue. The sample will show how severe the damage is.",
"       </li>",
"       <li>",
"        Blood tests &ndash; Results can show what is causing the disease.",
"       </li>",
"       <li>",
"        Imaging &ndash; Your doctor might take pictures of your liver with an ultrasound machine or with a MRI.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780497\">",
"      <span class=\"h1\">",
"       Is there anything I can do to prevent further liver damage?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. To help protect your liver:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Avoid alcohol",
"       </li>",
"       <li>",
"        Talk to your doctor before you start taking any new medicines, including pain killers (such as Tylenol&reg;), herbs, vitamins, or supplements. Some medicines and supplements can damage the liver.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780504\">",
"      <span class=\"h1\">",
"       How is cirrhosis treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatments depend on the cause of cirrhosis, how severe it is, and what symptoms you have. Treatments fall into a few main categories, including those that:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Treat the cause of the disease",
"        </strong>",
"        &ndash; Some causes of cirrhosis can be treated. One example is stopping alcohol in people with cirrhosis caused by alcohol abuse. Another example is treatment of chronic hepatitis C or B with medicines.",
"       </li>",
"       <li>",
"        <strong>",
"         Lower the risk of bleeding",
"        </strong>",
"        &ndash; Cirrhosis can cause the blood vessels around the esophagus to swell or even burst and bleed (",
"        <a class=\"graphic graphic_figure graphicRef63611 \" href=\"UTD.htm?8/39/8819\">",
"         figure 2",
"        </a>",
"        ). To prevent that from happening, doctors can:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Prescribe medicines called &ldquo;beta blockers.&rdquo; These medicines reduce blood pressure in the liver, and help reduce the chance of bleeding.",
"       </li>",
"       <li>",
"        Tie tiny bands around the swollen blood vessels (this procedure is called &ldquo;variceal band ligation&rdquo;)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Decrease fluid buildup in the belly",
"        </strong>",
"        &ndash; In people with cirrhosis, the belly sometimes fills with fluid. To decrease fluid buildup, doctors can:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Prescribe medicines called &ldquo;diuretics.&rdquo; These medicines help you pee out the extra fluid. People who take diuretic medicines often must also reduce the amount of salt they eat.",
"       </li>",
"       <li>",
"        Drain the fluid from your belly (this procedure is called a &ldquo;paracentesis&rdquo;)",
"       </li>",
"       <li>",
"        Implant a device in the liver that reduces fluid buildup in the belly (this procedure is called &ldquo;TIPS&rdquo;)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Treat or prevent infection",
"        </strong>",
"        &ndash; People with cirrhosis have a higher than normal chance of getting infections. When they get an infection, they can also get much sicker than people without cirrhosis. As a result, people with cirrhosis sometimes need antibiotics to either treat or prevent infection. Most people with cirrhosis should also get the flu vaccine and other vaccines to prevent common infections.",
"       </li>",
"       <li>",
"        <strong>",
"         Improve confusion",
"        </strong>",
"        &ndash; Advanced cirrhosis can lead to confusion. Doctors usually use",
"        <a class=\"drug drug_patient\" href=\"UTD.htm?18/59/19380?source=see_link\">",
"         lactulose",
"        </a>",
"        (a medicine that softens stool) or certain antibiotics to treat the confusion.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780511\">",
"      <span class=\"h1\">",
"       Will I need a new liver?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People with severe cirrhosis need a new liver. Talk to your doctor about the surgery before you get too sick, to find out if a liver transplant might be an option for you. That way you can get on the waiting list early enough. People often have to wait for up to 2 years to get a new liver.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H459780518\">",
"      <span class=\"h1\">",
"       Can cirrhosis be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chances of getting cirrhosis by:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Getting help if you have an alcohol problem",
"       </li>",
"       <li>",
"        Getting the vaccine for hepatitis B, if you haven&rsquo;t already",
"       </li>",
"       <li>",
"        Using condoms when having sex",
"       </li>",
"       <li>",
"        Not sharing drug needles",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H4728001\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?38/28/39361?source=see_link\">",
"       Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/41/26258?source=see_link\">",
"       Patient information: Hepatitis B (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/39/32370?source=see_link\">",
"       Patient information: Hepatitis C (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?43/42/44706?source=see_link\">",
"       Patient information: Liver cancer (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/40/7810?source=see_link\">",
"       Patient information: Hepatic encephalopathy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/40/16002?source=see_link\">",
"       Patient information: Fluid in the belly (ascites) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=see_link\">",
"       Patient information: Liver transplant (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=see_link\">",
"       Patient information: Cirrhosis (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/21/44371?source=see_link\">",
"       Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=see_link\">",
"       Patient information: Hepatitis B (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=see_link\">",
"       Patient information: Hepatitis C (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/47/12018?source=see_link\">",
"       Patient information: Nonalcoholic steatohepatitis (NASH) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=see_link\">",
"       Patient information: Liver biopsy (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?24/25/24979?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15380 Version 9.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-7484D81656-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24979=[""].join("\n");
var outline_f24_25_24979=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780469\">",
"      What is cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780476\">",
"      What are the symptoms of cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780483\">",
"      What causes cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780490\">",
"      Is there a test for cirrhosis?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780497\">",
"      Is there anything I can do to prevent further liver damage?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780504\">",
"      How is cirrhosis treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780511\">",
"      Will I need a new liver?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H459780518\">",
"      Can cirrhosis be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4728001\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15380\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/54/40804\">",
"      Organs inside the abdomen (belly)",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/39/8819\">",
"       Esophageal varices",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/21/44371?source=related_link\">",
"      Patient information: Alcohol use &mdash; when is drinking a problem? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?38/28/39361?source=related_link\">",
"      Patient information: Alcohol use &mdash; when is drinking a problem? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/3/44084?source=related_link\">",
"      Patient information: Cirrhosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/40/16002?source=related_link\">",
"      Patient information: Fluid in the belly (ascites) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/40/7810?source=related_link\">",
"      Patient information: Hepatic encephalopathy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/45/31447?source=related_link\">",
"      Patient information: Hepatitis B (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/41/26258?source=related_link\">",
"      Patient information: Hepatitis B (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?17/4/17478?source=related_link\">",
"      Patient information: Hepatitis C (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/39/32370?source=related_link\">",
"      Patient information: Hepatitis C (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/39/4721?source=related_link\">",
"      Patient information: Liver biopsy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?43/42/44706?source=related_link\">",
"      Patient information: Liver cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?24/34/25122?source=related_link\">",
"      Patient information: Liver transplant (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/47/12018?source=related_link\">",
"      Patient information: Nonalcoholic steatohepatitis (NASH) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_25_24980="Acanthamoeba trophozoites";
var content_f24_25_24980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F64215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F64215&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 534px\">",
"   <div class=\"ttl\">",
"    Acanthamoeba trophozoites",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 514px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Trophozoite of",
"    <em>",
"     Acanthamoeba",
"    </em>",
"    spp in tissue, stained with hematoxylin and eosin (H&amp;E).",
"    <br>",
"     (B) Trophozoites of",
"     <em>",
"      Acanthamoeba",
"     </em>",
"     spp in a corneal scraping, stained with H&amp;E.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced from: Centers for Disease Control and Prevention. Parasites and Health: Free-living amebic infections. Available at:",
"      <a href=\"file://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/FreeLivingAmebic_il.htm\" target=\"_blank\">",
"       file://www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/FreeLivingAmebic_il.htm",
"      </a>",
"      .",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24980=[""].join("\n");
var outline_f24_25_24980=null;
var title_f24_25_24981="Esomeprazole: Patient drug information";
var content_f24_25_24981=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Esomeprazole: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=see_link\">",
"     see \"Esomeprazole: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/38/21095?source=see_link\">",
"     see \"Esomeprazole: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F166971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      NexIUM&reg;;",
"     </li>",
"     <li>",
"      NexIUM&reg; I.V.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F166972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Esomeprazole&reg;;",
"     </li>",
"     <li>",
"      Mylan-Esomeprazole;",
"     </li>",
"     <li>",
"      Nexium&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691503",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat GI (gastrointestinal) ulcers caused by infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691535",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat ulcers of the swallowing tube (esophagus).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692103",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat syndromes caused by lots of stomach acid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702052",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to esomeprazole or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697754",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care if you have risks for soft, brittle bones called osteoporosis (alcohol use, cigarette smoking, other family members with brittle bones, taking drugs to treat seizures, taking steroids).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2769639",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hip, spine, or wrist fractures may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2769659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699038",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad muscle pain or weakness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699003",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Seizures.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021910\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695814",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 hour before the first meal of the day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Capsule:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695700",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow capsule whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696305",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may sprinkle contents of capsule on applesauce. Do not chew.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3744622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may make a liquid. Empty contents of capsule into a 60 mL syringe with 50 mL of water. Replace plunger and shake for 15 seconds. Flush feeding tube before and after this drug is taken.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705408",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Granules:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695389",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix 2.5 mg or 5 mg granules with 1 teaspoon (5 mL) and the 10 mg, 20 mg, or 40 mg granules with 1 tablespoon (15 mL) of water; let them sit for a few minutes. Mix and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695604",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rinse cup with more water and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3744642",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may make a liquid. Empty contents of packet into syringe with 5 or 15 mL of water. Replace plunger and shake. Let sit for a few minutes. Refill syringe with water, shake, and flush feeding tube.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12431 Version 38.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-222.190.118.195-6BDFF69EB2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24981=[""].join("\n");
var outline_f24_25_24981=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166971\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F166972\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021906\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021908\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021907\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021912\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021913\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021915\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021910\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021911\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021916\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021917\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/39/15993?source=related_link\">",
"      Esomeprazole: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?20/38/21095?source=related_link\">",
"      Esomeprazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_25_24982="Dermoscopy basal cell carcinoma";
var content_f24_25_24982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of basal cell carcinomas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 463px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Arborizing vessels.",
"    <br>",
"     (B) Spoke-wheel-like structures/concentric structures (solid squares) and leaf-like structures (dashed square).",
"     <br>",
"      (C) Multiple blue-gray non-aggregated globules and dots.",
"      <br>",
"       (D) Large blue-gray ovoid nest (solid arrow).",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24982=[""].join("\n");
var outline_f24_25_24982=null;
var title_f24_25_24983="Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis";
var content_f24_25_24983=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Polyarticular onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Thomas JA Lehman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Marisa Klein-Gitelman, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24983/contributors\">",
"     Elizabeth TePas, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/25/24983/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyarticular onset juvenile idiopathic arthritis (formerly called polyarticular onset juvenile rheumatoid arthritis) is a subset of juvenile idiopathic arthritis (JIA) that is defined by the presence of more than four affected joints during the first six months of illness [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/1\">",
"     1",
"    </a>",
"    ]. In the new nomenclature, this disease, which comprises 20 to 30 percent of patients with JIA, is included in the group termed childhood polyarthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35717?source=see_link\">",
"     \"Classification of juvenile arthritis (JRA/JIA)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of polyarticular onset JIA will be reviewed here. The management of polyarticular onset JIA and systemic onset and pauciarticular onset JIA are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/48/17162?source=see_link\">",
"     \"Polyarticular onset juvenile idiopathic arthritis: Management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21046?source=see_link\">",
"     \"Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/31/24056?source=see_link\">",
"     \"Pauciarticular onset juvenile idiopathic arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyarticular onset juvenile idiopathic arthritis (JIA) is more frequent in females than males. There is a bimodal distribution of the age at onset: the first peak is between the ages of two and five years, and the second between 10 and 14 years. This age distribution suggests that two or more distinct diseases may be included in this classification. The clinical presentation of polyarticular onset JIA is varied, although it tends to fall into patterns based upon the age of onset.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Younger children",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children less than 10 years of age, polyarticular onset JIA often begins similarly to pauciarticular disease with one or two joints affected. The disease then spreads to involve five or more joints during the first six months after disease onset. In young children, the development is often indolent, and the disease may be unrecognized until an intercurrent infection precipitates a dramatic increase in symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is uncommon for these patients to develop polyarthritis within a period of days or weeks. More often, their disease is relentlessly progressive with periods of apparent response to therapy, followed by relapses with an increasing number of involved joints. A rapid onset of polyarthritis is more characteristic of reactive arthritis in childhood, but some children present with a history of sudden onset due to a failure to recognize the initial symptoms of the arthritis.",
"   </p>",
"   <p>",
"    Other typical clinical features include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symmetrical joint involvement with the knees, wrists, and ankles most frequently affected. However, asymmetric joint involvement predominates in certain subgroups of children.",
"     </li>",
"     <li>",
"      Presentation with dactylitis (uniform swelling of a single digit, sometimes referred to as a sausage digit) followed by progression to polyarticular disease over a few months [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/3\">",
"       3",
"      </a>",
"      ] that may be associated with a family history of psoriatic arthritis. Many pediatric rheumatologists feel these children have psoriatic arthritis, but they do not always have sufficient criteria for that classification and some therefore call them polyarticular JIA. The important thing for physicians to remember is that children who present with dactylitis often go on to develop polyarticular disease, even if less than five joints are involved when they initially present.",
"     </li>",
"     <li>",
"      Development of uveitis, though much less commonly than in children with pauciarticular JIA. Patients with antinuclear antibodies (ANA) are at greater risk for uveitis than those without.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It is rare to see children &lt;10 years of age with a positive rheumatoid factor (RF). The finding of RF in a young child should prompt consideration of another diagnosis, such as bacterial endocarditis or mixed connective tissue disease, or laboratory error. However, occasionally young children are seen with polyarticular joint involvement, positive tests for rheumatoid factor (RF), and anti-cyclic citrullinated peptide (anti-CCP) antibodies. The International League of Associations for Rheumatology (ILAR) criteria require that RF",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anti-CCP antibodies are found twice on serologic testing three months apart, because of concerns about false positive test results. However, these children may be manifesting an early onset of aggressive adult type rheumatoid arthritis and should be treated appropriately without waiting three months for confirmatory testing results.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Older children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;These patients usually have a relatively rapid onset of inflammation in multiple joints. This often involves the many small joints of the hands and feet within two to three months of disease onset. Pain in the small joints is a common manifestation of polyarticular JIA and may be out of proportion, initially, to the degree of inflammation and stiffness. The joints of the fingers, wrists, elbows, the cervical spine, hips, knees, and ankles are most commonly affected.",
"   </p>",
"   <p>",
"    Children with polyarticular disease with onset after 10 years of age may be divided by the presence or absence of RF (eg, polyarthritis RF negative and polyarthritis RF positive). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35717?source=see_link\">",
"     \"Classification of juvenile arthritis (JRA/JIA)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with RF are more likely to be female and tend to have more severe disease, mimicking their adult counterparts. Some of these children may be HLA-DR4 positive",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      have anti-cyclic citrullinated peptide (anti-CCP) antibodies, which suggest an aggressive disease course in the absence of appropriate therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/4\">",
"       4",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"       \"Clinical features of rheumatoid arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Most children with polyarticular onset disease are RF negative and it is rare for these children to have antibodies to cyclic citrullinated peptide [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. Their disease is probably not etiologically similar to adult onset rheumatoid arthritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of polyarticular onset JIA is based upon the development of arthritis in more than four joints during the first six months of disease. Other causes of arthritis must be excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There are no characteristic laboratory findings, although the following abnormalities may be observed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An elevated erythrocyte sedimentation rate (ESR, &ge;40",
"      <span class=\"nowrap\">",
"       mm/hr),",
"      </span>",
"      anemia (hemoglobin concentration",
"      <span class=\"nowrap\">",
"       &le;11g/dL),",
"      </span>",
"      and hypergammaglobulinemia may be present. Children with an elevated ESR who present with pauciarticular involvement have a high probability of developing polyarticular JIA during the first six months of illness.",
"     </li>",
"     <li>",
"      Many children in the younger age group are ANA positive. The ANA is often low in titer and homogeneous in pattern. Antibodies to dsDNA, Sm, Ro, La, or RNP are not expected; their presence should prompt consideration of systemic lupus erythematosus or mixed connective tissue disease. The presence of ANA is unrelated to the severity of arthritis and is meaningful only as a marker for an increased risk of developing uveitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=see_link\">",
"       \"Measurement and clinical significance of antinuclear antibodies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because there is not a specific diagnostic test, polyarticular onset JIA must be distinguished from a variety of self-limited and chronic illnesses that include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Children with serum sickness, viral infections, and many other forms of reactive arthritis may have polyarthritis. These conditions are excluded by recognition of the associated events, and by their generally self-limited nature. The rapidity of the onset of polyarticular disease in these conditions often helps to distinguish them from true JIA. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link\">",
"       \"Specific viruses that cause arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Early onset psoriatic arthritis or early onset spondyloarthropathy may be difficult to distinguish from polyarticular onset JA. The asymmetric pattern of joint involvement, the presence of a positive family history of psoriasis or spondylitis,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the presence of prominent enthesitis are useful distinguishing features. The spondyloarthropathies, although clinically distinct from the diseases previously classified as JRA, have been incorporated as a subcategory (enthesitis-associated arthritis) of JIA in the newer proposed nomenclature. However, the distinction may be important prognostically and for understanding the etiopathogenesis of the disease. In addition,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      is ineffective for axial manifestations of spondyloarthropathies, but is recommended for JIA before anti-tumor necrosis factor (TNF) agents. Anti-TNF agents are effective for spondyloarthropathies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=see_link\">",
"       \"Spondyloarthropathy in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Systemic lupus erythematosus may be differentiated from polyarticular JIA by the involvement of other organs, especially the skin, and by the presence of autoantibodies other than ANA. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=see_link\">",
"       \"Systemic lupus erythematosus in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Systemic vasculitis also may manifest with arthritis. Evidence of a vasculitic rash or additional end organ involvement (especially renal or pulmonary) may help to identify children with vasculitis. As an example, two girls who were initially diagnosed with polyarticular JIA subsequently developed antineutrophil cytoplasmic antibody (ANCA) positive glomerulonephritis, consistent with an ANCA-associated vasculitis [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/7\">",
"       7",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40616?source=see_link\">",
"       \"Classification and incidence of childhood vasculitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Sarcoidosis is an infrequent cause of polyarticular arthritis in both young and older children [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/8\">",
"       8",
"      </a>",
"      ]. Significant hilar adenopathy is not common in children with sarcoid arthritis and therefore cannot be relied upon to confirm the diagnosis. However, hypercalcemia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      recurrent unexplained liver enzyme elevations are suggestive of sarcoid arthritis. In addition, angiotensin converting enzyme levels are often markedly elevated in children with sarcoid, especially those with pulmonary involvement, distinguishing them from healthy children who commonly may have moderately elevated levels. Uveitis, including inflammation of the posterior pole that is distinct from the anterior uveitis seen in juvenile arthritis, may be another characteristic feature of juvenile sarcoidosis. Radiographically, sarcoid arthritis is unusually destructive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"       \"Clinical manifestations and diagnosis of sarcoidosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory bowel disease is commonly associated with enthesitis in adolescents, but may initially mimic polyarticular JIA. In some children, arthritis may precede the onset of gastrointestinal symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/9\">",
"       9",
"      </a>",
"      ]. Even in a child who has previously been evaluated by gastroenterology, continued complaints of stomach discomfort should prompt further investigation by a gastroenterologist who may recommend endoscopy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=see_link\">",
"       \"Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epiphyseal dysplasia may cause joint pain and visible joint deformity, but is not associated with inflammatory markers, such as an elevated ESR. It should be easy to distinguish radiographically from JIA. One form of epiphyseal dysplasia, progressive pseudorheumatoid arthropathy of childhood (MIM 208230), results in oligo- or polyarticular joint pain and stiffness beginning about age three years and is associated with vertebral flattening seen on spine radiographs. Mutations causing the disorder have been mapped to 6q22 and affect the WISP3 gene [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/10\">",
"       10",
"      </a>",
"      ], which plays a role in regulation of chondrocyte production of matrix proteins [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/10/3240?source=see_link\">",
"       Minocycline",
"      </a>",
"      -induced autoimmunity has been reported to present as polyarthritis or polyarthralgia, primarily affecting the hands and feet, in adolescents [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/12\">",
"       12",
"      </a>",
"      ]. Although this is a rare complication of minocycline therapy, it appears to be increasing in frequency because minocycline is commonly used in the treatment of acne.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common complications of polyarticular JIA are related to arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Musculoskeletal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexion contractures, weakness, and difficulty with ambulation are not uncommon. Bony erosions and joint destruction frequently occur if therapy is inadequate to fully control the synovitis, and this may result in severe disability requiring total joint replacement. On the other hand, with adequate treatment, severe mobility problems are rare, educational attainment is often better than unaffected peers, and inability to work is unusual [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/13\">",
"     13",
"    </a>",
"    ]. Osteopenia often occurs among those with severe growth retardation even when glucocorticoids have never been used [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/14\">",
"     14",
"    </a>",
"    ]. Vertebral compression fractures can occur, particularly in patients with refractory disease. In one series of patients with severe JIA, risk factors for vertebral compression fractures included high disease activity, body mass index, and recent cumulative glucocorticoid dose [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/15\">",
"     15",
"    </a>",
"    ]. There was no association with bone mineral density or disease duration.",
"   </p>",
"   <p>",
"    Involvement of the temporomandibular joint (TMJ) may lead to micrognathia even in the absence of symptoms. Predictors of radiographic damage of the TMJ are pain with TMJ motion and the finding of limited forward movement of the mandibular condyle (limited translation) with mouth opening [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/5\">",
"     5",
"    </a>",
"    ]. The evolution of TMJ involvement is often slow and virtually imperceptible. In one study of 32 patients, magnetic resonance (MR) imaging often demonstrated TMJ involvement even in patients who were asymptomatic and had normal examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/16\">",
"     16",
"    </a>",
"    ]. TMJ abnormalities were found in 70 percent of adults with JIA assessed with MR or computed tomography (CT) imaging, including 8 of 21 patients with polyarthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Ocular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uveitis may be seen in children with polyarticular JIA, though less often than in pauciarticular JIA. This was illustrated in a retrospective review of 1081 patients with JIA from a single Canadian tertiary center that reported a 14 percent rate of uveitis in children with polyarticular JIA versus 20 percent in those with pauciarticular JIA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The serologic marker most strongly associated with uveitis is ANA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Thus, children who are ANA positive must be screened more often than those who are ANA negative, but both groups of children are at risk for developing uveitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/18,20,21\">",
"     18,20,21",
"    </a>",
"    ]. In contrast, children with RF negative polyarticular JIA are more likely to develop uveitis than those who are RF positive [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/13,18,21\">",
"     13,18,21",
"    </a>",
"    ]. In children with RF negative polyarticular JIA, diagnosis at a young age (less than six years) increases the risk of uveitis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sections on ophthalmology and rheumatology of the American Academy of Pediatrics have developed a schedule for ophthalmologic examination based upon the age of onset of JIA and the presence of ANA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/20\">",
"     20",
"    </a>",
"    ]. The suggested schedule is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age at onset &lt;6 years, + ANA",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Duration of disease &le;4 years: eye examination every 3 months",
"     </li>",
"     <li>",
"      Duration of disease &gt;4 and &lt;7 years: eye examination every 6 months",
"     </li>",
"     <li>",
"      Duration of disease &gt;7 years: eye examination every 12 months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age at onset &gt;6 years, + ANA",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Duration of disease &le;4 years: eye examination every 6 months",
"     </li>",
"     <li>",
"      Duration of disease &gt;4 years: eye examination every 12 months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age at onset &lt;6 years, - ANA",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Duration of disease &le;4 years: eye examination every 6 months",
"     </li>",
"     <li>",
"      Duration of disease &gt;4 years: eye examination every 12 months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age at onset &gt;6 years, - ANA: eye examination every 12 months",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rationale for frequent screening examinations is to minimize the risk of ocular complications due to late diagnosis and treatment of uveitis in children with JIA. As an example, in the previously mentioned Canadian study, about one-third of patients with uveitis (53 of 142) developed ocular complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/18\">",
"     18",
"    </a>",
"    ]. The most common sequelae were cataracts (n = 33) and synechiae (n = 31), followed by glaucoma (n = 22), band keratopathy (n = 20), and macular edema (n = 7). After a mean follow-up time of 6.9 years, 10 patients developed legal blindness in 10 eyes and 4 patients developed impaired vision in 6 eyes. The importance of appropriate screening must be emphasized to parents if the frequency of complications is to be reduced.",
"   </p>",
"   <p>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=see_link\">",
"     \"Uveitis: Etiology, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Visceral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Internal organ involvement is rare. Although many of these children suffer from chronic anemia and malaise, these symptoms typically resolve with successful control of the underlying synovitis. Similarly, systemic complications that may occur in adult RA, such as vasculitis and pneumonitis, are uncommon in children with polyarthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     COURSE AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with the early onset of polyarticular JIA (regardless of the presence or absence of rheumatoid factor) have a low likelihood of developing spontaneous remission. The majority of children who \"grow out of it\" probably represent misclassified cases of reactive arthritis. As an example, among 27 RF negative German children who were followed for 15 years after disease onset, 19 still had active disease (70 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite, the availability of new medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    and tumor necrosis factor [TNF] inhibitors) to treat polyarticular JIA, a significant number of patients continue to have some disease activity. This was illustrated in a retrospective review of 104 patients treated at a single tertiary center from 2000 to 2006 with a mean follow-up time of 30 months [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/22\">",
"     22",
"    </a>",
"    ]. About one-half of patients achieved episodes of clinical remission (defined as six months of inactive disease) while on medications. Patients with evidence of joint damage within six months of presentation or who were RF positive were more likely to continue to have significant active disease over time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     RF positive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adolescents with RF positive polyarthritis probably represent the early onset of adult type disease, and are at significant long-term risk for progressive arthritis and the other complications normally associated with adult onset rheumatoid arthritis (RA). These patients may present with antibodies against cyclic citrullinated peptides (CCP) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/4,23\">",
"     4,23",
"    </a>",
"    ], which are seen in adults with severe RA. Although the prevalence of CCP is low in patients with polyarticular JA, CCP can be seen in older patients (&gt;16 years of age) who are RF positive [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/23\">",
"     23",
"    </a>",
"    ]. Joint damage in RF positive polyarticular JIA occurs earlier, leading many investigators to believe that the therapeutic pyramid should be inverted with early and aggressive treatment of these patients.",
"   </p>",
"   <p>",
"    Studies of early aggressive therapy in adults with RA confirm better responses and improved joint preservation [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24983/abstract/24\">",
"     24",
"    </a>",
"    ]. Ongoing therapeutic trials in children are attempting to determine whether a similar approach involving treatment with disease modifying agents should be followed in JIA patients at high risk for progressive joint destruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"     \"Clinical features of rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/47/33528?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinically useful biologic markers in the diagnosis and assessment of outcome in rheumatoid arthritis\", section on 'Anti-citrullinated peptide antibodies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/61/12242?source=see_link\">",
"       \"Patient information: Juvenile rheumatoid arthritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyarticular onset juvenile idiopathic arthritis (JIA) is defined by the presence of more than four affected joints during the first six months of illness.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The clinical presentation of polyarticular JIA is varied and tends to fall into patterns based upon the age of onset. There is a bimodal distribution of the age at onset: the first peak in incidence is between the ages of 2 and 5 years, and the second peak between 10 and 14 years. It is more common in females than males at all ages. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis is made on clinical grounds based upon the development of arthritis in more than four joints during the first six months of disease. There are no characteristic laboratory findings, although an elevated erythrocyte sedimentation rate (ESR, &ge;40",
"      <span class=\"nowrap\">",
"       mm/hr),",
"      </span>",
"      anemia (hemoglobin concentration",
"      <span class=\"nowrap\">",
"       &le;11g/dL),",
"      </span>",
"      and hypergammaglobulinemia may be present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Without optimal therapy, polyarticular JIA is a chronic and progressive condition. Consequently, aggressive and early control of the disease process is important to reduce its morbidity. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Course and prognosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/48/17162?source=see_link\">",
"       \"Polyarticular onset juvenile idiopathic arthritis: Management\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/1\">",
"      Criteria for the classification of juvenile rheumatoid arthritis. Bull Rheum Dis 1972; 23:712.",
"     </a>",
"    </li>",
"    <li>",
"     Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Textbook of pediatric rheumatology, 4th ed, Cassidy JT, Petty RE (Eds), WB Saunders Company, Philadelphia 2001. p.233.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/3\">",
"      Naidu SH, Ostrov BE, Pellegrini VD Jr. Isolated digital swelling as the initial presentation of juvenile rheumatoid arthritis. J Hand Surg Am 1997; 22:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/4\">",
"      Ferucci ED, Majka DS, Parrish LA, et al. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2005; 52:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/5\">",
"      Twilt M, Mobers SM, Arends LR, et al. Temporomandibular involvement in juvenile idiopathic arthritis. J Rheumatol 2004; 31:1418.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/6\">",
"      Avcin T, Cimaz R, Falcini F, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002; 61:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/7\">",
"      Dhib M, Prieur AM, Courville S, et al. Crescentic glomerulonephritis in juvenile chronic arthritis. J Rheumatol 1996; 23:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/8\">",
"      Rosenberg AM, Yee EH, MacKenzie JW. Arthritis in childhood sarcoidosis. J Rheumatol 1983; 10:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/9\">",
"      Jose FA, Garnett EA, Vittinghoff E, et al. Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/10\">",
"      Hurvitz JR, Suwairi WM, Van Hul W, et al. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet 1999; 23:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/11\">",
"      Sen M, Cheng YH, Goldring MB, et al. WISP3-dependent regulation of type II collagen and aggrecan production in chondrocytes. Arthritis Rheum 2004; 50:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/12\">",
"      El-Hallak M, Giani T, Yeniay BS, et al. Chronic minocycline-induced autoimmunity in children. J Pediatr 2008; 153:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/13\">",
"      Minden K, Niewerth M, Listing J, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:2392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/14\">",
"      Rabinovich CE. Bone mineral status in juvenile rheumatoid arthritis. J Rheumatol Suppl 2000; 58:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/15\">",
"      Markula-Patjas KP, Valta HL, Kerttula LI, et al. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis. J Rheumatol 2012; 39:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/16\">",
"      Weiss PF, Arabshahi B, Johnson A, et al. High prevalence of temporomandibular joint arthritis at disease onset in children with juvenile idiopathic arthritis, as detected by magnetic resonance imaging but not by ultrasound. Arthritis Rheum 2008; 58:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/17\">",
"      Arvidsson LZ, Smith HJ, Flat&oslash; B, Larheim TA. Temporomandibular joint findings in adults with long-standing juvenile idiopathic arthritis: CT and MR imaging assessment. Radiology 2010; 256:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/18\">",
"      Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. Arthritis Rheum 2007; 56:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/19\">",
"      Heiligenhaus A, Niewerth M, Ganser G, et al. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007; 46:1015.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/20\">",
"      Cassidy J, Kivlin J, Lindsley C, et al. Ophthalmologic examinations in children with juvenile rheumatoid arthritis. Pediatrics 2006; 117:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/21\">",
"      Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008; 35:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/22\">",
"      Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology (Oxford) 2009; 48:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/23\">",
"      Dewint P, Hoffman IE, Rogge S, et al. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 2006; 45:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24983/abstract/24\">",
"      Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52:3381.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6414 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-87E6A227E7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24983=[""].join("\n");
var outline_f24_25_24983=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Younger children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Older children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Musculoskeletal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Ocular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Visceral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      COURSE AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      RF positive patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/42/40616?source=related_link\">",
"      Classification and incidence of childhood vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/56/35717?source=related_link\">",
"      Classification of juvenile arthritis (JRA/JIA)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=related_link\">",
"      Clinical features of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/47/33528?source=related_link\">",
"      Clinically useful biologic markers in the diagnosis and assessment of outcome in rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3288?source=related_link\">",
"      Epidemiology and environmental factors in inflammatory bowel disease in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28520?source=related_link\">",
"      Measurement and clinical significance of antinuclear antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/61/12242?source=related_link\">",
"      Patient information: Juvenile rheumatoid arthritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/31/24056?source=related_link\">",
"      Pauciarticular onset juvenile idiopathic arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/48/17162?source=related_link\">",
"      Polyarticular onset juvenile idiopathic arthritis: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=related_link\">",
"      Specific viruses that cause arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/31/8696?source=related_link\">",
"      Spondyloarthropathy in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/35/10810?source=related_link\">",
"      Systemic lupus erythematosus in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/35/21046?source=related_link\">",
"      Systemic onset juvenile idiopathic arthritis: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/16/23817?source=related_link\">",
"      Uveitis: Etiology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_25_24984="Etiology of hypocalcemia in adults";
var content_f24_25_24984=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology of hypocalcemia in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24984/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24984/contributors\">",
"     David Goltzman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24984/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24984/contributors\">",
"     Clifford J Rosen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24984/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24984/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/25/24984/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major factors that influence the serum calcium concentration are parathyroid hormone (PTH), vitamin D, the calcium ion itself [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/1\">",
"     1",
"    </a>",
"    ], and phosphate. Low serum calcium concentrations are most often caused by disorders of parathyroid hormone (PTH) or vitamin D. Other causes of hypocalcemia include disorders that result in a decrease in serum ionized calcium concentration by binding of calcium within the vascular space or by its deposition in tissues, as can occur with hyperphosphatemia.",
"   </p>",
"   <p>",
"    The causes of hypocalcemia in adults will be reviewed here. The etiology of hypocalcemia in neonates and children and the clinical manifestations, evaluation, and treatment of hypocalcemia in adults are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link\">",
"     \"Etiology of hypocalcemia in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36646?source=see_link\">",
"     \"Clinical manifestations of hypocalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34005?source=see_link\">",
"     \"Diagnostic approach to hypocalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44632?source=see_link\">",
"     \"Treatment of hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CALCIUM HOMEOSTASIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum calcium concentrations are normally maintained within the very narrow range that is required for the optimal activity of the many extracellular and intracellular processes calcium regulates. Calcium in the blood is transported partly bound to plasma proteins (about 45 percent), notably albumin, partly bound to small anions such as phosphate and citrate (about 15 percent), and partly in the free or ionized state (about 40 percent). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=see_link\">",
"     \"Relation between total and ionized serum calcium concentration\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although only the ionized calcium is metabolically active (ie, subject to transport into cells) most laboratories report total serum calcium concentrations. Concentrations of total calcium in normal serum generally range between 8.5 and 10.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.12 to 2.62",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and levels below this are considered to be consistent with hypocalcemia. The normal range of ionized calcium is 4.65 to 5.25",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.16 to 1.31",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Hypoalbuminemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;When protein concentrations (particularly albumin) fluctuate substantially, total calcium levels may vary, whereas the ionized calcium, whose level is hormonally regulated, remains relatively stable. Thus, total serum calcium concentrations may not accurately reflect the physiologically important ionized (or free) calcium concentration. As an example, in volume overload, chronic illness, and malnutrition or nephrotic syndrome (where serum protein can be reduced), total plasma calcium is low but the ionized calcium is normal. This phenomenon is called pseudohypocalcemia.",
"   </p>",
"   <p>",
"    The serum total calcium concentration falls approximately 0.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    for every 1",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    reduction in the serum albumin concentration. Thus, in patients with hypoalbuminemia, the measured serum calcium concentration should be corrected for the abnormality in albumin (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?17/35/17969?source=see_link\">",
"     calculator 1",
"    </a>",
"    ), or for standard units (",
"    <a class=\"calc calc_professional\" href=\"UTD.htm?14/51/15153?source=see_link\">",
"     calculator 2",
"    </a>",
"    ). If a laboratory known to measure ionized calcium reliably is available, some authorities prefer to measure the serum ionized calcium in this situation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=see_link\">",
"     \"Relation between total and ionized serum calcium concentration\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Acid-base disturbances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even in the presence of a normal serum albumin, changes in blood pH can alter the equilibrium constant of the albumin-calcium complex, with acidosis reducing the binding and alkalosis enhancing it. Thus, in critically ill or post-surgical patients, correcting total calcium for albumin is not necessarily accurate because of changes in pH and affinity of calcium binding [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/2\">",
"     2",
"    </a>",
"    ]. In one study, for example, the use of the formula that corrected the calcium concentration based upon albumin level had a sensitivity of only 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/2\">",
"     2",
"    </a>",
"    ]. Consequently, when major shifts in pH are present, it is most prudent to directly measure the ionized calcium level in order to determine the presence of hypocalcemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Hormone regulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major hormones that regulate serum calcium are parathyroid hormone (PTH) and vitamin D via effects on bone, kidney, and the gastrointestinal tract. Calcium itself acts to regulate its own blood levels by acting via a calcium sensing receptor (CaSR) in the parathyroid gland to inhibit PTH secretion and on a CaSR in the loop of Henle to stimulate renal calcium excretion.",
"   </p>",
"   <p>",
"    PTH is secreted almost instantaneously in response to very small reductions in serum ionized calcium, which are sensed by the CaSR. The increase in PTH release raises the serum calcium concentration toward normal via three actions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decreased urinary calcium excretion due to stimulation of calcium reabsorption in the distal tubule",
"     </li>",
"     <li>",
"      Increased intestinal calcium absorption mediated by increased renal production of 1,25-dihydroxyvitamin D (calcitriol), the most active form of vitamin D",
"     </li>",
"     <li>",
"      Increased bone resorption",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypocalcemia may occur when PTH secretion is insufficient to act on kidney, bone, and intestine to normalize serum calcium (hypoparathyroidism). When parathyroid gland and PTH are functioning normally, then other causes of hypocalcemia, such as vitamin D deficiency, are characterized by high PTH (secondary hyperparathyroidism). Thus, it is useful to characterize hypocalcemia broadly as associated with low PTH or high PTH (",
"    <a class=\"graphic graphic_table graphicRef62899 \" href=\"UTD.htm?3/62/4077\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     HYPOCALCEMIA WITH LOW PTH (HYPOPARATHYROIDISM)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia with low PTH occurs when there is decreased secretion of PTH due to destruction of the parathyroid glands (autoimmune, post-surgical), abnormal parathyroid gland development, or altered regulation of parathyroid hormone production and secretion. The most common cause of hypoparathyroidism is surgical.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Destruction of the parathyroid glands",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Surgical",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical hypoparathyroidism can occur after thyroid, parathyroid, or radical neck surgery for head and neck cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. It may be transient, with recovery in days, weeks or months; permanent; or even intermittent. Transient hypoparathyroidism may be due to manipulation of the blood supply to or removal of one or more parathyroid glands during surgery, whereas intermittent hypoparathyroidism is due to decreased parathyroid reserve.",
"   </p>",
"   <p>",
"    Transient hypoparathyroidism occurs in up to 20 percent of patients after surgery for thyroid cancer and permanent hypoparathyroidism occurs in 0.8 to 3.0 percent of patients after total thyroidectomy, particularly when the goiter is extensive and anatomic landmarks are displaced and obscured. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41064?source=see_link&amp;anchor=H16#H16\">",
"     \"Surgical treatment of differentiated thyroid cancer\", section on 'Hypoparathyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypoparathyroidism after parathyroidectomy also may be transient, resulting from suppression of the remaining parathyroid tissue by prior hypercalcemia, or it may be severe and prolonged, accompanied by hypophosphatemia, as in the hungry bone syndrome. Hypocalcemia due to hungry bone syndrome may persist despite recovery of PTH secretion from the remaining normal glands. Thus, serum PTH concentrations may be low, normal, or even elevated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3287?source=see_link\">",
"     \"Hungry bone syndrome following parathyroidectomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Autoimmune",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acquired hypoparathyroidism not related to surgery is most often an autoimmune disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/3,5,6\">",
"     3,5,6",
"    </a>",
"    ]. Permanent hypoparathyroidism can result from immune-mediated destruction of the parathyroid glands [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/3\">",
"     3",
"    </a>",
"    ]. Alternatively, hypoparathyroidism may result from activating antibodies to the calcium sensing receptor that decrease PTH secretion. The antibodies are not destructive and may remit spontaneously. Activating antibodies to the calcium sensing receptor have been reported in patients with isolated acquired hypoparathyroidism and in patients with hypoparathyroidism associated with polyglandular autoimmune syndromes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link&amp;anchor=H18#H18\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\", section on 'Acquired disorders of the calcium-sensing receptor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Autoimmune hypoparathyroidism is a common feature of polyglandular autoimmune syndrome type I, which is a familial disorder (the most common other features are chronic mucocutaneous candidiasis and adrenal insufficiency). This syndrome typically presents in childhood with candidiasis, followed several years later by hypoparathyroidism, and then adrenal insufficiency during adolescence. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/0/40969?source=see_link&amp;anchor=H3#H3\">",
"     \"Causes of primary adrenal insufficiency (Addison's disease)\", section on 'Polyglandular autoimmune syndrome type I'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other causes of hypoparathyroidism due to parathyroid gland destruction, all very rare, include irradiation and storage or infiltrative diseases of the parathyroid glands (hemochromatosis, Wilson's disease, granulomas, or metastatic cancer) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. Symptomatic hypoparathyroidism has also been described in association with HIV infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32313?source=see_link&amp;anchor=H11#H11\">",
"     \"Bone and calcium disorders in HIV-infected patients\", section on 'Alterations in bone and calcium metabolism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Abnormal parathyroid gland development",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic defects may result in X-linked or in autosomal recessive hypoparathyroidism due to abnormal parathyroid gland development. The latter has been associated with mutations in the transcription factor glial-cell missing B (BCMB). In addition, hypoparathyroidism may be associated with complex congenital syndromes (eg, DiGeorge syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link&amp;anchor=H9#H9\">",
"     \"Etiology of hypocalcemia in infants and children\", section on 'Genetic'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Altered regulation of PTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Autosomal dominant or autosomal recessive hypoparathyroidism may be due to mutations in the signal peptide sequence of preproPTH, which impair the normal processing of preproPTH to PTH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link&amp;anchor=H9#H9\">",
"     \"Etiology of hypocalcemia in infants and children\", section on 'Genetic'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Activating mutations of the calcium-sensing receptor (CaSR) that decrease the set point of CaSR, so that PTH is not released at serum calcium concentrations that normally trigger PTH release, may also give rise to familial or autosomal dominant hypoparathyroidism or to sporadic disease. In contrast to other causes of hypocalcemia, urinary calcium excretion is normal or high, presumably due to increased activation of the CaSR in the kidney. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link&amp;anchor=H20#H20\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\", section on 'Hypoparathyroidism'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=see_link&amp;anchor=H18#H18\">",
"     \"Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia\", section on 'Acquired disorders of the calcium-sensing receptor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, functional hypoparathyroidism can be caused by both hypomagnesemia and by acute severe hypermagnesemia. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Disorders of magnesium metabolism'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     HYPOCALCEMIA WITH HIGH PTH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other disorders that cause hypocalcemia are associated with a high PTH. In these cases, PTH is increased in response to low serum calcium concentrations, in an attempt to mobilize calcium from kidney and bone and to increase 1,25-dihydroxyvitamin D production. Chronic hypocalcemia occurs when these actions are inadequate to restore the serum calcium to normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     PTH resistance (impaired PTH action)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pseudohypoparathyroidism, which presents in childhood, refers to a group of heterogeneous disorders defined by target organ (kidney and bone) unresponsiveness to PTH. It is characterized by hypocalcemia, hyperphosphatemia and, in contrast to hypoparathyroidism, elevated rather than reduced PTH concentrations. This disorder is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=see_link&amp;anchor=H14#H14\">",
"     \"Etiology of hypocalcemia in infants and children\", section on 'End-organ resistance/pseudohypoparathyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Vitamin D deficiency or resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decreased production or action of vitamin D is a more common cause of hypocalcemia than disorders of PTH action. Causes of vitamin D deficiency include poor intake or malabsorption coupled with reduced exposure to ultraviolet light, decreased 25-hydroxylation of vitamin D to form calcidiol (25-hydroxyvitamin D) in the liver, increased metabolism to inactive metabolites, decreased 1-hydroxylation of calcidiol to calcitriol (1,25-dihydroxyvitamin D) in the kidney, and decreased calcitriol action. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38184?source=see_link\">",
"     \"Causes of vitamin D deficiency and resistance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Extravascular deposition",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ionized calcium can be lost from the extracellular fluid either by deposition in tissues or by binding within the vascular space.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Hyperphosphatemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with impaired renal excretion or in acute renal failure, increased phosphate intake (overzealous oral administration or phosphate enemas) or excess tissue breakdown (rhabdomyolysis, tumor lysis) can cause acute hypocalcemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13527?source=see_link\">",
"     \"Overview of the causes and treatment of hyperphosphatemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=see_link\">",
"     \"Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In hyperphosphatemia, calcium is deposited mostly in bone, but also in extraskeletal tissue. Chronic hyperphosphatemia is almost always due to reduced phosphate clearance in chronic kidney disease where primary impairment of calcitriol synthesis in renal failure (leading to decreased intestinal calcium absorption) further aggravates the hypocalcemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=see_link&amp;anchor=H7#H7\">",
"     \"Pathogenesis of renal osteodystrophy\", section on 'Hypocalcemia and calcium-sensing receptor'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Osteoblastic metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasional patients with widespread osteoblastic metastases, particularly those with breast or prostate cancer, have hypocalcemia. The presumed cause is deposition of calcium in the newly formed bone around the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. In a study of 131 men with advanced prostate cancer, 34 percent had elevated serum PTH concentrations, and of these, 56 percent had a low serum ionized calcium [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/12\">",
"     12",
"    </a>",
"    ]. Hypocalcemia and secondary hyperparathyroidism was most common in those with progressive disease and bone metastases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Acute pancreatitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia is also a frequent finding in patients with acute pancreatitis, where it is associated with precipitation of calcium soaps in the abdominal cavity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/13\">",
"     13",
"    </a>",
"    ]. The actual mechanism remains unclear. Although PTH concentrations are variable, they are typically elevated in response to hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Sepsis or severe illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of hypocalcemia in critically ill or postsurgical patients approaches 80 to 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/15\">",
"     15",
"    </a>",
"    ]. Sepsis and severe burns can also be associated with clinically important hypocalcemia. The cause appears to be a combination of impaired secretion of PTH coupled with reduced calcitriol production [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/16,17\">",
"     16,17",
"    </a>",
"    ] and end-organ resistance to the action of PTH; the probable underlying mechanisms include hypomagnesemia and actions of inflammatory cytokines on the parathyroid glands, kidneys, and bone.",
"   </p>",
"   <p>",
"    Hypocalcemia is common in the toxic-shock syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/18\">",
"     18",
"    </a>",
"    ]. In addition to the above mechanisms, high serum calcitonin concentrations (which inhibit bone resorption) have been found in some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia can occur during and soon after surgery, most often in patients who received large volumes of blood, because the citrate used as an anticoagulant chelates calcium. In these cases, total calcium is normal while ionized calcium is reduced as a result of citrate binding. It can also occur during and after major surgery in patients who do not receive transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/19\">",
"     19",
"    </a>",
"    ]. Most of the reduction in serum calcium is due to volume expansion and hypoalbuminemia and does not affect the ionized calcium concentration. However, some patients have ionized hypocalcemia with a compensatory increase in serum PTH concentrations. These changes, which are proportional to the severity of the",
"    <span class=\"nowrap\">",
"     surgery/anesthesia",
"    </span>",
"    procedure, subside within hours after the operation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DISORDERS OF MAGNESIUM METABOLISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, magnesium depletion can cause hypocalcemia by producing PTH resistance, which occurs when serum magnesium concentrations fall below 0.8",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (1",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 0.4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    or by decreasing PTH secretion, which occurs in patients with more severe hypomagnesemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link&amp;anchor=H4#H4\">",
"     \"Signs and symptoms of magnesium depletion\", section on 'Bone and calcium metabolism'",
"    </a>",
"    .) The hypocalcemia cannot be corrected with calcium; the patients must be given magnesium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44632?source=see_link&amp;anchor=H5#H5\">",
"     \"Treatment of hypocalcemia\", section on 'Concurrent hypomagnesemia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Malabsorption, chronic alcoholism, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    therapy are the most common causes of hypomagnesemia; others include prolonged parenteral fluid administration, diuretic therapy, and the administration of aminoglycosides. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/41/15000?source=see_link\">",
"     \"Causes of hypomagnesemia\"",
"    </a>",
"    .) Despite PTH resistance or PTH deficiency, most patients with hypomagnesemia have normal or low serum phosphate concentrations, probably because of poor intake.",
"   </p>",
"   <p>",
"    Although magnesium depletion is typically suspected from the presence of hypomagnesemia, a few patients with magnesium-responsive hypocalcemia but",
"    <strong>",
"     normal",
"    </strong>",
"    serum magnesium concentrations have been described. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=see_link&amp;anchor=H8#H8\">",
"     \"Signs and symptoms of magnesium depletion\", section on 'Normomagnesemic magnesium depletion'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe hypermagnesemia, a very rare disorder, can also cause hypocalcemia, by suppressing the secretion of PTH [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/20\">",
"     20",
"    </a>",
"    ]. This requires a serum magnesium concentration above 5",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"    (6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or 2.5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    a concentration encountered only when magnesium is given to women with eclampsia. Symptomatic hypocalcemia is rare in these patients, most likely due to its short duration and the antagonistic neuromuscular effects of hypermagnesemia. Similarly, asymptomatic hypocalcemia has been reported during magnesium treatment in aneurysmal subarachnoid hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32914?source=see_link&amp;anchor=H4#H4\">",
"     \"Symptoms of hypermagnesemia\", section on 'Hypocalcemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13220?source=see_link\">",
"     \"Causes and treatment of hypermagnesemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DRUGS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Calcium chelators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Substances such as citrate (used to inhibit coagulation in banked blood or plasma), lactate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    , and sodium EDTA chelate calcium in serum, thereby reducing serum ionized calcium concentrations but not serum total calcium concentrations. Acute respiratory alkalosis, which increases calcium binding to albumin in serum, also reduces serum ionized calcium concentrations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=see_link\">",
"     \"Relation between total and ionized serum calcium concentration\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Symptomatic hypocalcemia during transfusion of citrated blood or plasma is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/22\">",
"     22",
"    </a>",
"    ], because normal subjects rapidly metabolize citrate in the liver and kidney. However, a clinically important fall in serum ionized calcium concentration can occur if citrate metabolism is impaired due to hepatic or renal failure or if large quantities of citrate are given rapidly, for example during plasma exchange, leukapheresis, or massive blood transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/23\">",
"     23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6646?source=see_link\">",
"     \"Complications of therapeutic plasma exchange\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=see_link\">",
"     \"Massive blood transfusion\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=see_link&amp;anchor=H18#H18\">",
"     \"Procedures used for blood donor screening: Protection of potential blood donors and recipients\", section on 'Citrate toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A similar effect can occur in patients with lactic acidosis due to shock or sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/24\">",
"     24",
"    </a>",
"    ]. For this reason, serum ionized calcium should be measured periodically in patients with these disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Bisphosphonates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia may result from the treatment of hypercalcemia, skeletal metastases, Paget disease of bone, or osteoporosis with bisphosphonates, which act to reduce osteoclastic bone resorption. Hypocalcemia is more likely to occur when high doses of especially potent bisphosphonates, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/1/9241?source=see_link\">",
"     zoledronic acid",
"    </a>",
"    , are used and in patients with underlying vitamin D deficiency, unrecognized hypoparathyroidism, or impaired renal function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40842?source=see_link&amp;anchor=H43#H43\">",
"     \"Bisphosphonates in the management of osteoporosis in postmenopausal women\", section on 'Other'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/43/39610?source=see_link&amp;anchor=H1930509#H1930509\">",
"     \"Risks of therapy with bone modifying agents in patients with advanced malignancy\", section on 'Hypocalcemia and other electrolyte abnormalities'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Cinacalcet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients receiving a calcimimetic drug (only",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/23/26998?source=see_link\">",
"     cinacalcet",
"    </a>",
"    is currently available) to help control secondary hyperparathyroidism of renal failure may experience hypocalcemia as a result of acute inhibition of PTH release. Clinically significant hypocalcemia occurs in approximately 5 percent of cases treated with cinacalcet. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease\", section on 'Cinacalcet'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=see_link&amp;anchor=H25#H25\">",
"     \"Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients\", section on 'Calcimimetics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia can occur in patients treated with some chemotherapeutic drugs. Among them,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    is probably most common. As noted above, it causes hypocalcemia by causing hypomagnesemia. Combination therapy with 5-fluorouracil and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    caused hypocalcemia in 65 percent of patients in one series, possibly by decreasing calcitriol production [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Foscarnet",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     Foscarnet",
"    </a>",
"    is a drug used to treat refractory cytomegalovirus and herpes infections in immunocompromised patients. It complexes ionized calcium and therefore lowers ionized calcium concentrations, potentially causing symptomatic hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/26\">",
"     26",
"    </a>",
"    ]. Therefore, the ionized calcium concentration should be measured at the end of an infusion of foscarnet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Fluoride poisoning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, excess intake of fluoride can cause hypocalcemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]; this effect is mediated, in part, by the formation of fluorapatite [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SPURIOUS HYPOCALCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two of the commercially available forms of gadolinium-based contrast agents (used in magnetic resonance angiography),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/41/39573?source=see_link\">",
"     gadodiamide",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/55/25461?source=see_link\">",
"     gadoversetamide",
"    </a>",
"    , may interfere with the colorimetric assays for calcium that are frequently used in hospital laboratories [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. This effect is not observed with other gadolinium-based agents: dimeglumine gadopentetate,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/15/4341?source=see_link\">",
"     gadoteridol",
"    </a>",
"    , or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/0/4097?source=see_link\">",
"     gadoterate meglumine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/30,32\">",
"     30,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The interaction can result in a marked reduction in the measured calcium concentration of as much as 6",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.5",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    if a blood sample is obtained soon after the test [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24984/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. This effect is rapidly reversible as the gadolinium is excreted in the urine, and the patient has no symptoms or signs of hypocalcemia. Awareness of this phenomenon is particularly important in patients with renal insufficiency who may retain the contrast agent for prolonged periods. There is no reason to treat this type of hypocalcemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/18/6434?source=see_link\">",
"       \"Patient information: Hypoparathyroidism (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Extracellular calcium ions regulate numerous biological processes, including intracellular signaling for secretion of many hormones, muscle contraction, and the coagulation cascade. It is therefore important that serum ionized calcium concentrations be maintained within a very narrow range, which is achieved by the close interrelationship between serum ionized calcium, PTH, and vitamin D. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Calcium homeostasis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocalcemia has many causes. It may result from inadequate parathyroid hormone production or secretion, parathyroid hormone resistance, vitamin D deficiency or resistance, abnormal magnesium metabolism, or to extravascular deposition of calcium, which can occur in several clinical situations (",
"      <a class=\"graphic graphic_table graphicRef62899 \" href=\"UTD.htm?3/62/4077\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Hypocalcemia with low PTH (hypoparathyroidism)'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Hypocalcemia with high PTH'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Among all of the causes of hypocalcemia, postsurgical hypoparathyroidism, autoimmune hypoparathyroidism and vitamin D deficiency are the most common. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Surgical'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Autoimmune'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Vitamin D deficiency or resistance'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/1\">",
"      Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol 2010; 298:F485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/2\">",
"      Dickerson RN, Alexander KH, Minard G, et al. Accuracy of methods to estimate ionized and \"corrected\" serum calcium concentrations in critically ill multiple trauma patients receiving specialized nutrition support. JPEN J Parenter Enteral Nutr 2004; 28:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/3\">",
"      Goltzman, D, Cole, DEC. Hypoparathyroidism. In Primer on the Metabolic Bone Diseases and Disorders of Bone Metabolism, American Society of Bone and Mineral Research 2006; 6:216.",
"     </a>",
"    </li>",
"    <li>",
"     Fitzpatrick LA, Arnold A. Hypoparathyroidism. In: Endocrinology, 3rd, DeGroot LJ (Ed), Saunders, Philadelphia 1995. p.1123.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/5\">",
"      Blizzard RM, Chee D, Davis W. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol 1966; 1:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/6\">",
"      Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981; 60:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/7\">",
"      Angelopoulos NG, Goula A, Rombopoulos G, et al. Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia. J Bone Miner Metab 2006; 24:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/8\">",
"      Toumba M, Sergis A, Kanaris C, Skordis N. Endocrine complications in patients with Thalassaemia Major. Pediatr Endocrinol Rev 2007; 5:642.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/9\">",
"      Carpenter TO, Carnes DL Jr, Anast CS. Hypoparathyroidism in Wilson's disease. N Engl J Med 1983; 309:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/10\">",
"      Goddard CJ, Mbewu A, Evanson JM. Symptomatic hypocalcaemia associated with metastatic invasion of the parathyroid glands. Br J Hosp Med 1990; 43:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/11\">",
"      Smallridge RC, Wray HL, Schaaf M. Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism. Am J Med 1981; 71:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/12\">",
"      Murray RM, Grill V, Crinis N, et al. Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer. J Clin Endocrinol Metab 2001; 86:4133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/13\">",
"      Dettelbach MA, Deftos LJ, Stewart AF. Intraperitoneal free fatty acids induce severe hypocalcemia in rats: a model for the hypocalcemia of pancreatitis. J Bone Miner Res 1990; 5:1249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/14\">",
"      McKay C, Beastall GH, Imrie CW, Baxter JN. Circulating intact parathyroid hormone levels in acute pancreatitis. Br J Surg 1994; 81:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/15\">",
"      Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis 2001; 37:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/16\">",
"      Desai TK, Carlson RW, Geheb MA. Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. Am J Med 1988; 84:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/17\">",
"      Zaloga GP, Chernow B. The multifactorial basis for hypocalcemia during sepsis. Studies of the parathyroid hormone-vitamin D axis. Ann Intern Med 1987; 107:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/18\">",
"      Sperber SJ, Blevins DD, Francis JB. Hypercalcitoninemia, hypocalcemia, and toxic shock syndrome. Rev Infect Dis 1990; 12:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/19\">",
"      Lepage R, L&eacute;gar&eacute; G, Racicot C, et al. Hypocalcemia induced during major and minor abdominal surgery in humans. J Clin Endocrinol Metab 1999; 84:2654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/20\">",
"      Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/21\">",
"      van den Bergh WM, van de Water JM, Hoff RG, et al. Calcium homeostasis during magnesium treatment in aneurysmal subarachnoid hemorrhage. Neurocrit Care 2008; 8:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/22\">",
"      Rutledge R, Sheldon GF, Collins ML. Massive transfusion. Crit Care Clin 1986; 2:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/23\">",
"      Bolan CD, Cecco SA, Wesley RA, et al. Controlled study of citrate effects and response to i.v. calcium administration during allogeneic peripheral blood progenitor cell donation. Transfusion 2002; 42:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/24\">",
"      Cairns CB, Niemann JT, Pelikan PC, Sharma J. Ionized hypocalcemia during prolonged cardiac arrest and closed-chest CPR in a canine model. Ann Emerg Med 1991; 20:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/25\">",
"      Kido Y, Okamura T, Tomikawa M, et al. Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas. Cancer 1996; 78:1794.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/26\">",
"      Jacobson MA, Gambertoglio JG, Aweeka FT, et al. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 1991; 72:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/27\">",
"      Gessner BD, Beller M, Middaugh JP, Whitford GM. Acute fluoride poisoning from a public water system. N Engl J Med 1994; 330:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/28\">",
"      Harinarayan CV, Kochupillai N, Madhu SV, et al. Fluorotoxic metabolic bone disease: an osteo-renal syndrome caused by excess fluoride ingestion in the tropics. Bone 2006; 39:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/29\">",
"      Boink AB, Wemer J, Meulenbelt J, et al. The mechanism of fluoride-induced hypocalcaemia. Hum Exp Toxicol 1994; 13:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/30\">",
"      Mark PB, Mazonakis E, Shapiro D, et al. Pseudohypocalcaemia in an elderly patient with advanced renal failure and renovascular disease. Nephrol Dial Transplant 2005; 20:1499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/31\">",
"      Gandhi MJ, Narra VR, Brown JJ, et al. Clinical and economic impact of falsely decreased calcium values caused by gadoversetamide interference. AJR Am J Roentgenol 2008; 190:W213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/32\">",
"      Prince MR, Choyke PL, Knopp MV. More on pseudohypocalcemia and gadolinium-enhanced MRI. N Engl J Med 2004; 350:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/33\">",
"      Doorenbos CJ, Ozyilmaz A, van Wijnen M. Severe pseudohypocalcemia after gadolinium-enhanced magnetic resonance angiography. N Engl J Med 2003; 349:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24984/abstract/34\">",
"      Prince MR, Erel HE, Lent RW, et al. Gadodiamide administration causes spurious hypocalcemia. Radiology 2003; 227:639.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 840 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-95F309B6B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24984=[""].join("\n");
var outline_f24_25_24984=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CALCIUM HOMEOSTASIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Hypoalbuminemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Acid-base disturbances",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Hormone regulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      HYPOCALCEMIA WITH LOW PTH (HYPOPARATHYROIDISM)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Destruction of the parathyroid glands",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Surgical",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Autoimmune",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Other",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Abnormal parathyroid gland development",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Altered regulation of PTH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      HYPOCALCEMIA WITH HIGH PTH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PTH resistance (impaired PTH action)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Vitamin D deficiency or resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Extravascular deposition",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Hyperphosphatemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Osteoblastic metastases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Acute pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Sepsis or severe illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DISORDERS OF MAGNESIUM METABOLISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DRUGS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Calcium chelators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Bisphosphonates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Cinacalcet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Foscarnet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Fluoride poisoning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SPURIOUS HYPOCALCEMIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/840\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/840|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/62/4077\" title=\"table 1\">",
"      Major causes hypocalcemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   CALCULATORS",
"  </h1>",
"  <div id=\"relatedCalculators\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?17/35/17969?source=related_link\" title=\"calculator 1\">",
"      Calculator: Calcium correction in hypoalbuminemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"calc calc_professional\" href=\"UTD.htm?14/51/15153?source=related_link\" title=\"calculator 2\">",
"      Calculator: Calcium correction in hypoalbuminemia (SI units)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/56/40842?source=related_link\">",
"      Bisphosphonates in the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32313?source=related_link\">",
"      Bone and calcium disorders in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/58/13220?source=related_link\">",
"      Causes and treatment of hypermagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/41/15000?source=related_link\">",
"      Causes of hypomagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/0/40969?source=related_link\">",
"      Causes of primary adrenal insufficiency (Addison's disease)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38184?source=related_link\">",
"      Causes of vitamin D deficiency and resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/50/36646?source=related_link\">",
"      Clinical manifestations of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6646?source=related_link\">",
"      Complications of therapeutic plasma exchange",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34005?source=related_link\">",
"      Diagnostic approach to hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/51/19258?source=related_link\">",
"      Disorders of the calcium-sensing receptor: Familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/24/35209?source=related_link\">",
"      Etiology of hypocalcemia in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/13/3287?source=related_link\">",
"      Hungry bone syndrome following parathyroidectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32681?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in adult predialysis patients with chronic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/36/38474?source=related_link\">",
"      Management of secondary hyperparathyroidism and mineral metabolism abnormalities in dialysis patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/25/38294?source=related_link\">",
"      Massive blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13527?source=related_link\">",
"      Overview of the causes and treatment of hyperphosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=related_link\">",
"      Pathogenesis of renal osteodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/18/6434?source=related_link\">",
"      Patient information: Hypoparathyroidism (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/31/26106?source=related_link\">",
"      Procedures used for blood donor screening: Protection of potential blood donors and recipients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23685?source=related_link\">",
"      Relation between total and ionized serum calcium concentration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/43/39610?source=related_link\">",
"      Risks of therapy with bone modifying agents in patients with advanced malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/37/42580?source=related_link\">",
"      Signs and symptoms of magnesium depletion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41064?source=related_link\">",
"      Surgical treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/9/32914?source=related_link\">",
"      Symptoms of hypermagnesemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44632?source=related_link\">",
"      Treatment of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/1/19481?source=related_link\">",
"      Tumor lysis syndrome: Definition, pathogenesis, clinical manifestations, etiology and risk factors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_25_24985="Diabetic autonomic neuropathy of the gastrointestinal tract";
var content_f24_25_24985=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diabetic autonomic neuropathy of the gastrointestinal tract",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Thomas Frieling, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Nicholas J Talley, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24985/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/25/24985/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/25/24985/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 31, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetic autonomic neuropathy may involve the cardiovascular, genitourinary, and the neuroendocrine system as well as the upper and lower gastrointestinal tract. Abnormalities of gastrointestinal function in diabetics are thought to be related, at least in part, to autonomic neuropathy of the enteric nervous system (ENS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/46/8938?source=see_link\">",
"     \"Diabetic autonomic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most studies assessing the prevalence of gastrointestinal symptoms in patients with diabetes mellitus have suggested that diabetics are more likely to experience gastrointestinal symptoms compared with controls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/1-11\">",
"     1-11",
"    </a>",
"    ] (although discordant data have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/12\">",
"     12",
"    </a>",
"    ]). Upper gastrointestinal symptoms appear to be particularly common in patients with long-term type 1 diabetes mellitus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/13\">",
"     13",
"    </a>",
"    ]. However, the types and frequency of gastrointestinal symptoms have been variable. The difference among studies may in part be related to the inclusion of patients with different levels of disease severity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    glycemic control. Furthermore, studies have not consistently used validated measures of gastrointestinal symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the largest studies to evaluate this association focused on 1101 subjects who were recruited from outpatient clinics and the community [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients underwent evaluation for gastrointestinal symptoms, diabetic complications, and glycemic control. Gastrointestinal symptoms were significantly associated with the presence of other diabetic complications, particularly autonomic and peripheral neuropathy. Patients with at least one diabetic complication were significantly more likely to report constipation (29 percent), gastroesophageal reflux (19 percent), dyspepsia (14 percent), frequent abdominal pain (11 percent), and fecal incontinence (9 percent) (odds ratios ranging from 1.62 to 2.39 compared with patients without diabetic complications). Poor glycemic control was an independent risk factor for upper gastrointestinal symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ESOPHAGEAL INVOLVEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, gastroesophageal reflux disease (GERD) may be more common in patients with diabetes compared with controls. GERD may be caused by autonomic neuropathy with decreased lower esophageal sphincter (LES) pressure, impaired clearance function of the tubular esophagus, or delayed gastric emptying.",
"   </p>",
"   <p>",
"    The effects of hyperglycemia on esophageal motility in diabetic patients have not been extensively evaluated [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. In healthy subjects, marked hyperglycemia (blood glucose approximately 15",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and physiological hyperglycemia (blood glucose approximately 8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    affect esophageal motility and the number of transient LES relaxations (TLESR) compared to euglycemia (blood glucose approximately 4",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. It is known that gastroesophageal reflux episodes are associated with TLESR in healthy subjects and in patients with GERD.",
"   </p>",
"   <p>",
"    Although other esophageal disorders have been reported in patients with diabetes, these are rarely clinically relevant. Some studies found reduced amplitude and decreased wave speed of the tubular esophageal contractions in diabetic patients with peripheral neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. However, the LES pressure and the LES relaxation of diabetics were not to be different from those of healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/17\">",
"     17",
"    </a>",
"    ]. Autonomic neuropathy does not appear to predict the presence of esophageal motor abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Dysphagia for liquids",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    solids is rarely seen in diabetes mellitus, even when disturbance of esophageal peristalsis can be found in esophageal manometry. As a result, dysphagia in diabetes mellitus is more suspicious of peptic stricture, esophageal cancer, rings (eg, Schatzki's ring) or webs than dysmotility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GASTROPARESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroparesis is defined as delayed gastric emptying. Its true prevalence is unknown; however, it is estimated that 20 to 40 percent of patients with diabetes, primarily those with long duration of type 1 diabetes mellitus with other complications develop gastroparesis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Severe gastroparesis can contribute to poor control of blood glucose concentrations and be associated with aspiration of gastric contents and a poor prognosis while the prognosis is much better with milder forms of gastroparesis.",
"   </p>",
"   <p>",
"    Patients with diabetic gastroparesis may be asymptomatic or develop symptoms that are not directly related to the gastroparesis, such as poor glycemic control, particularly in those who are treated with insulin. Several factors may contribute to erratic glucose control in the setting of gastroparesis, such as variability in food and carbohydrate absorption. In turn, a variable glycemic state may further worsen the gastroparesis. Gastroparesis may also impair absorption of oral hypoglycemic drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with diabetes mellitus may also have delayed gastric emptying that is not necessarily attributable to diabetes but due to functional dyspepsia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35272?source=see_link\">",
"     \"Functional dyspepsia\"",
"    </a>",
"    .) The magnitude of the delay is often modest in such patients and not well-correlated with symptoms, except possibly bloating [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. One possible explanation for the poor correlation between delayed gastric emptying and symptoms in diabetes mellitus may be involvement of the afferent sensory nerve fibers by autonomic neuropathy thereby decreasing perception of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/24\">",
"     24",
"    </a>",
"    ]. However, increased pain perception in patients with diabetes has also been described (see",
"    <a class=\"local\" href=\"#H5\">",
"     'Pathophysiology'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Careful evaluation of diabetics with other \"dyspeptic\" symptoms such as epigastric pain, nausea, vomiting, early satiety, postprandial fullness",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anorexia may reveal other causes of symptoms (eg, peptic ulcer or reflux disease), with only a minority having significant abnormalities of gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed gastric emptying of solids and liquids is detectable with similar frequency in patients with type 1 and 2 diabetes and functional dyspepsia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Among those with delayed gastric emptying, a variety of gastric myoelectric and motor abnormalities has been observed (",
"    <a class=\"graphic graphic_table graphicRef66160 \" href=\"UTD.htm?6/29/6619\">",
"     table 1",
"    </a>",
"    ). However, abnormalities of gastric emptying in diabetics are not strongly correlated with either disturbed gastroduodenal motility during manometry or clinical indices of autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/25,27-29\">",
"     25,27-29",
"    </a>",
"    ]. A more complete review of the changes in the gastric function that may be associated with diabetes is available elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14312?source=see_link\">",
"     \"Pathogenesis of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diabetic gastroparesis is thought to result from impaired neural control of gastric function. In animal models of diabetes and in patients with diabetic gastroparesis, abnormal myenteric neurotransmission, impairment of the inhibitory nitric oxide-containing nerves, damage of the pacemaker interstitial cells of Cajal, and underlying smooth muscle dysfunction have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Morphologic abnormalities found in older studies include inflammatory changes in some autonomic ganglia and dropout of vagal myelinated fibers [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood glucose levels may also have an important role in the control of gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/5,19,30-33\">",
"     5,19,30-33",
"    </a>",
"    ]. In diabetics with autonomic neuropathy, the induction of hyperglycemia stimulates gastric electric activity (so-called \"tachygastria\"), whereas the electric rhythm may be normal under normoglycemic conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/32,33\">",
"     32,33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In healthy controls and patients with type 1 diabetes, marked acute hyperglycemia relaxes the proximal stomach, suppresses the frequency, propagation, and contraction amplitude of antral pressure waves under fasting and postprandial conditions, and stimulates phasic pyloric pressure waves, all of which retard gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/27,30,34,35\">",
"     27,30,34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In type 1 diabetic patients, gastric emptying is slower during hyperglycemia compared with normoglycemia. In addition, changes in blood glucose level within the physiological postprandial range also slow gastric emptying. As an example, in one report, intragastric retention of a solid meal at 100 minutes in eight nondiabetic subjects was 55 percent at a blood glucose of 144",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    compared to 37 percent at a blood glucose of 72",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4",
"    <span class=\"nowrap\">",
"     mmol/L);",
"    </span>",
"    the comparable values in nine type 1 diabetes (without autonomic dysfunction) were 44 and 36 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/31\">",
"     31",
"    </a>",
"    ]. The difference between normal subjects and those with diabetes was not significant, suggesting that the slowing of gastric emptying during physiologic hyperglycemia was not mediated by changes in plasma insulin.",
"   </p>",
"   <p>",
"    In contrast to the effects of hyperglycemia, the induction of hypoglycemia leads to accelerated gastric emptying even in patients with delayed gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/36\">",
"     36",
"    </a>",
"    ]. The effect of acute hyperglycemia on gastric emptying in patients with type 2 diabetes has not been well studied, although both the emptying of liquids and the lag phase for solids appear to be related to the blood glucose concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/37\">",
"     37",
"    </a>",
"    ]. These findings suggest that gastrointestinal motor function is influenced by the glycemic state and varies over relatively brief intervals [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The rate of gastric emptying has a substantial impact on carbohydrate absorption and the release of gut peptides, such as the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The slowing of gastric emptying associated with elevation of the blood glucose concentration to postprandial levels is likely to constitute a physiological mechanism that regulates the release of nutrients into the small intestine. Thus, gastric emptying is a major determinant of postprandial glycemic excursions that influence initial glycemic and insulinemic responses to oral carbohydrates. This illustrates the close bidirectional interrelationship of gastric emptying with postprandial glycemia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute hyperglycemia also affects perceptions arising from the gastrointestinal tract. In the esophagus, the threshold for perception of balloon distension is reduced by elevation of blood glucose concentration within the physiological range and gastric perceptions, such as nausea and fullness, during proximal gastric distension, are increased both in the fasted state and during intraduodenal lipid infusion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. As a result, patients with type 1 diabetes mellitus may exhibit increased perception of gastric distension with exaggerated nausea, fullness, and epigastric pain for a given distending stimulus [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/19\">",
"     19",
"    </a>",
"    ]. Thus, increased sensitivity of the proximal stomach may be responsible for postprandial dyspeptic symptoms when stomach is distended by a meal [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These findings suggest a role for acute elevations in the plasma glucose concentration in gastric sensory and motor function [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/38\">",
"     38",
"    </a>",
"    ]. In contrast, the role of chronic hyperglycemia is less clear. In one study of 87 randomly selected diabetic patients, gastric emptying of a liquid meal was slower in those with blood glucose values above 270",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (15",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/26\">",
"     26",
"    </a>",
"    ]. Similarly, in the study described above, upper gastrointestinal symptoms were associated with poor long-term glycemic control [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/5\">",
"     5",
"    </a>",
"    ]. There are, however, no data showing that a chronic improvement in glycemic control enhances gastric emptying.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of gastroparesis is based upon the presence of compatible clinical features, delayed gastric emptying, and the absence of an obstructing structural lesion in the stomach or small intestine by endoscopy or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     barium",
"    </a>",
"    radiography [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/20,27\">",
"     20,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diabetic gastroparesis is usually suspected on clinical grounds by the combination of symptoms or findings or unexplained poor glycemic control despite strong therapeutic efforts. Clinical symptoms that suggest gastroparesis include early satiety, nausea, vomiting, bloating, and postprandial abdominal fullness. In contrast, dyspepsia refers to a symptom complex of chronic or recurrent upper abdominal pain or discomfort that may have associated symptoms of early satiety, nausea, and postprandial",
"    <span class=\"nowrap\">",
"     fullness/bloating.",
"    </span>",
"    There is an overlap of symptoms of gastroparesis and functional dyspepsia. Idiopathic gastroparesis may be one of the causes of functional dyspepsia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35272?source=see_link\">",
"     \"Functional dyspepsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of residual food in the stomach after an overnight fast during upper gastrointestinal endoscopy supports the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/27\">",
"     27",
"    </a>",
"    ]. The combination of these clinical and",
"    <span class=\"nowrap\">",
"     radiologic/endoscopic",
"    </span>",
"    findings may justify empiric treatment without further diagnostic evaluation.",
"   </p>",
"   <p>",
"    A consideration is that incretin-based therapies such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/22/13669?source=see_link\">",
"     pramlintide",
"    </a>",
"    and GLP1 analogues (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14375?source=see_link\">",
"     exenatide",
"    </a>",
"    ) retard gastric emptying. Thus, iatrogenic gastroparesis should be considered and medications for glycemic control modified before instituting treatment for gastroparesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of delayed gastric emptying\", section on 'Glycemic control in patients with diabetes mellitus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Methods to measure gastric emptying",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct noninvasive measurements of liquid and solid gastric emptying can be performed by means of stable isotope breath tests, scintigraphy, ultrasonography, and magnetic resonance imaging. The traditional \"gold standard\" to establish the diagnosis of gastroparesis is scintigraphic measurement of gastric emptying [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/19,20,39,40\">",
"     19,20,39,40",
"    </a>",
"    ]. Scans taken immediately after ingestion of a test meal that contains the radionuclide (99m) technetium and then taken two and four hours later are sufficient for most evaluations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=see_link\">",
"     \"Etiology and diagnosis of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild diabetic gastroparesis does not appear to increase mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/41\">",
"     41",
"    </a>",
"    ] or to be progressive [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/42\">",
"     42",
"    </a>",
"    ]. Thus, treatment should be directed toward alleviating symptoms related to gastric stasis bearing in mind that there is a poor correlation between delayed gastric emptying and symptoms. Similarly, if treatment is being considered in asymptomatic patients solely to improve metabolic control, one must be aware that no conclusive data exist showing that such therapy improves long term diabetic control or prevents complications [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/43\">",
"     43",
"    </a>",
"    ]. Primary treatment of gastroparesis includes dietary changes and administration of antiemetic and prokinetic agents.",
"   </p>",
"   <p>",
"    Treatment of delayed gastric emptying is discussed separately. The following general comments pertain to patients with diabetic gastroparesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=see_link\">",
"     \"Treatment of delayed gastric emptying\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The contribution of gastric emptying to glycemic control is clinically significant. As an example, in type 1 diabetic patients with gastroparesis, less insulin is required to maintain normoglycemia in the four hours after a meal than in those with normal gastric emptying [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/44\">",
"       44",
"      </a>",
"      ]. Similar, in patients with type 2 diabetes, high dietary fiber intake improves glycemic control most likely by slowing gastric emptying [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Management strategies for control of postprandial hyperglycemia involve slowing of gastric emptying by diet or oral hypoglycemic drugs in patients with type 2 diabetes who have impaired early, but intact late, postprandial insulin responses. Slowing of gastric emptying is likely to be an important mechanism by which exogenous administration of glucagon-like peptide-1 (GLP-1) and longer acting GLP-1 receptor agonists (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14375?source=see_link\">",
"       exenatide",
"      </a>",
"      ) and analogues (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?20/47/21238?source=see_link\">",
"       liraglutide",
"      </a>",
"      ) reduce postprandial glycemic levels in type 2 diabetic patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, in type 1 diabetic patients and in insulin treated type 2 diabetic patients, prokinetic drugs may allow more predictable entry of carbohydrate into the small intestine and thereby optimize the coordination between glucose absorption and the action of exogenous insulin [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/35,46\">",
"       35,46",
"      </a>",
"      ]. However, the effect of prokinetic drugs may depend upon the glycemic state. As example, in healthy subjects, hyperglycemia attenuates the stimulation of antral pressure waves and propagated antral wave sequences by",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/29/36304?source=see_link\">",
"       erythromycin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/47,48\">",
"       47,48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIABETIC ENTEROPATHY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diarrhea and rarely steatorrhea can occur in diabetics, particularly those with advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"     49",
"    </a>",
"    ]. The diarrhea is watery and painless, occurs at night, and may be associated with fecal incontinence. Bouts of diarrhea can be episodic with intermittent normal bowel habits or even alternating with periods of constipation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Epidemiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of diabetic diarrhea has been estimated to vary between 8 and 22 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/8,50\">",
"     8,50",
"    </a>",
"    ]. It is likely, however, that the true incidence is substantially lower. In a population-based study, for example, no differences in the prevalence of diarrhea were detected between non-insulin-dependent diabetics, insulin-dependent diabetics, and healthy controls [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/12\">",
"     12",
"    </a>",
"    ]. Another study of 200 diabetic patients attending an outpatient clinic found only two who complained of nocturnal diarrhea, both of whom had autonomic neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fecal incontinence due to anorectal impairment has also been thought to be relatively common. However, one report found that this problem was present in only 4 percent of 160 diabetic patients surveyed at an outpatient diabetes clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/51\">",
"     51",
"    </a>",
"    ]. Fecal incontinence was present in 9 percent of diabetics with other diabetes-related complications (but only 4 percent of those without complications) in the study described above [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link\">",
"     \"Fecal incontinence in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Pathophysiology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of diabetic enteropathy is unclear but multiple factors are probably involved. The putative mechanisms may be divided into causes resulting from autonomic neuropathy, other diseases associated with diabetes, incidental cases, and the acute effects of glycemic state on small intestinal and anorectal function (",
"    <a class=\"graphic graphic_table graphicRef69533 \" href=\"UTD.htm?11/34/11819\">",
"     table 2",
"    </a>",
"    ). Diabetic autonomic neuropathy may include vagal nerve dysfunction as well as sympathetic nerve damage [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The functional impairment of the enteric nervous system can result in disordered motility of the small bowel and the colon [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"       49",
"      </a>",
"      ]. The impairment in fasting and fed intestinal motor function can cause either delayed or accelerated small bowel transit [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/50\">",
"       50",
"      </a>",
"      ]. A detailed immunohistologic study of the small bowel from a single patient with insulin-dependent diabetes found a marked reduction in the number of Interstitial cells of Cajal in the jejunum as well as a decrease in inhibitory innervation and an increase in excitatory innervation [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Abnormal small bowel motility may be associated with small bowel bacterial overgrowth, resulting in bile acid deconjugation and fat malabsorption [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/55,56\">",
"       55,56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=see_link\">",
"       \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Both of these mechanisms can induce diarrhea by stimulation of small bowel (passive secretion due to osmotic gradient) and colonic (active transport mechanisms) fluid secretion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fecal incontinence can result from anorectal dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/51\">",
"       51",
"      </a>",
"      ]. Anorectal manometry often demonstrates decreased anorectal sensation during balloon distension, and reduced resting anal sphincter pressures with normal squeeze pressures. Proctoscopy often reveals internal prolapse of the rectal anterior wall during straining, which results in functional obstruction, incomplete evacuation, and fecal incontinence. Medications may also be a contributing factor; one study suggested that use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"       metformin",
"      </a>",
"      was an independent risk factor for chronic diarrhea and fecal incontinence [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Autonomic neuropathy of the enteric nervous system (ENS) can directly alter mucosal water transport and ion fluxes. In one study in diabetic rats, for example, impaired adrenergic regulation of mucosal transport of ions led to reduced absorption of water and electrolytes in the ileum and colon [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/58\">",
"       58",
"      </a>",
"      ]. This may reflect dysfunction of both the autonomic nervous system and the alpha-2-adrenoreceptors [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"       49",
"      </a>",
"      ]. Evidence supporting the role of alpha receptors comes from observations that the alpha-2-adrenergic agonist",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"       clonidine",
"      </a>",
"      can increased total gut capacitance and small intestinal transit times, thereby reducing rectal effluent volumes during experimentally-induced diarrhea and in diabetic patients [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/59,60\">",
"       59,60",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The development of exocrine pancreatic insufficiency (as a further cause for diarrhea) seems to be rare in patients with diabetes mellitus [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/61\">",
"       61",
"      </a>",
"      ]. However, there is an association of celiac sprue with juvenile or adult forms of insulin-dependent diabetes [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49,62\">",
"       49,62",
"      </a>",
"      ]. A genetic predisposition to both diseases with a high prevalence of HLA-B8 and -DR3 has been suggested [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/62,63\">",
"       62,63",
"      </a>",
"      ]. A prevalence of serologic markers for celiac disease (antiendomysial and antigliadin antibodies) of 3 to 4 percent in asymptomatic diabetic children and adolescents has been found in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/64\">",
"       64",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=see_link\">",
"       \"Diagnosis of celiac disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      It has been suggested that alterations in the endogenous bile salt pool and increased fecal secretions of hydroxy fatty acids may contribute to the pathogenesis of diabetic diarrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"       49",
"      </a>",
"      ]. However, therapeutic trials with the bile acid sequestrant",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"       cholestyramine",
"      </a>",
"      (up to 16",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      have been disappointing [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Artificial sweeteners such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/0/29699?source=see_link\">",
"       sorbitol",
"      </a>",
"      or polyols may have a role for diarrhea in diabetics. The ingestion of as little as 10 g of sorbitol can significantly alter bowel habits in diabetics [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/65\">",
"       65",
"      </a>",
"      ]. In addition, a higher prevalence of chronic diarrhea has been observed in diabetic patients consuming sorbitol than in those diabetics not using sorbitol [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/65\">",
"       65",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As noted above, changes in blood glucose concentrations can have profound effect on gastrointestinal sensory and motor function. As an example, there is evidence that physiological changes in blood glucose concentrations act synergistically with stimuli arising from the small intestine to slow gastric emptying, and decrease duodenal compliance while increasing the stimulation of duodenal waves by duodenal balloon distension. In healthy volunteers, marked hyperglycemia decreases the motility index and propagation of duodenal and jejunal waves, reduces the cycle length of interdigestive motor activity in the fasted state, and slows small intestinal transit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. In addition, both the gastrocolic and ascending components of the colonic peristaltic reflex may be inhibited, whereas rectal compliance has been reported to be increased and resting and maximal squeeze pressures in the anus to be either decreased or unchanged during marked hyperglycemia.",
"   </p>",
"   <p>",
"    In type 1 diabetic patients, acute hyperglycemia is associated with suppression of proximal duodenal pressure waves and reduction of rectal compliance and maximum anal squeeze pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast, the effects of hyperglycemia on colonic motor function have not yet been well studied.",
"   </p>",
"   <p>",
"    The effects of hyperglycemia on sensory function involve increased perceptions arising from duodenal balloon-distension or intraduodenal lipid infusion, suggesting a synergistic relationship between small intestinal stimuli and the glycemic state [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ]. In contrast, marked hyperglycemia does not appear to influence the perception of colonic distension. The effect of hyperglycemia on rectal perception has not been well studied but it appears that in but both healthy and type 1 diabetic patients, perception of rectal distension may either blunted or enhanced [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the multifactorial pathophysiology of diabetic enteropathy, the diagnostic evaluation must systematically evaluate the underlying mechanisms (",
"    <a class=\"graphic graphic_table graphicRef69533 \" href=\"UTD.htm?11/34/11819\">",
"     table 2",
"    </a>",
"    ). A combination of several factors (eg, disordered small bowel motility, bacterial overgrowth, and anorectal dysfunction) is present in many patients. The question is often which factor is more clinically relevant than the others. In one study of 33 diabetics with diarrhea at the Mayo Clinic, a systematic diagnostic approach was able to identify the predominant cause of diarrhea in 91 percent of the patients [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/66\">",
"     66",
"    </a>",
"    ]. The main causes were bacterial overgrowth, anorectal dysfunction, impaired intestinal motor and secretory function, and celiac disease [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/66\">",
"     66",
"    </a>",
"    ]. A practical approach to the diagnosis of diabetic patients with diarrhea is shown in Table 3 (",
"    <a class=\"graphic graphic_table graphicRef69401 \" href=\"UTD.htm?35/26/36267\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial therapy should focus on correction of water and electrolyte imbalances, tight control of blood glucose, and restoration of possible nutritional deficiencies. Intravenous hyperalimentation may be necessary in some patients because of frequent hypoglycemic episodes resulting from insulin administration to a patient with impaired enteral delivery or delayed absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Chronic treatment should be directed at the identified main cause of diabetic enteropathy rather than unspecific treatment on empirical grounds.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with bacterial overgrowth should be treated with antibiotics [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/66\">",
"       66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=see_link\">",
"       \"Treatment of small intestinal bacterial overgrowth\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For accelerated intestinal transit, a trial with antidiarrheal agents such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"       loperamide",
"      </a>",
"      (2 to 4 mg four times daily),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/0/35848?source=see_link\">",
"       codeine",
"      </a>",
"      (30 mg four times daily), or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/56/9094?source=see_link\">",
"       diphenoxylate",
"      </a>",
"      (5 mg four times daily) has been proposed [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"       49",
"      </a>",
"      ]. However, controlled clinical studies in patients with diabetic diarrhea are lacking.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/53/19289?source=see_link\">",
"       Clonidine",
"      </a>",
"      may have beneficial effects on both accelerated intestinal transit and increased small intestinal secretion [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/59\">",
"       59",
"      </a>",
"      ]. In one study, oral administration of clonidine (0.6 mg three times daily) significantly reduced the number and volume of stools in diabetic patients with chronic diarrhea refractory to other measures [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/60\">",
"       60",
"      </a>",
"      ]. Adverse effects of clonidine at this dose are often limiting. These include dry mouth, orthostatic hypotension, and delayed gastric emptying.",
"     </li>",
"     <li>",
"      The long-acting somatostatin analogue",
"      <a class=\"drug drug_general\" href=\"UTD.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      has been tested against diabetic diarrhea based upon its apparent benefit in patients with scleroderma who have small intestinal dysmotility and bacterial overgrowth [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/67\">",
"       67",
"      </a>",
"      ]. In one report of five such patients, octreotide (50 to 100 &micro;g every evening) increased the mean gut motor migrating complex frequency (a reflection of fasting intestinal motor function) and significantly reduced breath hydrogen excretion (indicating reduced bacterial overgrowth). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/9/11415?source=see_link\">",
"       \"Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Thus far, only a small number of patients with diabetes-associated diarrhea have been reported to respond favorably to long-term treatment (up to one year) with octreotide (50 to 75 &micro;g subcutaneously twice daily to three times daily) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/49,68-70\">",
"       49,68-70",
"      </a>",
"      ]. However, octreotide treatment may be complicated by recurrent episodes of hypoglycemia that may be related to reduced secretion of counterregulatory hormones [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/69\">",
"       69",
"      </a>",
"      ]. Furthermore, octreotide may inhibit exocrine pancreatic secretion and can therefore aggravate steatorrhea. For these reasons, octreotide treatment must be closely monitored, and should be restricted to severe cases refractory to conventional measures.",
"     </li>",
"     <li>",
"      Treatment of fecal incontinence in diabetics with chronic diarrhea involves two major approaches: pharmacological intervention to reduce stool volume and enhance stool consistency (",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"       loperamide",
"      </a>",
"      is recommended, since it also increases the anal sphincter resting pressure) and biofeedback techniques and toilet training [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/71\">",
"       71",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The goals of biofeedback training are to lower the threshold of conscious rectal sensation as far as possible (by training with a rectal balloon distended by progressively smaller volumes of air) and to increase the contraction force of the external anal sphincter (by training with a surface electromyography electrode which registers the anal squeeze contraction force). The goal of toilet training is controlled emptying of the rectal ampulla by using agents such as CO2-suppositories that stimulate peristalsis. Patients should learn the mechanisms of internal prolapse and avoid straining. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=see_link\">",
"       \"Fecal incontinence in adults\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Biofeedback training is performed on an ambulatory basis with the patient doing home exercises two to three times daily, each lasting 20 to 30 minutes. In our experience with this technique, improvement in incontinence can be expected after three to six months of training. In one study, biofeedback conditioning significantly lowered the thresholds of rectal distension in six of seven diabetics with fecal incontinence due to abnormal rectal perception; five of these patients became continent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/72\">",
"       72",
"      </a>",
"      ]. In another study of nine diabetic patients with fecal incontinence, eight became continent due to improved striated muscle responsiveness after biofeedback training [",
"      <a class=\"abstract\" href=\"UTD.htm?24/25/24985/abstract/51\">",
"       51",
"      </a>",
"      ]. All maintained improvement of sensory and motor parameters and remained continent for 18 months after the end of biofeedback conditioning.",
"      <br/>",
"      <br/>",
"      This risk-free treatment should be offered to all diabetics with fecal incontinence who demonstrate abnormal sensory and motor function by appropriate anorectal manometry studies. Operative measures (anal repair, permanent sigmoid stoma) should be restricted to refractory cases.",
"     </li>",
"     <li>",
"      Patients with concurrent celiac disease or exocrine pancreatic insufficiency should be treated with a gluten-free diet or pancreatic enzyme supplementation, respectively. (See appropriate topic reviews.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?7/60/8130?source=see_link\">",
"       \"Patient information: Gastroparesis (delayed gastric emptying) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diabetic autonomic neuropathy secondary to chronic hyperglycemia as well as acute hyperglycemia affect the cardiovascular, genitourinary, and the neuroendocrine system as well as sensory and motor function of the upper and lower gastrointestinal tract.",
"     </li>",
"     <li>",
"      Gastroesophageal reflux disease may be more common in patients with diabetes compared with controls. Other esophageal disorders are rarely clinically relevant.",
"     </li>",
"     <li>",
"      More than 50 percent of patients with long-standing type 1 or 2 diabetes mellitus have delayed gastric emptying. However, the magnitude of the delay is often modest and not well-correlated with symptoms except possibly bloating. Treatment should be directed toward alleviating symptoms related to gastric stasis (such as dyspepsia) bearing in mind that there is a poor correlation between delayed gastric emptying and dyspepsia. Similarly, if treatment is being considered in asymptomatic patients solely to improve metabolic control, one must be aware that no conclusive data exist showing that such therapy improves long term diabetic control or prevents complications. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=see_link\">",
"       \"Treatment of delayed gastric emptying\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diarrhea and rarely steatorrhea can occur in diabetics, particularly those with advanced disease. The diarrhea is watery and painless, occurs at night, and may be associated with fecal incontinence. Bouts of diarrhea can be episodic with intermittent normal bowel habits or even alternating with periods of constipation. A practical approach to the diagnosis of diabetic patients with diarrhea is shown in the following table (",
"      <a class=\"graphic graphic_table graphicRef69401 \" href=\"UTD.htm?35/26/36267\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/1\">",
"      Sp&aring;ng&eacute;us A, El-Salhy M, Suhr O, et al. Prevalence of gastrointestinal symptoms in young and middle-aged diabetic patients. Scand J Gastroenterol 1999; 34:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/2\">",
"      Ricci JA, Siddique R, Stewart WF, et al. Upper gastrointestinal symptoms in a U.S. national sample of adults with diabetes. Scand J Gastroenterol 2000; 35:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/3\">",
"      Ko GT, Chan WB, Chan JC, et al. Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus. Diabet Med 1999; 16:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/4\">",
"      Locke GR 3rd. Epidemiology of gastrointestinal complications of diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/5\">",
"      Bytzer P, Talley NJ, Hammer J, et al. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002; 97:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/6\">",
"      Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161:1989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/7\">",
"      Lluch I, Ascaso JF, Mora F, et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 94:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/8\">",
"      Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Ann Intern Med 1983; 98:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/9\">",
"      Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84:868.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/10\">",
"      Maser RE, Pfeifer MA, Dorman JS, et al. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990; 150:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/11\">",
"      Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes--the role of autonomic neuropathy. Postgrad Med J 1991; 67:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/12\">",
"      Janatuinen E, Pikkarainen P, Laakso M, Py&ouml;r&auml;l&auml; K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/13\">",
"      Schvarcz E, Palm&eacute;r M, Ingberg CM, et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabet Med 1996; 13:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/14\">",
"      Quan C, Talley NJ, Cross S, et al. Development and validation of the Diabetes Bowel Symptom Questionnaire. Aliment Pharmacol Ther 2003; 17:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/15\">",
"      Rayner CK, Samsom M, Jones KL, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/16\">",
"      Stewart IM, Hosking DJ, Preston BJ, Atkinson M. Oesophageal motor changes in diabetes mellitus. Thorax 1976; 31:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/17\">",
"      Hollis JB, Castell DO, Braddom RL. Esophageal function in diabetes mellitus and its relation to peripheral neuropathy. Gastroenterology 1977; 73:1098.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/18\">",
"      Annese V, Bassotti G, Caruso N, et al. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999; 29:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/19\">",
"      Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/20\">",
"      Parkman HP, Hasler WL, Fisher RS, American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127:1589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/21\">",
"      Groop LC, Luzi L, DeFronzo RA, Melander A. Hyperglycaemia and absorption of sulphonylurea drugs. Lancet 1989; 2:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/22\">",
"      Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24:1264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/23\">",
"      KASSANDER P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/24\">",
"      Rathmann W, Enck P, Frieling T, Gries FA. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care 1991; 14:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/25\">",
"      Horowitz M, Edelbroek M, Fraser R, et al. Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991; 26:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/26\">",
"      Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/27\">",
"      Mearin F, Malagelada JR. Gastroparesis and dyspepsia in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/28\">",
"      Buysschaert M, Moulart M, Urbain JL, et al. Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1987; 10:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/29\">",
"      Wegener M, B&ouml;rsch G, Schaffstein J, et al. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 1990; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/30\">",
"      Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/31\">",
"      Schvarcz E, Palm&eacute;r M, Aman J, et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/32\">",
"      Jebbink HJ, Bruijs PP, Bravenboer B, et al. Gastric myoelectrical activity in patients with type I diabetes mellitus and autonomic neuropathy. Dig Dis Sci 1994; 39:2376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/33\">",
"      Jebbink RJ, Samsom M, Bruijs PP, et al. Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus. Gastroenterology 1994; 107:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/34\">",
"      Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991; 32:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/35\">",
"      Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited? J Clin Invest 2006; 116:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/36\">",
"      Russo A, Stevens JE, Chen R, et al. Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes. J Clin Endocrinol Metab 2005; 90:4489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/37\">",
"      Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/38\">",
"      Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/39\">",
"      Akkermans LM, van Isselt JW. Gastric motility and emptying studies with radionuclides in research and clinical settings. Dig Dis Sci 1994; 39:95S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/40\">",
"      Gregersen H, Frieling T. Function and dyspepsia: a start of a new friendship. Neurogastroenterol Motil 2004; 16:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/41\">",
"      Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/42\">",
"      Jones KL, Russo A, Berry MK, et al. A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus. Am J Med 2002; 113:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/43\">",
"      Stacher G, Schernthaner G, Francesconi M, et al. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin-dependent diabetes: a double blind cross-over trial. J Clin Endocrinol Metab 1999; 84:2357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/44\">",
"      Ishii M, Nakamura T, Kasai F, et al. Altered postprandial insulin requirement in IDDM patients with gastroparesis. Diabetes Care 1994; 17:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/45\">",
"      Chandalia M, Garg A, Lutjohann D, et al. Beneficial effects of high dietary fiber intake in patients with type 2 diabetes mellitus. N Engl J Med 2000; 342:1392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/46\">",
"      Horowitz M, Jones KL, Rayner CK, Read NW. 'Gastric' hypoglycaemia--an important concept in diabetes management. Neurogastroenterol Motil 2006; 18:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/47\">",
"      Rayner CK, Su YC, Doran SM, et al. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia. Am J Gastroenterol 2000; 95:2233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/48\">",
"      Jones KL, Berry M, Kong MF, et al. Hyperglycemia attenuates the gastrokinetic effect of erythromycin and affects the perception of postprandial hunger in normal subjects. Diabetes Care 1999; 22:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/49\">",
"      von der Ohe MR. Diarrhoea in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/50\">",
"      Dandona P, Fonseca V, Mier A, Beckett AG. Diarrhea and metformin in a diabetic clinic. Diabetes Care 1983; 6:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/51\">",
"      Wald A. Incontinence and anorectal dysfunction in patients with diabetes mellitus. Eur J Gastroenterol Hepatol 1995; 7:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/52\">",
"      Duchen LW, Anjorin A, Watkins PJ, Mackay JD. Pathology of autonomic neuropathy in diabetes mellitus. Ann Intern Med 1980; 92:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/53\">",
"      Low PA, Walsh JC, Huang CY, McLeod JG. The sympathetic nervous system in alcoholic neuropathy. A clinical and pathological study. Brain 1975; 98:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/54\">",
"      He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/55\">",
"      Scarpello JH, Hague RV, Cullen DR, Sladen GE. The 14C-glycocholate test in diabetic diarrhoea. Br Med J 1976; 2:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/56\">",
"      Green PA, Berge KG, Sprague RG. Control of diabetic diarrhea with antibiotic therapy. Diabetes 1968; 17:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/57\">",
"      Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther 2001; 15:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/58\">",
"      Chang EB, Bergenstal RM, Field M. Diarrhea in streptozocin-treated rats. Loss of adrenergic regulation of intestinal fluid and electrolyte transport. J Clin Invest 1985; 75:1666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/59\">",
"      Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Studies of the antidiarrheal action of clonidine. Effects on motility and intestinal absorption. Gastroenterology 1985; 89:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/60\">",
"      Fedorak RN, Field M, Chang EB. Treatment of diabetic diarrhea with clonidine. Ann Intern Med 1985; 102:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/61\">",
"      el Newihi H, Dooley CP, Saad C, et al. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci 1988; 33:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/62\">",
"      Shanahan F, McKenna R, McCarthy CF, Drury MI. Coeliac disease and diabetes mellitus: a study of 24 patients with HLA typing. Q J Med 1982; 51:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/63\">",
"      Cudworth AG, Woodrow JC. Genetic susceptibility in diabetes mellitus: analysis of the HLA association. Br Med J 1976; 2:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/64\">",
"      Rossi TM, Albini CH, Kumar V. Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus. J Pediatr 1993; 123:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/65\">",
"      Badiga MS, Jain NK, Casanova C, Pitchumoni CS. Diarrhea in diabetics: the role of sorbitol. J Am Coll Nutr 1990; 9:578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/66\">",
"      Valdovinos MA, Camilleri M, Zimmerman BR. Chronic diarrhea in diabetes mellitus: mechanisms and an approach to diagnosis and treatment. Mayo Clin Proc 1993; 68:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/67\">",
"      Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/68\">",
"      Dudl RJ, Anderson DS, Forsythe AB, et al. Treatment of diabetic diarrhea and orthostatic hypotension with somatostatin analogue SMS 201-995. Am J Med 1987; 83:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/69\">",
"      Mourad FH, Gorard D, Thillainayagam AV, et al. Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut 1992; 33:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/70\">",
"      Walker JJ, Kaplan DS. Efficacy of the somatostatin analog octreotide in the treatment of two patients with refractory diabetic diarrhea. Am J Gastroenterol 1993; 88:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/71\">",
"      Frieling T. [Diagnostic in anorectal disorders]. Praxis (Bern 1994) 2007; 96:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/25/24985/abstract/72\">",
"      Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med 1984; 310:1282.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2643 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-5AC2A9890B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24985=[""].join("\n");
var outline_f24_25_24985=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ESOPHAGEAL INVOLVEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GASTROPARESIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Methods to measure gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIABETIC ENTEROPATHY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Epidemiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Pathophysiology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2643\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2643|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/29/6619\" title=\"table 1\">",
"      Del gastric emptying diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/34/11819\" title=\"table 2\">",
"      Intestinal dysmotility diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/26/36267\" title=\"table 3\">",
"      Diagnosis diabetic diarrhea",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=related_link\">",
"      Clinical manifestations and diagnosis of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/46/8938?source=related_link\">",
"      Diabetic autonomic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/2/14377?source=related_link\">",
"      Diagnosis of celiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/12/43209?source=related_link\">",
"      Etiology and diagnosis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/59/22458?source=related_link\">",
"      Fecal incontinence in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/28/35272?source=related_link\">",
"      Functional dyspepsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/62/14312?source=related_link\">",
"      Pathogenesis of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?7/60/8130?source=related_link\">",
"      Patient information: Gastroparesis (delayed gastric emptying) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/50/33576?source=related_link\">",
"      Treatment of delayed gastric emptying",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/9/11415?source=related_link\">",
"      Treatment of gastrointestinal disease in systemic sclerosis (scleroderma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=related_link\">",
"      Treatment of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_25_24986="Through and through retention sutures";
var content_f24_25_24986=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F70261%7ESURG%2F58213%7ESURG%2F68915%7ESURG%2F67727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F70261%7ESURG%2F58213%7ESURG%2F68915%7ESURG%2F67727&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Through and through retention sutures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 376px; height: 330px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFKAXgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKqatcXFpptzcWdq15cRIXS3Vtpkx/CCe/p71yek+MpHgLXQguVFxG3nxExj7JMxWKXa3dW/duucgqx9qAO3ooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiisrS9ai1HWNZsIYnU6ZLHDJI3R3aMSYH0DL+dAGrRRRQAUUUUAFFFFAHO+Op2XRorSKRo5b+7gs1ZSQQHkG/BH+wHroq808WauB8VtBspZ5Ps8Bifyf4PMk81A3ueYx7bvevS6AIL66hsbK4u7p9lvbxtLI+CdqqMk8ewpbO5ivbOC6tm3wTxrLG2CNysMg4Psa4n4oeLtAsPBfiO2n13S4b1tPuI44Hu4xIzmNgAFJyTk9Kj0D4meBIdLsLIeLtE8yGCOL5rpV5Cgdz7UAdjr11LZ6TcS20lvHdbdkBuDiMyscIrH3YgfjXm1t9n1DxPYm3sJHsb8PJNbEElFd9twjenl3EcTHHeR67y5m0nxboV9Z2Go2d5BcRNEZLaZZApI4OVPUcGuA8PXwGpaNfsuJ5Z7eeUrwp+1xPFIAPQzQB/xzQI9bopNw3bcjOM4paBhRRRQAVm+I9Ti0bQb/UJpY4lt4mcPJnaGx8oOATycDgE+1aVcRc3dx4l8eLplqsEnh/RsSai7xh/NvOGiiUnoY+HY9iUHrQB1OhJfRaLYJq0yT6isCC5lRdqvJtG4gYGBnPar1FRG4h+1C286P7QU8wRbhu25xux1xkgZoAlooooAKKZNuETmPG/adufXtWb4VuL668OabNrHk/2k0CG58ggx+ZtG7aQSCM+hNAGrRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcp4SDQ+J/FcMmntbyNcW9w9wHZkuGaBASueAF2bcD0z3rq647Vr1tH+JekPO7ix1q0exXJO1bmImRB6AsjS/XaKAOxooooAKKKKACiiigDxL4i63ZnWoJU0trzU9QlfSNPiWURSwX8Uhw7N2jKlHzzjavHIrQn8MnyUl8f+Ir7xDqk8ohOl2tybaxSdkZ0iMaYODjaGkJzkcc1V8beGl8V/FiIeGp7jTNf0GKO/l1E4kthJICqRvCcbmZE5YEYUKOeMbsHw81nUr+S88WeLbqcyBRJb6PANOSQLnaJHUmRwMnHzDFMRyV34g8MeFkgmtvDnhzR7O6tzPA01tHG7sbfemc4ORKskbcZB25xmib4paNOXkePRJ9NLgK7WjN+6JYg4x2VkB90b1Fd5q/gjw1ofhbX59L0azhu2sZ910U8ydj5bcmRssT9TWt8Myr/DfwqQAFOlWvGP8ApktIDyG3n8FeIJba4tdE0b7WIFnurnRJDBcwFbcyTMjREHIkaJFB6sxHOKreMtZh+EviLTW8U6lqOuaPexrcWKybVu7d7beY4pMACRC033uCCBnIFeseNvDGg6wVtvs2n2/iOaN3sLooY5ldMHKyJhhgkHg5HXBxXjEXgSLWPF02u+Kbu/8AEl7YIZotM1JVYNbRnZNCNm0GaN+em1wyEj58hgdH8Hda8XeJLs+Jbvw1cC61SYLNfX04ggtrMNlIraPBdxj5i2F3MeScV7xVfTrm2vNPtrmwdHtJo1khZPulCMgj2xirFIYUUVleKNdtPDeh3Op3+9ooQAscYzJM5OFjQd2ZiAB6mgDI8f8AiC4063ttI0NkfxLqxaGxRhuEWB887j+4gOT6nA71qeEtAtfDOhW+m2bPJsy8s8hzJcSscvK57szZJNYvgvRru3mvvE/ioQx67fJh1D5Swtl5SBW6ccszdCxJ6AVQfV9U8ehofClxJpvhzeUm1sDEtyB95bRSOB2848ddoPUAGxrPixF1iXw/oEYvvEIhMhUqxt7XI+U3Dr9wHsoyx9Mc1c8N6EdOBvdSeC88QXESpeX6QiMyhc4UDnagzwM+5ySTVnw5oGm+HNP+xaParbwljI5yWeVz1d2PLMe7Ek1qUAFFFFAHOfEbVTovgXXL+ONJZY7VxFG4JEkjDaiHBB5ZgOCOta2i2aafo9jZwwR28dvAkSwx/djCqBtHsMYrmPiG6ahe+HfDgUyNqN8lxMnYW9uRK5b23CNfq1dpQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXM/EbRZtb8LXCWHGqWbpfWDf3biI70/AkbT7Ma6aigDG8Ha/beKPDOn6zZgrHdRBmjb70Tjh0b3VgVPuK2a880x4/B3xJudIZTHpXiZnvrNv4I7xV/fRe29QJB7h69DoAKKKKACqGpaiLK602DyjI97ceQuDjbiN3LH8E/Wr9c/4tcQPot1lf3GoRlgTztcGIkfQyjNAHP+C9w+K3xF3KwBbTypI4I+znp+NegVzBn2eNbK8t2M1lqFrJZs6AlUmhcsoJ7ZBlH1XHeunoAx/GbbPB+usRnFhOcev7tqp/DSMxfDrwsjZyul2oOf+uS0/wCI0vkfD7xPLnGzS7pv/ITVDok/9m/DfS5BKsHk6ZABMyF1jPlqA7DOSo6nnoDQBl37HUNQaxW7jmN039paFfsQ6JKg+aLI7Dk+6O4/hNRWNrc6x4l0vWbKI20JZprlG5aC4QGGaJsf3gV/GEHuKy7SWaZJbZLWK0uri4M9vFn5LbU4xvKg/wDPOZfnUjqGfPLYo+HGuqfGOtQIk32DW7p7u2BXIgnjhh8+NvQ5YHHqr0CPQfD+lnSLSa1Eoe3NxJLAoXb5SO27Z9ASce2B2rToprusaM8jBUUEszHAA9TQMg1O/tdL0+5vtRnjt7O3jMss0hwqKBkk1wXh2GTxXqMfjTxLE9npNqpk0ewujtEKYObuUHgSMv3QfuL7k1BY7vidrkOos5HgjTJ91rFtx/alwh/1rZ6wofuj+Jhk8AVY13zfHniqXw9CwHhjSZEfV5Aci8n+8toP9kfK0nrkL3NAiG3W6+KMiXMxltPAqPmK3KlZNYwfvv3W39F6v1PGAfSYo0hiSKFFjjRQqoowFA6ADsKVFVEVUUKqjAAGABS0DCiiigApk0scELyzOscUalndjgKByST6U+vP/F858W+JY/BlqpfTYQl1rsw+6Is5jts/3pCMsOyA/wB4UAWfh+v9u3+oeM5kcLqSrBpyyDmOyQ/KwHbzGzJ9CnpXb01EWNFSNQqKMKqjAA9BTqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAON+LWiy6x4KupLAY1XTGXU7BgMkTwneo/4FgqfZjW14P1628UeF9L1uxI8i+t1mAznaSOVPuDkH6VsV5j8GYW0HUvGXhFuIdK1M3Nop/htrkeYgHsG8wUAenUUUUAFebfE24vzr+nW9vaQNbR2k87XRlYPEDiM4UKQwDPEx5GNpPavSarXtha3ob7XBHLmJ4TuH8D43L9DgZ+lAHD+EvF2mab4Xu7nWLlLOOK7kZUc5d/NYyBEUfMzbmdNoBOUI7VYi1zxVrqmXTNLtvD+nMPlutay1ww/vC3UjaP99wfVa8/0Ow0nwf8RtbttWmh/tlcy6Nd6ncqY7WzeMkyKHIyfOVw+Pm5z0JNVNc8T654n1Cw/sTTpr4akXsIbmb9zahJYlE/lAgSSxo0fmCUBcZxk5AoEdXquk2+p2l1a+JviFq19DNHJHJaWCQ2ySKBKHTCIWP+qlGC38JqpH4f8OQ2AW28beNLaCKCVwBqMjBEijR2G1lIwEdCBjkdM1g3XhDWNS8O+LtTu/EbJLpa3KQSadZRwCeaNPMkYlt7AedvHykchiMZrovCfwyttW8DaNLP4n8U7LzToWkRb1Qm14lyoGz7uMDHoAO1FguzLl8Ha/osNzbeFvGFtqs6KltFY6zAI3DQATIUmTHzIHXBKkYIBIA45vSvGN7pOs6kupWiab4uluZDp+kXY2f6TeMoaUv914IxFneDzls4OK6vxV8PtX8PWU2o6b4mn1GEuTcQ6xAsi7HkV5C0sYVlViiBm2sQo7AcU/BPhzRPih4jvvEXxA0dP+Ejt5fLi015WaGC3jO1eAcSZfeTkfxDgAjIgO3+H2qeHNEtbPw5Z+IRrusTSPLdXEJa4aWdjud3KZWMZ6AkAAAVU8STXHxC8SXHhXT3KeF7BlGt3kZ/4+X6/YkI9sGQg8A7eM1b8damdGg07wf4MghtNc1cmOAW0QVLGAf6y5ZQMAKOF9WIHrXVeEvD1h4W0C00jSkK20C8sxy8jHlnc92Y5JPqaAMnx9q7+HPDMFnoSRR6rfSJpulwhQFWVuA2P7qKC59lrT8G+HbXwr4ctNJsmaRYQTJNJ9+eVjl5HPdmYkn61zVvEfEPxhubqQhrHwxaC3hXqDd3A3SN9ViCD/toa9AoGFFFFABRRVbUb620ywuL2/njt7S3jMssshwqKBkkmgDA8feI5tB063t9Lijutf1KX7Lptq7YDyEZLt3CIuWY+gx1Iqx4G8Nr4Y0FbSS5a8vppGub28cYa5nc5dz6egHYADtXN/Dqxn8Q6tP491mCSGe9i8jSrWUc2tlnIbHZ5eHb22jsa9EoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvNZJBpv7QsS/cj1jw+QRn78sE2R+ISQ16VXmfj/bb/GD4ZXRBy76ha5H+1ACP1WgD0yiiigAqC+uobGyuLu5bZBBG0kjdcKBk1PWT4msH1LTBbCRI4fPikn3E/NEkisy8eoXH40AeaeGvBlh421vWNV8c6f8AabyO7ieKwnclbYbFdMqDj7pVcHOcMcYauzlUnxfqt7BEZX0nS1gtoFX+OQs7BR6kRxDipvhtGW8KW+oSri51V31GY+rSncv5JsUeyitbxDejR9C1TVI4VeS2tpJ9vTeUQkAn8MUCOXawk0n4L3dtOrrcpo00lwG+8ZmiZ5CfcuzGtn4dLs+H/hhfTS7Udc/8slqx4oUXPg3V1mAUS2EwYZ6ZjOeayfhrfxx/C7wjcXsqp5mm2cYZuAWaNFUfiSB+NAzX8Sai1pa+RaJDPqMyM8NpLx9pVMF0U9NxUnGfqeAa4/Rdc8PeDPC2p6zqM0dtpMThre6dfnmiZFKRDuzrjy9vX92M9Ko+LvFK21rdXetCSyjibNqsib3tdSi5WJdo+cSowK46gsOM4HB2eh/8J3pvjC8120/4nA0+5udI0VJTImnmUSB/lIH+kGQHdkfKWGMdgRo+E/Fuv2uoap8Rta8KOfD2quiJffaQbiz05f8AVt5IB+TJLuc5O7OMAV6Va/FXwTd3s1pa+IbOWaJHkyCQkgQFmCORtcgDkKTXn/jH4g2Fz8Jjovhu31D7VcWkGlyyPYyxQ6d5m2E+a7qAMbiMDP5c1V+O1hpelfCeLwLommpf3On2aXjgYBsraE5e4ZuzPhlA6sWbrg0AejfBSCU+BLfVrvd9t12aTVrjcMYMzblH0CbFH0ru6q6SYTpVmbRQtv5KeUo7LtGB+VWqBhRRRQAV5p4hEvxA8Ynw5EufCmkSJJq8v8N5cDDJag91X5Wf8F9a3fiP4iudG0uCx0UJJ4k1aQ2mmRMMgSEZaVv9iNcuT7Ad60fBXhu28KeHLXSrWSSYpukmuJDl55mJaSRj6sxJ/SgDcACgAAADgAUtFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5j8UyB8Q/hec/N/ak4/D7O1enV5d8RGE/xl+F1pkZSTULkjGfuwAD9TQB6jRRRQAUy4iE0EkTfddSp/EYp9FAHDfCTWhfeG7bSnhaO40q1gt5Cx+8VDRk47YaJx+FSfE3xNoWneH9T0nUdVtoNRvbOWKC1BLzOzIQMRqCx5PpXnesaVfL8Udfs/D+rSaZaRxLc3ksEgSeZrjLrZRbgQGZ43kDj5l8xgAc1XtNQtNL0a8uPDVhb6fBc4ke93M1y6zW6PBJJO5LYMyyRMxOAeDjmgR1uqeNdQ17wtdabpHhbWGvLuxaEPdmG0VJHXZyssgcgMwH3fT1rnr8+KtK8FaVbaj4OnttP0nT0tb6aLWICGt0jAdghIG4bQ6tnII9Cc8TqnjPRVv8AVtTsdRadTI19FLBA8wTFzFcqH2ghThpEOejRc1p6h8TNN8ZRaNa61dal/wAIPY28b6xfx6dOYtQul2/umYJ8sQPzNnGcgdKAMe38Wy+IPEum+J/F9pfaVCLZDozXUMkVrJdRgNHcySf6vdJ86YPCgjk9a9J8A67b6n8Sbi60qGKz0zUme/WZ1Ae6V4kjVBnkZkgmfA6hN1d74d8UeEPG+mSWujahpmqWjR7JLQYPyY6NEwyBj1FeKfEDU9P+C/jO1i0pZrq1u9PuZtL0wgyCxvG2orKfvGNhuG052/MFxnFAWPobWNNsNe0m80zUoY7uxuEMM8LHIIPUHHQ/qK888aeFNH8MfDbVdF0C3MNxr0seneZLK0sszzMI/mdyWO1SxAzgAGnfCa71G20vTtNs/DerCybdPf6vqzLbSTzvlnkWEku25j3C4GPStPUUbxJ8VbG0IJ03w1D9tl9HvJgViX/gEe9v+BrQB3NrAltbRQQjEUSBFHoAMCpKKKBhRRXJ/FLWLjRfA+oy6c+3VLkLZWOOpuJiI48fQtn8DQBj+CxF4p8d654sJ82zsidG0snphDm4kX/ek+XPpH716JWR4Q0G28MeGdN0WxH7iyhWIHu5/iY+5OSfc1r0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV5T4lLSftG+DExlYtIvZPpkgf4V6tXlXiUeX+0b4NdshZdIvI19yCCf0oA9VooooAKKKiup47W1muJjiKJGkc+gAyaAPGvGySaT481u2ttGk1+48Spay2sVrcLHJZXNuuFeQ53RoMowkHQ5GORnZ8JfCi0C/b/HIttZ1WR3k+zKpFja723MkUJ4I3ZJZgSSc4FR/DMNY23iTxv4qi+wyXYWd55wQUtxGJMAnnaoYJjv5dcvr/wAR9XurWHX9Ru9Q8M+Fb2Gf+y1t44Tc3LRqHVpDIrYMvKogHqSelAjU/aE8RnSvCF74Q8MWMb313ZM9wsShI7OzLBC5xgZYnYo9ST259J0jwlo+m+DI/DEFjEukC2Ns8GMh1YYYt6k5JJ9TXgNs2t6f4W8dad45iV/FepQ2OpfawRmSCSWONYzgAAROCCoGPmOOua+nqAPl+HwJb25ns7i0eLVLJJrayuYCYZkaN3lgMbjBG8RXK5H95favQvhla6db66LjVjdavrV5JJDbavflZHEUarLBGvA2kwyhyQOWD5PArqvHGnXC341i3gEkdpZPLJyAd8MscsXv0Eo/4EfWuPlhXRNQmVgFtbS48+2Kk4UW7CUAfW2uHT6RUwPVtc1O30XRr7VL5itrZwPcSkDJ2qpJwPXiue+Fum3ll4WF7q4I1fV5n1K8B6o8nKx/8AQIn/Aaq/E2cXsvh7wui721u+Xzx2+yw/vZs+x2qn/A67mkMKKKKACvOvF6nWPi34M0hvmttPhudamTsXULFCT9GkYj6V6LXCeH4xefF/xbekZ+xWNjp6N6E+ZMwH/faUAd3RRRQAUEgDJoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACvMfifGbH4kfDPWU/h1CfTX46ieE4/VK9OrhPjVp8914DnvrFGe90a4h1eBVHLGBw7Ae5UMPxoA7uiqmkaja6vpdpqOnyrNZ3cSzwyDoyMMg/kat0AFYmsancR61pelaeIzcXDGednGRHboRuOPViyqPqT2xW3XlHjfxVLo7+KrvTkEuuSzW2gaVEOr3DxiQY+hnLH2SgCr4gJ+J3xAk0JJP+KN8NyrLqpXOL67HzLb+6JjLe/HoaoeLoTq+pTyX0kEmiziG/tb+MBYo4oW8yK5VyDHui3OrxtjehUjuK39O0Gw8D+CdM8HW73Nxf3xJuLizuI0ujM3zNchXYFgHA6ZwAMggGuG8PeHR8SfF93ZicHwPot2Dem3UxQ6zfryx8sEqqDjIXhjz1bIBEHiRtQ8V6NN4vuWP2Ew22jWdw1ubdtQWTUIXMyxEsUTC4XJJbk4FfSNedfGravh3w/aRrgT6/psKqo4AE6t09MLXS3E0yePbCESv9nl024Yx5O0sssODjpnDH86BmxqVqL7Trq0ZtqzxPEWxnAYEZ/WvPNV0lBqL2cxE9vZyab5m4cOHElvJn6owyK9LrD8TwRJpsjxxos1xc2ys2MFz5yAZNAHOWsf9o/G6+nKkxaNosUCZ6LJcSszY99sSV39cL8M5Be6r431Ij55dcktg3qsEccQ/DKt+dd1QAUUUUAFcN8MplvdQ8a3ykt5uvTQgnuIYoouD6ZQ12V/dQ2NjcXd04S3t42lkc9FVQST+QrjvgpaTW3w30uW6jaK4vmm1B0bqPPlaUA++HFAHcUAgkj0oooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigApGVWUq4DKRggjIIpaKAPPfhNC2gya/4PkLeXo935ljuPJs5hvjA9QreYn/AAGvQq83+ILP4d8f+EfE8JcW93ONC1AA/KY5STCxH+zL3/2zXpFABXlPhvR7LxF8Ytb1+GM/YNDkNtD8xZJb941E8oB4BWNY4+O+6vRfEeoNpPh7VNRRPMaztZbgJ/eKIWx+lYPwk0g6L8O9Fgmbfdzwi8upD1eeb95IT/wJiPoBQBx3xS8Q6lBpOoQWE12mpavcjQ9Ls7mzWIpJJhXnRxlmULuO7pzXX+CLGz8JfYfBek2bfZNP05biS6yBudnK8juzFZGJ9q5bRp4PF3x71W7dke08KWgsbVSwObqX5pnA9VUBDXeaYoHjHXW/iNva/l+9x+uaAOV+L7tJrHw8s4+TL4jhlI/2Y45GJ/lXQ6zcw2/jbS5Z5Eiit9OvJZZHOAi74Bkn8P0rzT47a19j+K3wntFk2k6m0j/RikY/9CYV3XjWwnJ1vUJ1UWxsre1iOckgzFpcjtwU/KgDuKq6hYwX6QrcglYZknXDEfOhypP4jpVbRdUOpS6mjQ+UbK8a1653YVWDfjupvizVIdE8L6tqly22GztZZ2OcfdUnH1oA4n4KXDN8LZNVLBZLu71C9LNyPmuJSD9MAV03grUbrUY7qa73ZdbeXac4jd4EZkAPQZIOP9quG8EbrH4QeHvCdtifXrrTU821jcBoY5Rvd5DzsGGIBPViMZr0bwrpcul6XtuzG17PI1xcGP7gdv4V/wBlQFUeyigRsA0UVU1fUbTSNMutR1KdLeytY2lmlfoigZJoGcj8Trtb4aX4QgBe51+Xy51Q8x2aYadz6ArhB7uK7hFVEVUAVVGAB0Argvhpa3WrXV/411i2a3vNXRYrK3kHzW1ipJjU+jOSZG9yB2rvqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDwr45+IX1pPEfh3TdUsbJtDsU1RhKoM1zcxkTLHFkgAKqqWIBPzqOOa2rvxd4m8PeG9N1641PQtbsLq0W9NrLGbK7eMR+Y/lYZlchcnBA6daz/DOjeHvE/gC/v/Fmlf2rDq+tX17CBbyyMP3jRoQ0alkGyNRn0rAvvDFvoHgzxXcWGi/2YJtLaxjzFLIcysI1iEtw3mdXB2qiL9eKBH0ARbarphDqJrO7hwVYcOjr0P1BrxWXxN4k8H2Nzp3hNrPxHoltINO01r1njuWuOVFtGygicRgcsQoABBYlSa9P8Si5ttCsdH0zzRcXjJYrLHnMMe395JnsQitj/aK1W8MeHEg1P7fcWaW0NgrWOk2oORb24wGf03yEZJ67Qo6lsgHJfCX4V3PhhItU1q/Ua5O5uLz7FGq+a7HcyySMC7jJ6KVX2PWu+0N4NS1W81mymLQOn2AoUI+eCWVWYHuMkj8KzPHfiubQ57Ow02KOfULkMQr5+XIKRcDu0rIPoHP8JqeVrfwF8Pid3nf2fbYXPW4nPQf7zyN+bUDPBfj5eRX/AMTLC/haEtoV1bDdu5CQsJZyPcefCCPY19Ka/p41bQ7+w3bPtMDxB/7pIIB/A4NfJuu6bcT+Jo7S7keRrezksL6UfMs99eeYtw+RwAk0kSA9Pkxnivpr4Y63/wAJF8PvD+qn/WXFnH5oz0kUbXH4MGFAkZPhrWXTVbe8uwI7fWFW3uFPH2fUYhseNvTcFwPeMf3hWp8SvBdl4+8J3Gg6lcXFtDK6SCWAjcrKcjg8Ee1ak2gadONSWWAtHqJVriPeQrMowHAH3W4X5hg/Kp6ir9lb/ZbWKASzTCNdu+Ztzt9T3PvQM8+im8Q6RqYtZZdPtruUJHbq8GLS/wBq4CiUfPHJtX7r7/8AZ3DIHY6DrceqiWKSGSz1G3wLmzmI3xE9DkcMpwcMOD9QQLeqafb6nYS2l2paKQDlThlIOQynsQQCD2IrBn0fUZrGC7d4v+EisN6QXSnatymeFkA6K4A3D+FuR0FAjqa838ZRS+NvGtp4Tj/5AOm+XqGtHtM2cwW30JG9h/dC+tdNd+LLG08E3PiWYOlrb27yyREfOrrkNFj+9vBX61W+Gmj3mleGUm1jnW9TkbUNQPpNJglB7IoVB7JQM6sDAwOlFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVXVLgWmmXdyTgQwvJn0wpP9KtVhePJDD4H8RSg4KadcsPwiagDz/wAC6JK3wP8AC08Lypexaek/D3OCsnzt+7gdWcnPHWs7VrFIvCnhuwEUcTa54mtfN2WpgaSONvNO4M7uf9T1dt3PQdK6ldOjl+BOn2Zf7Oi6NbZYMRt2xoeoVj2/un6Vh/EK5sPDvib4YWwiVbC0e7uEhjQKWaO1IQBcDks+Og5NAj2Gqesala6Rp099fyeXBEMnAyWPQKo7sTgADkkgVF4fhvodKi/taYS38mZZtv3UZjnYv+yv3R64z3p17pVheX1re3lvHNcWeWgeTkRE9WAPAPv1FAznPD3hqW61dfE3iDzf7Vky8VmWBjs1wVReOrhGYE5xl3x1rkviJrr6rrrw2UiSWeiTxwQxHkXesS4FvGexWLIkb3x/dNdT4u8aJa+FbS40JWm1XWZPsmkRMuDJK2QJCD/yzUDeT/dHvXmEem6eHhgt5bia28PO09rct0vdQjuIjeXRI+8cvsHUcyDsKBGHH4Ykmv7i4t2l8ptHhsg0khcxXMxn3Sn/ALe4Y2J6ZbPArvP2c/EEV1Y6npLfu3dxq0ERP3EnJ81AP9i4WZfxFc3bSabc+K/EECuLbVxr8emWV0AVltkMzySGNvpKeD8pyMg1zfhzUz4c8U3N8HT7ToN299PJbr+7utMuGC3Owd1STbMo7B+KYkfVtFNikSaJJYmDxuoZWU5BB6EU6kUFFFFAHnPjhhqvjrwt4RtFVbdpW1zUlVcBooW+RT67pipP+4a9Gry/wJMms/Gbx/qgIZdPS10eE+m1WkkH/fbfpXqFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVznxJIHw78UE4x/Zd11/65NXR1zXxORpPhv4qRPvHS7rH/fpqAMHW9cOk6DpGlWmoafBcvZRq0Elq91OwKhV8qJD83QjnjpniuK+MsrTfGD4a2iQNdXqQ3UturqNqzFVCSuOm1Cpc4/u1o+Mb3UZtM0uSzutThtLjTIZf9DacxlNmSW2oFU895kyMZxWJ4w0q21z42fC+1n81LGTSJmaOKQAOqoW2EqSCp4BAJBBIyQaBHuXh54X0SyNrfNqMPlALds4cz44L5HBycnjj0rI8ZX6yhdDikVHuomlu5WOFt7Rf9Y5PYkZVfck9FNdBIDbWTCzgVjFGRFCpCA4HCjsB0HtXjPjVp2nuPDl7eqJbyD+1vFOoITstrBCcW0XcbsFADyRvbqxoGYt14wRf7Q8Zx2+26ktFt/DkDwkpZ2JmWLz3A+40zsduOSqAetZXhqYeH/BStqdvcwNZrcxy2r/NKsk09nGVIBPzM4kbGe/PenR3U+tXUr6joOq26arJYpZwOgiis2MrLagpuB2rHGxyRjexOOhrS1C5s7m71p5RBPb3eoG9YkZMENrNLPK/oCUSID3lWmScxocl3dfErxCl3b/2lr1nrUOpCzjYbWkEeZYgT12Rq6qf7yr2qW5bRh9j1fTUXVJtMjh+0C3jf/S9MIeK5iIIG5442iLoOVPXpXDfCO5vtQ8WX3icw/aNQ1m4urQFpQm2WaOQgAkhfmJ4z3j2/wAQr134Ia3otpFe6PeWsUr6dqEC2YCgmFLlSgbB6YLmNh2JwetAHe/B/UfsEd14Ourz7XLpUaXGnXJOftOnSZMD57leUP8Auj1r0mvCtb0e48Ka5aRaQjtqmhLLfaOg4+3aYSDcWOe7R5yme2zHevZfD2s2PiHRLLVtJnE9jdxiWJx3B7H0IPBHYgikUaFFFFAHjPwevF0XSfHuo3CefeT+K7uFY0bmaQsiRoCfUnr25Nej+DtSl1SxuZ5r2K9cTsm+3iKQLgAFI2PMgByN/c56YwPOdP0XVNG8e+I/Ddx4envvCGuzSavFfW7BfsspQeZGT2LMuBgg/N9cdjZeO9FjskSO0u7D7MFFxZ3Fv9mls4eglMbYzEDgFk3AdegNAjtKKRWDKGUgqRkEc5paBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXkvxie98Sibwxolva6hdNEf3apJKYWYFd0xDJHGADxuLE9QhxXrVQWlnbWaOlpBFAju0jCNAoZmOSxx1JPU0AeNaRc6xa+DdJ8O698OtWvtY0y1Wyiu4ktJYNyqEEiPI5AGAp5X6iun8LeEdYuvF1n4s8YSW6X1lZGysbG3bzPJVvvSSSbVDyHp8qqo7ZrotO8QS3HibxJaXEUNvpWkJB/pTtjc7IXkyTwAq7PzNcifGV343v7jQPD9pNBZzsBLqOSGjtMHdIRj5Gk+7GD82CZCAMZBHVeJ/GemaJ4SutdikW9jRzBbxwnJubjdsWJD3Jfjj3PavE9X0u7eLVPDuo32/W7iIeIPEU0DcNMzqltZr6RqcHHoo/vV0uq32n3GpXXiFIY/wDhGvBv+gaLZjiK71HATcvqEJWNevO49q5vV9/hfxFDHqV2ZIo45X1S7hj3S3F2nlXR2g8HMrwoAeAqgUAbHxV169j1i6bSLWWVxfj/AElRlLeK0gzJK3PRJJyfrHjvXJ/ErWLWXwCLnw9YzC31pINH0qKVfKlubOL97cTewchVyeoUHuKvaTYXeiaDex6hI0uvzabq2mXDSzb97NLCIE4AGfMmwSB8zMx5zXE/GFYLvxppHheKK5n0zwxp0WmR3EDnC3WxcZA7l2hT25/BiMz4b3Vpp+jeIdI1WKCMme8VVYb4TtjHmRhsYwNqMrfwvGh4DZr1bwvaxN8HvC3iXRILJ45bSHTNZtZ2KQ3EQlKGV3X5kkRyW8wZIBOc4GPONN8PP4avNd0J9ZvIkttWAjjiiEkku+J4HlXjkguC0ZzvQ8civVvgf4ssotY1DwtqtlFp8GtRR6vp8LlWimE0YEsakcYLq7BSAeWBHFAI6bx1Y65rL6A4hTTNZh86XTkNz50a3cW14wz4GVkjEyn2NZfgDxRb6XqsN1b272vhzxDevDPayDDaPq3SSF/RJCMj/a/3q9B1HUdIl8P3tzb2bXcOgTnMEalGjkgwSEHHRemOCOO9cB8VLLStKuY/EUsgfwr4mWPT9ahjHBDITDeqR0dMDJ/u4PVaQz2iiuD+G+u3Syz+FvEF0lzrOnRJJBdg8ajaN/q7hfU/wvjOGGejCu8oGFeeyatY+Mtb1vwvf2kuk+INJYT2cku12aM8JcREdVJ4ZfQ7W616FXI/EC40/wAN2UvjSbSPt99pUBQvG22RLdnXzSM8HAG7Ht2zQBm/DbU5LSRvD95GYQhl+zJu3LE0bYltwTztXKumf+WbqP4TXoFY1xY2utx6TqFlOqrHOl/FNEoPmgxlfyZGxn0xWzQAUUUUAFFFFABRRRQAUUUUAFFB4rI8R397beGtRvNAt4tQ1CKF2t4N/wAskg6LkH17Z56cUAa9FeCP8Tdag0G9kutV8jVLd7Rp7O90k2cturzKjn5mZWTBIz1HFdtZeP11m78L3FglxBp2rX9xbQNhG+0JGjfOwPKAlTgfe45xQB6LRXnPg/4nf8JFqehQSaDdWNprcE8tjcyTxv5hh++CqnKgep6+lejUAFFFFABRRRQAUUUUAFFFFABRRRQAVQ1XVrLSljN9MUMhIRVjZ2bHoFBNX6KAObk8Vgk/ZdC1+5UfxLZ+WD/38Kmmf8Ja6Eef4b8RRAjOfsiyY/74djXT0UAchD8RvDUrBVu7nf02/Ypzg+nCGt3SNcsNWilkspZCkZwxlgkh7Z43qM/hTLvw7ol25e60jTpXPJZ7ZCfzxXMarZ/DXRiRqsfhazIH3bkwofyagR2UWo2M1wIIby2knIyI1lUtj6ZzWL4t8Ur4etbuQaZqN4be2e4Z4YgIlCqT80jFVHT1JrmNP8a/Dy0uDL4atI724UlN+i6RJMfcb448frWf4x+JeqR2lrb6d4IvWh1G7j0+OXXClrC7yZ4MeWcrtDclQKBk/hzR9f8AiL4I0y78dXn2GO6gW4FjpoMW4t8yPKWzkgYwn3QeTuOML4mv9M8NQWHw/wDBrw22s6sXDOJNz2sOC011KxOS+0HBY5LY7Csq91i+1fzrHV/GUcsoGG0jwVbmSYj+6053Mv1/d/UVy3jPwtLo9poVwdAsvD2hy3EsEsNvcGTUJ5ZYXVFuJuQVkYKjAFj833qBEHiFU1vU/DugeH7Zl0GC3I0BEwXaWGRCb7B4b5UmC7gd3J/jrUS2j0bSmXULiWW4EkWn3Ussu9nnkkF3end/GQixxjHdQPalutGuoTZ6h4cvm07U9IeDwxo7tGpgkKA/apnUgkqP3vIxjyie9c/cajpc3hrw7ruqJLc2mnyQywoAT5kwlNxdXSg8sSPKQnkBpCopiLHhnUNQXxbr+v8Ai+wgth4ft7nUrqJZCUNzuzCoHIGAzYGSS654wBWX8MNDvtT8daGl6JAZbl7rUw20maaFvPkdu4CzyQxj1CH3pPGKaz4e8FWtnqEMcniHXrx/EuuQyvsSK2ikDJCx6Ab2QY9ciux/Zo8P+T4h8V6/JJ5v2gQxRPjB+YeY5b/abMbn/eoAb4k0qG3+L+s+bCrLPFJdQblyfPSKGeIpjod9vKc/7wqtrvhzTbbXNP1OKPbY6hq82lXTCQ4WK8AuLeZOfkZJWTBGOffmuv8Aiqh0/wAa6VqvAVII7lT6m2mBkX8YLif/AL5rG1/Sbi58L+LPDiAi6j08vZHPPm2cm6Ij3MbWxoA0Phjd61oOknUNUfUdegvpGj1TZCslzZX0X7p/3aAFoyI16AsMAnIYkdB4AtbHxF4In0yVZfI06+u7O3MqFJYVVnWPKMOGEcgABHTHHNZPgrxUi2el+LBsHh3xJFE1+6fdsb8ARszekblQhPZlUn7xNJpd/qsfjG6+wm3HiRjNHfWNxmG2v4onHlSo43FJfKkj7EMvB+6CEM880sy6FrFh4N1G4+y6nZXEsnhnVJchIblTh7Nz3hkUoQP7sgHUKa9+8FeJE8S6R50lvJZalbuYL6xl+/bTD7yn1HdW6EEEVxni3w7Y+K9X0bR9Yso0vLuSe/1CKGfzTbIIBEGV9oIO7ySDgcqT2rz688JXM+tavf8Ai3Q18UXNveQ6WmqWerSWTBQsax70GBuBYbmDcFjxxQB9KVX1C0h1CwubO6UPb3ETQyKe6sCCPyNfPEvg+xhl1JZ/DjacLFo4p/tPjC7X7+Nkh2RthTuxuJxkHPSrdl4X8NTwwrZ6D44a9lHmpb22qTjdH081mkkUIhYMF3bXYDO0CjULnpHwTvLSf4fWlnYxXcMelTTaY0d3KJJFaFyuGYAA8AdBx07V3lfN9t4ZsrAiTSNE8YWMc93JG00XiYIPtAbDeYVdgrFhjLdTWl/wkT+HQ32zxF4rt8cHdqmm6iAR22n5/wAhQFz36ivI7Hxbqk0dq2neNdDkedBJHBrumPZvKpHBVg6hvqqkVrReK/GkCAzeG9C1KMsVWbT9cVQ5AzgCRBzjnGaBno1FeSXXxO8T3CrHongC6upicPINRt5o4/f90zFv0rU0O98Tatpl/feKrq+8N2kC7iI7WCIlMZZgS8zADuTtoA9FkdI0Z5GVEUZLMcACsG58ZaBBkJqcN1IDjyrIG5kz6bYwxqpb+BtAm8qe/jm1qT7yy6lcPdA+hCsSg/ACumtbaC0gWG1higiXhUjUKo+gFAHM/wDCSaxfY/sXwtfMp487UpVs0+u35pP/ABypEsvFd7ERe6vp+m5/hsLUyuB/vynB/wC+K6eigDlB4F024IbW7nUtafOcX90zR/8Afpdsf/jtbM2haXLokmjmxgTTJFKG2iXy0xnPAXGOeeK0qKAOSj+HXhdLaeE6a0onaJpHmuppZG8tgyDzGctgEA7c49qs2fgfw9Z30V5a6f5U0V3JfR7Z5NiTOpV2VN20ZB6AY9qn13xf4d0C7S11vWrCwuXQSrHcTKjFCSA2D2yCPwrcRldFdCGVhkEdxQBgaX4N0HS/7F+w2Hlf2Mk0dj++kbyVl/1g5Y7s4/izjtiugqvp99aajaJdafdQXVs5IWaCQOjEEg4I4OCCD7g1YoAKKKKACiiigAooooAKKKKAMfxTHqbadv0fVbPS5I23yz3dt5ybADkY3rj1zmuItNR8SanOIdL+IXg65mJPyRWG9vwAuDXU+O4xdWlhYz38VnZ3t0kE2YBNLNnJWONSCASRksQcBSeOojg8B6IqSpfQy6nFIoXy9Rf7QFx3XcCVP0xQIwbxPGVmcX3j3wzanp+80rb/ADnrHvfEk1mVF98YfDEDHJIWygz+GZjWzcfCjQdOlvNR8NadaR6lJ+88q9QXMEzjoGEmWTPTcpGM556VY8CRf8JNpbXmu+G/D1pBtMCW0K+fJG6sVlSTdGoXDDG0A9OvSgDn7XXLm6P7r4i6neoRuH9n+Hg+R6hhEwx71zq+K7PV7y2trTxH8S9VuLmNpYU0+yhtxJGG2lgfLX5cgjdnHvXsbeFtOi8P6ho+nJJYWl6jqy2zkbNwwfLByE47AAd6z/h2ujzaPNremWf2GS+bFzHI+WgMP7oRHsoQJjaOBz65IB55qXg1Li3luZ/B3ijXCkZYjWfELKz8Z2qiSMCfYgVqaJ4J8yVl0bwT4a8MxwkI9xe2a3k8j4G7ywNo2g8B2bnrtFeugggEHINFAzk/+Ee142kkTeKp4ztIQWtlDCFPbqrHH05ryPWfD0OjeLtGg+K1zfa/Z3k73FpKt3LLbWwhiy3nW7DG35t28Zx3wAc+w+N/Ey6LbLaWUkTazcqWhjflYox9+eX+7GgySSRnGByQK82t9bvNe+L1vrklrqF5o2m2EyWtna2294TLsAklzjaZFDEIeQoUkDdQI9l0u0sbOzjTSre2gtCAyLbIqoQehAXivKfjD4u0+61nQfC+lXVtPrY1KK4aM/MsTxnKKexbeyEr1CqScCuusvE3hR9CvLA3A0a1tIds9pcq9jJBGRjgHaQOoDLxnoa8h8Wa54cu5fD2lXGjpZaDY6p9qhijhKMIxbSGOKY/wyXD9Iz8xXBYfNQM0J8IdKTTrmFfC1vJd6YJpJDJcyogkkvrlT90FihQOSSAxwBuGMTwbeXWqWOleGtX0eaQ/akvpLKKHzTaaeD50dsQeVBYwZBIGCAcbaxb/SLfSPEen+fePaWtpexNqUTTk2jO0kT3CCP7oTzC4IXAIgNdpplxqPhXwn4u8Y3upQHUNRh/cWhgC3JklJEDv82Y9zPuEeOFwCTtNMk4f4o68PEPiXVNR+0O2n6hNLo0MPk7ozbWw3eazdl+0Fj/ALQjx2r3/wCCOjXGjfDjS/7RH/Eyvl+3XRwB88mCBgdMJsXH+zXzfp/huK48U6B4e0SSIaZey23+kRPlr9Yt8c8pB/gb/SiCOvFfZQAUAAAAcACkNHC/GDTRe6BZTkDbb3qRyk9oZwbeT8lmJ/4DWHo2pW8mheEdWnKLrUUpgvw2fnMYFrc57ZVtjfRe+K77xlYHU/CesWSDMs1pIsfs+07T+Bwa8j0y7stXivY3ZUjea21lxuxi1v4PLn2/7shkb2IFADfh/b/8I9B4u8DM9lBYC5uZYW1EEwmEkeapwRj93JC3X+Mmsbwd4dnt7aZfC1zBdeKPDVxny/tJdNStyG8iZWLHBMbNGQDt4I4IUie91No/HH2m+Ky3UFr9quURQyyXFmTDex4777d1cD/ZXvXXeNopLPUtL8VeDNDvWvtPBVltYE8nUbF8M6Aqev8AGhIHzDHemIn0jXzp2vz+JdR0a90iy1OOOHVlu4SDZTRgrHIZMYaJgdpI+6QpOATWRrGq/wDE61yPSp7C50LVmiaWynJQOJodq3iSDlUMoRGIBAwW4JzXY2njaCVYdbaQXPg3UYEeG+RP+PSTJDrOOqqePmPCkMGxxXnXieOw8eeNtVGqWqanb6Y/k6Xbwz7o7mHyUe5jAUjErI4dGzyEwMYbKGauh3WrW2rX19rn2vUNS0+Y6RAZj9mLOFLQySiPAMUzkKu7cASCTknHWW3iey8QaNqUGqQvLCVW5jS2VhL9mLAeYADu3xOrBtvIZOByBXAJpj3mpWEMeuzJaSIbESSxCeOW1lObQP8Adk2H51DFiySpgEbq0PEmkv4K8IX3ia912PWZNLmMpijjFt50zOiSpvUsVaToy8qWwxXOTTFc4X4PRk6FrF7r4lu9KnvH1W1gudxjvbf7RsuJ5AMB2RQCFbgZztOcj2Wz1caXrC2psNMttPgvjazfZ4QuyKVQbWbjgKTlCf7x7YNcrprSWduunveLbw3enixmliYfLBLn7LeLwAQC7RSEdWwTxWBa6Pe2Yt9MutYFnDHEumzHVYTciJyfmtZHBXMDjDQsw43EBlPBAPSNd8caakmn6TqugzXN9eyyWo011jdxMoBUYfCmNhyJAdvTODwL8PgDwtfut1eaDZCXEebQBTFbsOSqquFBJPzcfNgZyAK8+adrGxibxENWglO6wup7y2dWMKSs8FxFN8wVomOcO2SMk5IBO54e8TRvNb3+l6nZ6trd6fs9xp+nTK8F9IqHZcbj/qPkXLHngBcMQuVcZtePdC0rTtOt72Dwxot7DHIsUtu1qiSNvIRPLkA+XDlc5B4J6YqCy0nwsfCGqXvhewtrW71TSWYxIf3pWSNiqlc+oYfVT6VqXOja/rccUeq63Y23lTw3EtpY229QUcSKpd23HJUc4XPpTf8AhEdO0LQGuYU87U7DTzFDdOOQUWQqwXopzK/I/vYp3ATwx4r0HTfBOgHUta063f8As+3JWW5QOT5a/wAOck1ei8baVdIW0yLU9Q9Ps1hMyn6MVC/rVf4Z6Pptr4L8P3Vtp1pDdTafbySzJCqu7tGpLM2Mkkkkk119IZyjeINfuWxpvhG6VT0k1C8hgX8kLt+lKkPjS6b9/eaFpsZ7QQS3Tj/gTMg/8drqqKAOal8N393GFv8AxPq7eotfKtwfxVNw/wC+ql0zwhpGnX0V8kd1cX0edtxd3cs7jIwcb2IHB7V0FFAHl/inwNqHiD4ux6qbm/0/SE0MW32yyliDmYXBbyyrqxxtOc7ew57VgzeEfFM/xRTVH0t4LEanJ5lxbXSLHLZMhA3Av5hbplcAD+Ed69uooA8++Cnhy88LeFpdM1LTZLO7juJS0puBKlwpkcqyAMdoClRghTkZI716DRRQAUUUUAFFFFABRRRQAUUUUAZWtaxBpM+nC8ifyLqcW/2gAFIXYHZu9Ax+UHpkgd61awfFFzvj/sv+wrjWEuomMkYCLCFGBh3cgZOeAMnjPauT07RPF02rmCDWNV0TRViVjHcfZ76QuWOVjlbLKAMffDdeMYoA3bjxNqGpX91ZeEdPgvjaSNBc3t3MYbaKUdYxhWaRh0OBgHgnPFbmhJqK2R/teKxiuzIxIsixQj1+YA59a5jSvh3DpNu8Om+I/EdujyPMQt0hG92LM2CmOWJPTHNbdjol4mnXllqOuX1/HMAI5iqQzRD2eMLk55zj86AN2uTbwFown1Ge3fUrafUH8y6eG/mUStjGSm7aeOOR0pNSXXPDulRjTrv+04Y/9ZJfxyT3BJPGBCnIHH8P41zB1XxdrF0iCHVNsZDmG0sP7PjcgggPPOxfb6hEBIoC5Q1yDUPhnpq21vq90dJuZsWVy5DywzhWKWzo2VaNwCq7AhDADvmp/wDhKPildaejab4RsTPKoYPdt9n2ZH8SGQnPtmrgsb208faRrfj7XrAK0EsdhpyQslta3BK8rK3DybNwy20nJ2gDIrR0PxNd6E99Y+MZJjHDMRZXq2kj/aYiSQzNGGTdggYBB46CmhMxNN+H+va1pzQeKZtN0yK6eOa/TTTJNcXkinI3TyH5FB6KoOOxFHiWxt/CvxC+GOnaIHstMnu74TwRyNieQwZDyHOXbPdsmu60jxVY61fG10uK/lAQubl7KWOFSP4Szhcn2GazPHesaTo/iLwg+s6fHKZ7yWG3v5HCrZSGFjk5/vAFaQDfHGn6PqniXw3banCftKfaZ0nUL+7iWPEgZjygO9SGHIZV5Fec+MdZ8M2914S0TwjpyXtlDq0lwk0CF7Z75IXMYab+Ng7B3bJwEOTmmyeN4rzWNTW31Cxury7H2aTU5rV5Ujt8E+Xa2ihnlXkEuxCseeQAKoaj4MTxlb+HtA8NagPD1lpv2mUS3rgX980ykSP5CEFFYFsltpw3CgCgNzM0qzsPEmtRT3erkaTYThrbbYNdy30y5Jl2AHnLvJkggNPgjK8dD8edcP8AwmXh3StOt43+xFdYvWJVMSsRBaM+cZIkcHB5wK6KyutO8Fi00ceIHuP7PUMuj6HZpHHEo5JnYlyi9yzuoOcnNeDPrg1q81zxdr88qQ60l5dRWAw6usC+TaKG9RI8h46mPPagD0z4B6LHefEPVr03a6hbeGYpNHs7nbg48wgAnudqsSR/z0r6Jryn9mvRLfS/hsl7bQvCmr3Ml8iuct5ZwkeT6lUDfVjXq1AIK+cL+0l0jxFpdnDth+2LqfhBmk+4CxM1mTjthwPavo+vnz49adeXCeIU0tR/aVldaZrtmOhLktbsR75RP0oBlLXrkeHdN8N60FtxP4euUi1W2hOSkqK0Vxnv++iy4J+95a9Sa7/w5F/ZV8+l21zqF09sgvNGt4rzy4buxZhtQZ+UmPdtOeduw964TwL4rX7Nrl74iig1DS9f2a95c65WGL7sqDOdxRImwP8ApifUVCNd0rwxa6t4RvL91v8ARroXXhS9kbaQr7dkO9yBtXdtbJwYmz0HACO9NrrHgnUZtesNLl/4Rm/d5dX0aIiaSzkJ5uYQv3gerxj6gE5FeP8Ah5rCAR6jpniOysNZvrj+07sIY5kGxmPEAI2GMEMNuC8TuOSMV6omtnUrxLvUYvB97ebVVpNN8TujZA/hUqB3PfvVi50nw3IzT694I1W/jmjC+ZLGuqRoAeqlXdx+AoAoaFo2r67bXd29lpqShnWW0tp2EZDENLDvPIWTKzxuuQrc5wxqr4u0waXq2nWGqazb6hm9TUZLD/VtIIgAt3PgbQF4MmSiv5akFWJB5fU9H0/TpLv/AIRPxJZ+GBNgPE811Zwuo4AkgmRhwD/Cy/hVHw2t94Ludd1X+0PDviHU7yNY4L7S9UgiaONGDBHtm2BgxA3EMWxkc0xHb2EnhB9EtrWPxAtmxgmWOO0tWurJVkOJGjaaFiI2JGQG284z0NYvhTxO2iW7ajbxWOsTqlxYjUrzUpGJgt5lDDAjYAAOJQuSdgJzxisfRfiVo0d9bwWyahYy6e0s0EUsTlEglIM9k8iA/KG+aOUcDaoO3HMth4h0S71aK8PiXSBaRgRo+otGl1tO5M3EbfLMQrFCdwYrgq2SwKD0Ou8Tan4l8UW13pE2o21u0yXUEVlZ2xVLq5gIY2sskhLYdPmG0LuQnnqK19a8RaHrUejXegwXl3eWcILaba2cuZbSdfLkjyq7VIxxyMNEVyOa4XT7/wAMCJ4IfiBokdxBcKkjvL5aIigNbzQMxJMkWdmSTuTMbHgEWrfxR4fl1C6uYtY0JtQCk3Nvb6iLcea3/LxZzB03I5+Z4WYfNk5B+8aDszrvh5Isur20tjc6jdSx7rOZ0RWWS0XPk/apAdnmoSQCjFyPvDrj0xdMjOitplxPc3MLxNC8ksmZGUgg5YYOcHGev481598PfF3hyKMxal4jhj1lnW3ktrnWluULnBBhyxypzwcbux5Fdpq/izQdImMGoataR3PT7Or75j9I1yx/AUDsa1pbQ2dpBbWsYjghRY40HRVUYAH4Cpq5iLxRc3ysdI8PavcAfdkuYxaRt/38IfH/AAGo2i8ZagSGudI0WE9BCj3kw/4E2xQf+AtQB1dUZNX02O/+xSahaLe7S/kGZRJtAyTtznAHesWLwdDKGOs6trGrM33lnujHGf8AtnFsXH1Bq9B4V0K3026sLTSrS1trqJoZhbp5TOrDBBZcNkg9c5oA8y8D/F6bV9Z15dSWzawWyn1LS0t2xK0MUjqUk5OJCqqwHHHPeptY+L1/FoV9cWnhyS2vP7Hj1qyN1OkkcsDOilmCMCMbwcZyR6dK7AeDPBl7cQ2cFjZG50eE23l287JJAksWwrJsYMd0f9/JI5HrVyXwN4clhSKXTVeNNMGjqrSyEC0BBEf3vVV+b73HWgZyWs/Fk6PPDaXPh+7lv0tY7q8hhlVjErsQoTGd7YBbGRxjnPFTeIPiNMNN8VPYaXfxQaLvjl1FWhKq4VWAVHO4khu64Hc10Fx8PPDNwtsJLGcPbw/Z0lS9nSQxZJ2O4cM65J4Ymk1bRfClja3Wl6jAsUPiS58uWIyS/wCkzFOgIOV+VOxA4oEZN98S4bLU5oDplxNp9lPa2l7fiRV8qWcKVwnVgNy5IxjPANbPg7xbJ4nub8Q6PdW1laTzW32uSWMpJJG+0qqg7vfJAFT3Xgjw7da1Fqs+mo99GY23eY4VmjGI2dAdrso6MwJFaeiaNYaJbzQaXB5EU08lzIu9mzI53M3zE9T26UAaFFZN/wCJNHsLa4nudRthFbzpazFH3mKViAqMFyQSWXg+ta1ABRRRQAUUUUAFFFcb420fVdUuYms7cPFCn7uW31eexmUnqCEUqw4HBoA1LDWpH8Xapo14sURiiiuLPnDTxEYc++1xg46Ar61vV88+KfDV9INIGo2nizz5nP2ZrnxEoWGbaxSPzAjMsj7SML8uSoLZPGrpnh661jTrG5j1rUrhL5GeCGTxVdI8hTl02iJcMp4I6gg56GgVz2+WRIo2kldUjUZZmOAB7mvK/HXjOTWkOm+D7jSbixGRqGp3F6beG35G0RSqRukBBPykgYGeuK4vSvC9j4j1P+zryy0+T7QGe3bUdQv7sXBjP71CGkXbJG33kIz3GRnF3X/Ao0iQ2dhpfhGO8jtheLFDoCyNLCjgSiNpZGzIoIIGOdwoA3bn4u2HhqIwanrmg+ITHws2m3ai4kHbdEMru/3WwfQVb0j402OqxF7Pwf42k4yuzSCwb6ENj8zVGO1XT7e3Ua3qDx30Hn2CaFa21lBeYGfLVwpYylRuwWXdztAwQNC68MWms6Ha6n4bnv8AWbK4icOlzrN0sxzxujZnKq6ndlGXrwSuKAG6x8R7x9NdrvwLcx2Eg5OsahZWsbjPcNIc/ka87i163hn1SfSrPQ7G+vyEWe21pZPsqcAxwrBAQhK7hv8Avc5zwAOz0n4XXdjNJbrY6IYGZHW6EYEsEoB2zwgglCCFLRbijZJUrkqe28caZfnT47rTfNlhhhkhvdOtyU+0wuBuMePuzLjch78r3yADx6bxTJcTuzeJNPt48rHHAvim7h8oBRhAPswJOBnLZY9c1zvjSxtPFFvaxya5Zm7hkWWF21jUNR+YMCD5fkY6AjjH3jXeSX0ckTGa5W9N7FG4ubcYlvTFxHe2+f8Al6jAAkg+8dvA7HrvAraxqk2pyGTy7K+t8SXUJcRvMVAW5twfuh1J3IcFHj75JIByGna94yOnmx0yCbyWJUmHQ7ydzn1lvZY1xj1yB6Yok8F+LZLfZY6QZHk5I1TVEtbYe7W1kihh7Fz+Nc74fTxZea2nhrxHrMl1f2dzJpsd1cZUxzIpkhlU92aM7uf9YgkRskKa2/D1h4mXWtLn0PT7qGG8sp1mt7lytvZ/eSSAF8nasyo8YwcK7jG2gDhPHXwh+KV9Avn32m3GjF90um6EfIjRMjJWHaiu2OmSWPTNYF1r2m6jrl1o+h6EtvYXeppBZnIBhdrZra3Vl/gYO0srLjg9ea9v0bwjqmpMBab9NmtGwxlh+zPG+VyrJGPLZsHcs8OAcbWVhkVg6don2v8Aadu9OidJrGzig1vUP3QUG9WExqw67c+YHIz1+lCA990jT4NJ0my06zXbbWkKQRL6KqhR+gq3RRQMK8t+LljJ/a1rPbj95f6Xe6evP/LZFFzD+OYX/OvUq5P4lRqujafqLHH9mana3ZPovmhH/wDHHagDwbUTp9p4n0jS5bFrjRruZPEdmiAOE0+UGW6gde4SRA4A6gsO+K67RtOXW9VkttCsrWd9MElpdXOrQJcWcMBO6AIQf3zrGQVKlfkZQ5yBVLV/D2oNoBtbC4aHU/DOoypp91c3cMFtbMjeZCpBG9t8UgUgnGPSs74Ya3c+K/hprGjeGRaaX4t0zV5NRGlrIESVfP8AN2e6ZJTPQbVzxTJOgj+Dnw80TQdQ1qSyi1+7KNcmSST90NwDZWKIhVjAYNgAkL0zxWDplxoUcIl0jwvpa27qGENm8kUiyZVdu9X/AL6TRZHG9oSeGrqoPCOu2l/FqOmaVNbhZvPgtJLhM2zKN6plWxsOZoeOqSJ02DFbUtX034eWr3GsaTp39r2EUr/bWQcsd7W6DAHzyRq6FhjLIBzxQMf4l1LQtG8RaVpdnq/jK3mvbM6hKkOpuy2dvxhpEm346ngdMGtjTLGx1bWzp8viXxXHdMZ0VZ5LddzwvskQFY87gNr+6uCO+MjRdG03xBe6hqUESy6/qpGr2kt63F7p8ibDak87FVHMbKM7W2vzkCuj0fw/DpupxvrurxzSW7WsiRAnzUmyYoHZgeWdMxN2fYDxyKQHPPc6IPNSHU/GN5HuVAE1OSJmDNJH935cfvovK+rL2NXdMsPDWqC8YXniRnjtRfW6jVJ5HuYAvJRWb76vuRkPKtjPUVHqWnp4hv5L3wpDbanZ3AF1Namb7PLEJlxKjBh9yXYGHQpLHu9cWfD1kmky2Vz4hnePU2mW4s7VlEc3murx75WXKp5vyK4BKmQBs5bFAESWnhuSNHPiTxAkDzQQb5LiJ12zR74nYshxG33QT/FxUy+DL+9EWp6Z4l1G20wJJ9otdS0iC4uGZSR8u6MFRwegbOQRV7QbjRGljtrPRorV9QS4hiF6N4trsfNJZsh+4vHmBVO1sMRjgki+JF3Dppmu9FkluUt/PNtbkiWQxfLdRIp6yxOCdmRuQgg9aBaGT4f+FGlajc2GuyeIZtas5MTLE9pAkEidcBI0UL/MV6ppukadpaldMsLSzDdfIhWPP1wOawPAuqw6nPrJsJFfTRPFNabVCgRywRyHj3ZmP1JrrKBoKKKKBnh3/Cv/ABIvwytIoxd/8JA995mo28moF/tFss0pWJcuY1yrI2AQDjBot/BniGHTdEjvNK1LVNHtbi6abRpr+KOTDhfKIIk2FVO/Cl+M556V7jRQB4Hd/DzXlHjIaVo09pcapYWhsZ/7TD+S6Rx+bAzF9zOWUgORjjqM4q9rnh/xl4gbxTdXWkajYJqEmnNb2kGoQSHESyeaCC4VlyUypK5yDk4xXt1FAHnGh6DrsHwgu9Ju7U2uryRTKkVhc+W6hmO3DMzKrY7BtvYEduJ0f4d+Ibi30i11fSVSwh1lJ5QtwIpjbiF1ZpAkrKDuIH7tsnJyK99ooA+fb34feLjpdjZNBeXGk2tzfIljHeRmRI3fMMql5ArYXIGWDLnOKd4s8G+Nr6Swa10+5kurOysktr1L2ITB0YeaJmZx8wGeUGG7k9K+gKKB3PCNb+HeryTeMLe00WZ/7S1WC8t7tL5VVofNiZ1wXDKw2sc4B4wD0r0D4c+Hbvw3qnii3MUsOjS3qS6cj3HmjYY13kZYsPmzwcV29FAgooooAKKKKACsvxBq66NFZzSxF4J7uK2kkzgReYdqsfbcVH/Aq1Kqatp1tq2mXWn30fmWtzGY5Fzjgjsex9D2oA53UL61u7aXQ/E7W0st406RfZdxEgQhlUf3ZwpVgoOcqSOnHDW2janqNtNc6b5Oq6ddRLd/aY5RALqROBKp6214uOSAUfB3bDkVsTeCtZuLq+ju7ixvd8cSyyzZUX4X7jyBfmhuEA4lTIPHyjAxFbXFj4D1e8S8vL/VJL1wJlSFQsvH33A+V7hVA3BdrOhDbGIzQI1tL0NNMv5da8T32ntGRC/muixb5R8qTSDJVZQGKbkOGB6DAFYnil7c6zeano9xPPFDcLLPNZJ5txpVyq7DIYfvPDIgCuo7LkZzlY30yW0n0qLTZ3uNPZWTRtUjjNzAYJMZsrpVzmI8bZO2ByCPmg0zw7rEmpRvpun3Wk3Nju+z/aJN6WTgBvISQf66zlGRjrGw6LwAAW4/D2qakmo2qaalhHcgTT2u/fY3TFsi4tpB88EwPzYK9QDgn5q1fF11e+GIbC1061VhezK89yFCLeT8K8UhAxE0q5KycDeoBIyKbqHjbUNP1TWLO4jtQIZiIp8Fo4IiihJZAOWj8zzEdhjyyBkY5rG1Dxvr0TGSFhCQ4nls7mJWe3XHPK8TWrEj9/HkpwWBGQACiury2AW4tb+d1igFjJPcEwOy5O2C7OM286ZOyYjY2TnGQaQ+NvE13JHZaPNLc6mixp5TWoUyANnMi4/dPjIbkxuuTGwYYr0TTG0HxNb2fiVrNBd2ySRMz/LLAeVkhfB5AOflOVPBHY157qXjJYbMWnhVdPsIY2XyIdOX7ROI3fdnykUlGRhl4iuGVjtYGgDu9ch8PaQX1a/02FtRmX57WL5zNIqmTAThXkARiGI3YXj0rC1fxBfavK8dhOCoj+021vaTlJL6DJIntpRwXAOGicEZAzgEE8l4x1qXWbW11NdMv9I1WWKH7TFqMkVlB5iEskiSTOrrIjFtrhSCDhlI4GJFe3t0AHfRLiOSfzri205Lq+Wdv+eyrBGRBP33xuATzigDr/Hvi6TRtL8J6k0mn6lYXpZ59QmsGDW7rjyLpwPuBGYK4ODljjHSq1/rt7rxnkvZrk2yAGW1EKzxWhI4EioN7wnkx3MJyAeehq6viTxZd6QNPTw9qd3E0Xkv9r0fJmUjHzmW4QHI65H1Fc9q83izwroMM+souheHoGjto4re6jtY4AxwNxgilcLk9nH1oA6y48fD4e+GJLvxnO5gMHmWUU06PdvICQYMj/WLwCsuBlW+bkc81+ym914hTxj421Rf9N1nUfLB7KiLnavsN4H/AAEUzV/g7H4hhnv5/D/h/Urm6jyl2dfvnY5HysHZWBHfpzXrHw08JweCPBGlaBAyyG1i/eyKMCSVjudvoWJx7YoA6eiiigYVneItLi1zQNR0q4JWK8t3gZh1XcpGR7jOa0aKAPAtL8TNJ4iEsljpt9qK6bHFqyX13FbfYr2J3hLo7g8uFOQBnaqHnOKwPGWh6Prtx9vfxBoemeIrcKINUtdXuLmeHaeB8iKrDr2+hr6BtfCmgWuq3mpwaPYrqN2/mT3JhUyO2MZ3Hn8qd4n8SaL4T0pr/Xr63sLVeFLnBc/3UUcsfYAmmI8T8PeK/F2kRLFP8RfB2rRodmdWgltm+m8Ac+5Bq3rVrd+MfE2j6nr2j6TrC6bkxxaH4gj2yNkFWZXVGJUjIG/GSfWt2zt9b+KurWGo6pZ3Oh+C7C5S6trKcbbrUpUOUkkH8EYOCF5J/LHo+p+GtD1Xd/aWj6ddlhgma2Rz+ZFIGcXBq3hmwkE2qaNrmjNFdm+j+02cpjhlZSHKPFuRQ2Tlc4JJOOa5S5uNJW7u7fSdShubKSGVV8i4RZDbu/mBEDMCJoZGZ0BGGUlc5Feir8PtKtTnRbvV9H4+7Y38ixj/ALZsWT/x2o5fCuvEFD4pW/hxgR6ppcM/6p5eaAOS0ex1KKSfU7WOyS+t5DcRtBcIBcOSvnRgE48qYfvADgxybuOhOn400jz9ca/0680iZJjiaC7uRGMFAkiNwd0bqqZHBVkVhnkVel8D3LD5rPwXM3TMmg4/9q0ieBr0LiP/AIRK0wePI8PgkfnLQBjx6RZcNceLtNhlzH80lykr4jw8LMSwzLG2U8z+NOGGea7uwbw8dWuL2yu7J7y52+Z5dyGDMowG25xuwcbgMkYHasIeDdcBXZ4h06NB/AmhwgH/AMerndWjTT7m4sNZXRLrbwHvvDMscL8AjEyFkx+FAHQ2/hjT9Z8V+JJ9QtpwYZoIraaCaSBlUQISFZGBwGY/ia0T4UvbYZ0rxTrdt6JcPHdp+PmKW/8AHqo/DW60+C2uLCzOgxJv8xI9L1I3CsT975GAMeMDgcfSu5oGc2LfxZaxAJf6PqDD/ntbSW5P1Ksw/wDHah/tzxHaH/iYeFHnUdX02+jm/wDHZPLNdVRQByo8d6VCANUg1XS2P/P7YSov/fYUp/49Wvpuv6PqbKunapY3Lt0SKdWb8gc1p1A9nbPcJcPbwtOn3ZCgLL24PUUAcHZ/FOwuPEf9lvpWoxRHVpdFS8JjMbXMfUbQ+8DGDnbjn646K08aeHLzVptMt9XtXvIg5ZNxC/J9/DH5W298E471xdj8Ik07xY3iXT9YEWsNrFxqJla03K0E33rZhv5x82HBH3jxRpvwdtbK6mjbUUm0tlu0SNrX/SY1uEdGUTb8ceYedmT3NAGxqXxa8IWMdtINRa5Se5jtwYYzhd5IEh3YzGNpyy59s10T+K9DSG5lfUoBHbSxQzEk/I8mNin3O5fzrkZ/h5rFzoem6dceJ4XGkz2k+nONMVRGbcnb5gEnz5GBwVHHSodc+F97qepapNH4k8i01K5tby5tjYq+ZYdvIbeCAdnTt6noQDstO8XaFqervplhqMc94hZSqKxUlfvAPjaSO4B4qHW/HHhnQtSGn6vrNpaXmUzHKxBUP90njAHueB3rB8KfDmTQPGE2tjV8xSeaTZ2sDW8cpc53SL5jIxHbaqc8nNHi34cf8JDdeI5v7V+z/wBsRWUWPs+/yfs8okz94bt2Mdse9AHQaZ408O6pDby2GrW8yT3RsoyCQWmA3FMEZzjn6VFeePPDNmqmfV4MtJJEFRWdt0Zw/wAqgnCngnGK53UvhpNPeXV9Y66bS+fWhrMEhtBIsR8ryzGylvmBGecj6Vj3XwamnsI4D4hj+0Ce4nN2LApMpmfcSjJKpUj3yp/u0Ad5d+OPD1vfix/tOF75kRlhTcfvjKBiBhSwxgEgnNZemfEzw9L4e0jU9WvItMfUbcXK28jF2jTdt3MQOFzxuOBUdj4Fv9L1S+l0rxC6WOoSRy3kN1aLPLK6oEJEu4Y3BQTlTznGK51vgwiWmlpBrETTW2nrp0/2myMsU6BmYMEEilW+Yj7xHtQB66pDKCpBB5BHeiobG3FrZW9uCCIY1jBAxnAx07UUAT0UUUAeO+MNZ1hNUGotplloNvPGbS4XW9Yit1voMnjbHuZXXc21gcjdyD25ITahfSE3F/od+k0RguGS6uXkmReYCzpbYMsTAMsuAcZBz1r6GmsLOe7juprS3kuY1KJK8YLqpOSASMgZAqzQKx4X4T8Wa74YtLiCTSLS6SaTzm23E8MMchUeYYw1twrsGfb0BY4rZl+L8sCn7RpGmRPjID60iDHvujH8q9boIB4IzQFj521DXtO1PVZr+FvC9hMz+ft/4SF3aOYgBpVEMJKswG1gGCuPvAmnaXdal58kOg6dc3ayuZIRo+iMtrallKt5Ut44jjDAnOxMH0r6FWNFJKooJ6kDrTqAseLWXw68QaiqDWLbTPITAjj1a7l1HywBgYgQRQDAA4wa621+He6NI9T8R6zNAv8Ay6WMi6fb49NkAUkfVjXeUUDOY0jwD4T0hxJY+H9OWYHd50kIllz673y2fxrpwAoAUAAdhRRQAVDeWtvfWk1reQxz20ylJIpFDK6nqCD1FTUUAeXjwDrfg9p5vhlqsFvZSOZToWpq0lpuPXynB3xZ9ORk9Kdb/FVtKXyvH3hrWfD9whw9wkDXdmf9oTRg8fUDFenUUAcppHxG8G6woOneJ9IlJ/gN0iN/3yxB/SugTUrGRWaO9tmVepWVSB9eayda8EeFtcYtq/h7SbyQ8l5bVC3/AH1jNc3N8E/h1KwY+FrNSDn5HkT+TUAdPqnjLwzpKbtT8Q6Raj/pteRqfyJrmrj4weEmk8nRbi91+6J2iDSLOS4OfdgNo/E1oaV8LvA2lSLJZeFdIWRejvbrIR+LZrr7eCG2hWK2ijhiXhUjUKo+gFAHmS+IfiT4kdo9E8L2nhuzb5Re61P5kwH95YI+49GOKv8Ahr4XWFjrcev+JNQvPEviFOY7u/I2Qf8AXGIfKn6kV6FRQAUUUUAFFFFABRRRQAUUUUAZGr+GtD1nJ1XSLC7Y/wAc0Csw+jYyKyh4Hs7Ug6NqetaVt6JbXzPGP+2cu9P0rrKKAOaOn+KLWEi012yvWHQX9lgn/gUTKB/3zUP9seKLIgah4aivEH3pdMvVYn/gEoQ/hk11dFAHMx+NNNWIvqVvqel4OD9tspEUf8DAKfrWFrfxT0/R/EOqadc6ZqL2umS2sV3fReWY4jcKDGdpYMRzg4Bxj6Z9DrhY/hrpU3jzWvE2rbL976S1lt7eRCFtnhj2ZPzYcngjK8Y49aANpfGfh5tcfR11W3OoozoYhn76DLJuxtLAclc5HpWd/wALE0C5ey/snUrC+imnWGV0uMeVuRnBxg7jhD8vBrDtfhVHaeI59Qt9Rha0lvJb5YZ7PzJYnkzuCSbwAMseqE44zWhYfD37JofgzThqe7/hHLkXHmfZ8faMK64xu+T7+c5PSgCxonxN8Mat4cXWlvWtbVpjb+XOn73zMsAoVd2SQpYAZ49OauX/AMQvCdhZWt3da5aJb3UJngcEt5iA4JAAJODkEdRg+hrnLD4Z3en6Ppdna6+om0e+lvNNmexDCMSFy6SLv/eZ8w8grjAqXRvhfFpUto8eqvKYtNu7KTfAMyPcSeY0nDYUAk4XHTv6gHRaj478MacLQ3mtWka3cSzxNuLKY2OFckAhVJPDHAq6fE+ijdnUYPlvxph5PF0cYi/3uR+dedz/AAZjMFisGrwl4tOh065F1YmaOYR52uqiRdp5PBLD2q6/wtuRrHnQeIiml/23DrpsjZKT5ybdw8zcDghQBxx70AdBc/Evwda3M9vP4gskmg3iRMnIKHDL05YH+Ec+1dNpt9a6np9vfafOlxaXCCSKVDkMp6EVwen/AA0+x6jpl1/a2/7Ffaje7fs2N/2tGXbnfxt3Zzzn0FdT4I0H/hF/CemaL9p+1fYoRF53l7N/J525OOvqaANyiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vertical mattress retention sutures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 406px; height: 310px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parallel retention sutures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 404px; height: 333px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Double retention sutures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 405px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24986=[""].join("\n");
var outline_f24_25_24986=null;
var title_f24_25_24987="Fungal infx in transplantation";
var content_f24_25_24987=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80777&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fungal infections in transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Organ transplanted",
"      </td>",
"      <td class=\"subtitle1\">",
"       Estimated incidence (percent)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mortality Aspergillus (percent)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mortality Candida (percent)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Kidney",
"      </td>",
"      <td colspan=\"1\">",
"       0 to 20",
"      </td>",
"      <td>",
"       20 to 100",
"      </td>",
"      <td>",
"       23 to 71",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Liver",
"      </td>",
"      <td colspan=\"1\">",
"       5 to 40",
"      </td>",
"      <td>",
"       50 to 100",
"      </td>",
"      <td>",
"       6 to 77",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Heart",
"      </td>",
"      <td>",
"       5 to 20",
"      </td>",
"      <td colspan=\"1\">",
"       78",
"      </td>",
"      <td>",
"       27",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       Lung",
"      </td>",
"      <td>",
"       10 to 36",
"      </td>",
"      <td>",
"       21 to 100",
"      </td>",
"      <td>",
"       27",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pancreas/pancreas- kidney",
"      </td>",
"      <td colspan=\"1\">",
"       6 to 38",
"      </td>",
"      <td>",
"       100",
"      </td>",
"      <td>",
"       20 to 27",
"      </td>",
"     </tr>",
"     <tr>",
"      <td colspan=\"1\">",
"       Small bowel",
"      </td>",
"      <td>",
"       33 to 59",
"      </td>",
"      <td>",
"       0 to 100",
"      </td>",
"      <td>",
"       0 to 5",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24987=[""].join("\n");
var outline_f24_25_24987=null;
var title_f24_25_24988="Headache triggers PI";
var content_f24_25_24988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F68062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F68062&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Headache triggers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tr>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Diet",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Alcohol",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Chocolate",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aged cheeses",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Monosodium glutamate (MSG)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Aspartame (Nutrasweet)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Caffeine",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Nuts",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Nitrites, Nitrates",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Hormones",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Menses",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Ovulation",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Hormone replacement (progesterone)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Sensory stimuli",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Strong light",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Flickering lights",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Odors",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sounds, noise",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"      <td class=\"container\">",
"       <table cellspacing=\"0\">",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Stress",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Let-down periods",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Times of intense activity",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Loss or change (death, separation, divorce, job change)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Moving",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Crisis",
"         </td>",
"        </tr>",
"        <tr>",
"         <td class=\"subtitle1_single\">",
"          Changes of environment or habits",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Weather",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Travel (crossing time zones)",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Seasons",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Altitude",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Schedule changes",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Sleeping patterns",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Dieting",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Skipping meals",
"         </td>",
"        </tr>",
"        <tr>",
"         <td>",
"          Irregular physical activity",
"         </td>",
"        </tr>",
"       </table>",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24988=[""].join("\n");
var outline_f24_25_24988=null;
var title_f24_25_24989="Antiretroviral drugs";
var content_f24_25_24989=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F60927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F60927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of antiretroviral drugs",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug (abbreviations)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Brand name",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Abacavir (ABC)",
"       </td>",
"       <td>",
"        Ziagen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Didanosine (ddI)",
"       </td>",
"       <td>",
"        Videx, Videx EC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Emtricitabine (FTC)",
"       </td>",
"       <td>",
"        Emtriva",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lamivudine (3TC)",
"       </td>",
"       <td>",
"        Epivir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Stavudine (d4T)",
"       </td>",
"       <td>",
"        Zerit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tenofovir (TDF)",
"       </td>",
"       <td>",
"        Viread*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zalcitabine (ddC)",
"       </td>",
"       <td>",
"        Hivid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zidovudine (ZDV, AZT)",
"       </td>",
"       <td>",
"        Retrovir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Non-nucleoside reverse transcriptase inhibitors (NNRTIs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Delavirdine (DLV)",
"       </td>",
"       <td>",
"        Rescriptor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Efavirenz (EFV)",
"       </td>",
"       <td>",
"        Sustiva",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nevirapine (NVP)",
"       </td>",
"       <td>",
"        Viramune",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rilpivirine (RPV)",
"       </td>",
"       <td>",
"        Edurant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Protease inhibitors (PIs)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amprenavir (APV)",
"       </td>",
"       <td>",
"        Agenerase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Atazanavir (ATV)",
"       </td>",
"       <td>",
"        Reyataz",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Darunavir (DRV)",
"       </td>",
"       <td>",
"        Prezista",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fosamprenavir (FPV)",
"       </td>",
"       <td>",
"        Lexiva",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Indinavir (IDV)",
"       </td>",
"       <td>",
"        Crixivan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lopinavir/ritonavir (LPV/r)",
"       </td>",
"       <td>",
"        Kaletra",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nelfinavir (NFV)",
"       </td>",
"       <td>",
"        Viracept",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ritonavir (RTV)",
"       </td>",
"       <td>",
"        Norvir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Saquinavir (SQV)",
"       </td>",
"       <td>",
"        Fortovase, Invirase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tipranavir (TPV)",
"       </td>",
"       <td>",
"        Aptivus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Fusion inhibitor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Enfuvirtide (T-20)",
"       </td>",
"       <td>",
"        Fuzeon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Integrase inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elvitegravir (EVG)&bull;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Raltegravir (RAL)",
"       </td>",
"       <td>",
"        Isentress",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        CCR5 antagonist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Maraviroc (MVC)",
"       </td>",
"       <td>",
"        Salzentry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Fixed-dose combinations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zidovudine + Lamivudine",
"       </td>",
"       <td>",
"        Combivir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Zidovudine + Lamivudine + Abacavir",
"       </td>",
"       <td>",
"        Trizivir",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lamivudine + Abacavir",
"       </td>",
"       <td>",
"        Epzicom",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Emtricitabine + Tenofovir",
"       </td>",
"       <td>",
"        Truvada",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Efavirenz + Emtricitabine + Tenofovir&nbsp;",
"       </td>",
"       <td>",
"        Atripla&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rilpivirine + Emtricitabine + Tenofovir&nbsp;&nbsp;",
"       </td>",
"       <td>",
"        Complera&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Elvitegravir + Cobicistat +&nbsp;Emtricitabine + Tenofovir",
"       </td>",
"       <td>",
"        Stribild&nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Nucleotide reverse transcriptase inhibitor.",
"     <br>",
"      &bull; Only available as part of fixed-dose combination pill",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24989=[""].join("\n");
var outline_f24_25_24989=null;
var title_f24_25_24990="Paclitaxel-carboplatin- bevacizumab chemotherapy for NSCLC";
var content_f24_25_24990=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F76013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F76013&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Paclitaxel, carboplatin, and bevacizumab chemotherapy for advanced non-small cell lung cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: Every 21 days for a maximum of six cycles, followed by maintenance therapy with bevacizumab every three weeks.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Paclitaxel",
"        </strong>",
"       </td>",
"       <td>",
"        200 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL normal saline (NS, final concentration of 0.3 to 1.2 mg/mL) and administer over three hours*.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Carboplatin",
"        </strong>",
"       </td>",
"       <td>",
"        AUC",
"        <sup>",
"         &Delta;",
"        </sup>",
"        = 6 mg/mL x min IV",
"       </td>",
"       <td>",
"        Dilute in 250 mL NS and administer over 30 minutes",
"        <sup>",
"         &loz;",
"        </sup>",
"        (administer 60 minutes after the completion of the paclitaxel infusion).",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Bevacizumab",
"        </strong>",
"       </td>",
"       <td>",
"        15 mg/kg IV",
"       </td>",
"       <td>",
"        Dilute into a total volume of 100 mL of NS",
"        <sup>",
"         &loz;",
"        </sup>",
"        . The first dose should be administered over 90 minutes one hour after carboplatin. If well tolerated, the second infusion may be administered over 60 minutes. If well tolerated, all subsequent infusions may be administered over 10 to 30 minutes",
"        <sup>",
"         [2]",
"        </sup>",
"        .",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        MODERATE (MINIMAL when bevacizumab is given as maintenance). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Premedicate with dexamethasone plus both an H1 and an H2 receptor antagonist prior to paclitaxel administration. There is no standard premedication regimen for bevacizumab. Refer to UpToDate topic on \"Infusion reactions to systemic chemotherapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Paclitaxel can cause significant tissue damage and carboplatin is an irritant; avoid extravasation. Refer to UpToDate topic on \"Extravasation injury from chemotherapy and other non-neoplastic vesicants\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with hematopoietic growth factors is not recommended (risk of febrile neutropenia is approximately 5 percent",
"        <sup>",
"         [1]",
"        </sup>",
"        ). Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        Each carboplatin dose should be calculated based upon renal function by use of the Calvert formula",
"        <sup>",
"         &Delta;",
"        </sup>",
"        . A lower starting dose of paclitaxel may be needed in patients with liver impairment. Bevacizumab does not require dosage adjustments for liver or renal dysfunction",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; CBC with differential weekly during treatment.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Serum electrolytes and liver and renal function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess changes in neurologic function, blood pressure, urine protein concentration, and risk for bleeding prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity/neurologic toxicity:",
"        </strong>",
"        Treatment with paclitaxel and carboplatin should be delayed until the absolute neutrophil count is greater than 2000/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelet count is greater than 100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        <sup>",
"         [3,4]",
"        </sup>",
"        . If a patient develops severe neutropenia (less than 500/mm",
"        <sup>",
"         3",
"        </sup>",
"        ) for a week or longer, or febrile neutropenia during the prior course, then the paclitaxel and carboplatin doses should be reduced by 20 to 25 percent for subsequent courses",
"        <sup>",
"         [5]",
"        </sup>",
"        . An alternative to dose reduction is the institution of hematopoietic growth factor support. Both the carboplatin and paclitaxel doses should be decreased by 25 percent in patients whose platelet count nadir is less than 50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        for longer than five days",
"        <sup>",
"         [4]",
"        </sup>",
"        . For patients who develop severe neuropathy (grade 3 or 4) for a week or longer, then the dose of paclitaxel should be reduced by 20 percent for subsequent courses",
"        <sup>",
"         [4]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Renal/hepatic toxicity:",
"        </strong>",
"        Alterations in renal function during therapy may require a recalculation of the carboplatin dose. Paclitaxel dose may need to be adjusted for hepatic impairment on day 1 of each cycle. Refer to UpToDate topics on \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\" and \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Neurotoxicity:",
"        </strong>",
"        The development of severe symptomatic peripheral neuropathy requires a dose reduction of 20 percent for all subsequent courses of paclitaxel",
"        <sup>",
"         [4]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Other toxicity:",
"        </strong>",
"        Assess changes in blood pressure, urine protein concentration, and risk for bleeding prior to each treatment. Discontinue bevacizumab for hypertensive crisis or hypertensive encephalopathy, serious hemorrhage, arterial thromboembolism, nephrotic syndrome, gastrointestinal perforation, fistula formation, or reversible posterior leukoencephalopathy syndrome (RPLS)",
"        <sup>",
"         [2]",
"        </sup>",
"        . Do not administer within 28 days of surgery.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs.",
"        </strong>",
"        Dose reductions may also be indicated if there are other grade 2 or higher nonhematologic toxicities. The dose reduction is at the discretion of the clinician, as formal guidelines are not available.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     IV: intravenous; CBC: complete blood count; GFR: glomerular filtration rate.",
"     <br/>",
"     * Paclitaxel can be administered in NS, D5W, or NS/D5W at varying concentrations between 0.3 to 1.2 mg/mL. Use glass or polypropylene bottles or polypropylene or polyolefin plastic bags, and administer through polyethylene-lined administration sets with a microporous membrane 0.22 microns or less.",
"     <br/>",
"     &Delta; AUC (area under the concentration X time curve) is converted to a patient-specific carboplatin dose (in mg) according to renal function by using the Calvert formula. The Calvert formula is total dose (mg) = (target AUC) x (GFR + 25). If using measured serum creatinine, limit the maximal GFR for the calculation to 125 mL/min. Refer to UpToDate topic on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\".",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Diluent solutions should not be modified without consulting a detailed reference due to potential incompatibility(ies).",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Sandler A, et al. N Engl J Med 2006; 355:2542.",
"      </li>",
"      <li>",
"       Avastin (bevacizumab) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 13, 2011).",
"      </li>",
"      <li>",
"       Carboplatin injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 13, 2011).",
"      </li>",
"      <li>",
"       Taxol (paclitaxel) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 13, 2011).",
"      </li>",
"      <li>",
"       Langer CT, et al. J Clin Oncol 1995; 13:1860.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24990=[""].join("\n");
var outline_f24_25_24990=null;
var title_f24_25_24991="Oral contraceptive therapy in hirsutism";
var content_f24_25_24991=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F82541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F82541&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 555px\">",
"   <div class=\"ttl\">",
"    Oral contraceptive therapy decreases hair growth in hirsute women",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 535px; height: 341px; background-image: url(data:image/gif;base64,R0lGODlhFwJVAfcAAP///x8fHxAQECQkJBsbGw0NDRcXFwAAAAoKChMTEwwMDAUFBQNOoggICAMDA4Gm0EJ6ucDS51VVVSJkrRJZp6qqqlGFvzJvs3Gbys/d7aC83LDH4YCAgN/o87+/v2GQxBUVFRwcHJCx1u/z+UBAQOrq6uPj4ysrK9XV1SAgIDk5OY6Ojv39/e/v75WVlfz8/N/f32pqamBgYHFxcYKCgsbGxvDw8IuLi+Dg4CwsLPX19cLCwqCgoDU1NSoqKtvb2zAwMM3NzZeXl76+vmlpaSEhIeXl5X5+fjExMefn53V1dUtLS9PT08rKymtra1lZWWRkZF9fX/Hx8SgoKH19fXZ2dj4+PiMjI4qKiqenp7S0tH9/fxkZGVhYWFZWVj09PRgYGIGBgZKSkuvr6z8/P+3t7ebm5js7O87Ozq2trUpKSp2dnd7e3tjY2JycnP7+/vT09IODg8XFxWdnZ/r6+piYmOHh4UlJSaWlpUFBQdDQ0M/Pz/j4+C0tLUNDQzY2NtbW1nBwcFpaWlJSUm5ubtTU1C4uLpubm2NjY5+fn+zs7NfX16+vr/Pz8+7u7uTk5Nzc3Ojo6Li4uJ6enrCwsGVlZScnJ7u7u2xsbI2NjcnJyd3d3VdXV1NTU+Li4pGRkW1tbcDAwK6urpCQkF5eXnp6ekxMTJmZmXl5eVtbW/v7+8PDw8vLy9HR0aurq/Ly8kdHR8TExKamppaWli8vL8HBwZqamrm5uWJiYqGhoVFRUampqTIyMjo6Or29vXd3d3Nzc+np6YmJiVBQUCkpKdnZ2ba2tjg4OLe3t5OTkx0dHUJCQhQUFCIiIiYmJo+Pj7GxsXh4eNra2tLS0pSUlMjIyKysrLq6uqioqHx8fIaGhoeHh2ZmZmFhYVxcXERERMfHx4WFhaOjo01NTUVFRbOzszc3N/b29ry8vDMzM/f393R0dGhoaIiIiEhISE9PT11dXczMzKKiojw8PDQ0NEZGRk5OTnt7e7W1tVRUVIyMjISEhG9vb6SkpHJycvn5+SH5BAAAAAAALAAAAAAXAlUBAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3r9+/gAMLHky4sOHDiBMrXsy4seOcIzQ80DACYYQIlR9r3mz1AgMIDC4c1MCAQQTOqFM33cDAAgALDDYU7ECh9GmBD0rr1j1Bte/fN3M/ACC8IITjphkyAM68ucvixQeKoNAB9G2Fy51r305SBAMMADAw/xBBEPTu6wizc1/PXmMHBhMiTGDQAcBnABkuexaROaH69gAGGJEG802ggUD3DWSdcgI26OBJ/z0o4YQaRUjhhRhCZGGGHHZo0IYehsghiCKWOCGJJqYoIIoqtrgeiy7G2ByMMtaoGo025qgZjjr2uBiPPgZpGJBCFhkYkUYmyReSSjZ5F5NORikXlFJW2RaVVmaJFpZadilTBvW5xKWXZLaUmwWysTRmmWyiFAFsDFCAQZgordnmnSV14FlpEKRkJ56AevRmaRR84JmfgSZKU24QUCZQBogqKulLYL70J0JwuLAECe+wMilVSXhwCA88UPKIYZI9oOpKlxpUQggHxP8aawWfRlWBrLhiQ5h3u7EqUh2xCkBArAi0UOtTEuAqqwSEHXeBCBj0qVKrBQ1zQAqRAMBBrIwc65QTB8jAhAceGHLAOs0+YIEGEVDbkLsDxXBAKQKZEGsaOb4xhlu30jBQsqVgsk8JgVnwwXTz+RrStgIIIgGsB3yBhbdMPXOAvwIlKysCM9jwVwQPjODZgdOKFIqyByTAxQEkoEFxUtsew0EiHDhwgARpaHyAKRW8kiG8Au2AMghjLBOrFi8XhQIKwKB8gBMCoaAGM7EWQI3Pd0V73NbSRgqSB7HSUIESsaJTQi8HgKBJ0kKRDUIL8ByAxAlX5LCMNAVlI4CsMxD/XJd5uwGNnUjCHJDDQMOSwMMQ8oKgK9saRSLFGyDpIEOsxzykiAvExApGFdXY9cFwAGjQdZ0iyROrC8LojPI4kGtE+UcmqBArFH5DxIrtseazCx1zQeAaAKwpDFIJTqNirrJn3BL7Ta/GKoZF1/B+QAjUyJXbBaD1VrJIpKC8AwBlgNOOLubIagAJmIgRhMfPu4RPCgcEgDRGi3DgTKw+ONEKXBiozQUg9b2Q2I4SAEgDCA4wA4PgwHq4yoMsmBA/lXQiVrDwSB3+sCxjcEdwkIiVEQRCNmYd5BNOi5UE4uAB+AFgbRX8yOUOoIaQaAFiB/jGENKCmZgIThOxkgUA/xZRhJ0lRB4LDEQs0sCO9G3MClXAhhykEEOONCEHsaoCFUUyBCvICginyN1YIFAoArZEcDaAGA6T8QsTIMQEsLheIQTyAjFEAYLXo0YQFFHFi4DtAAiglUlMQIgFyKoLKCBLBj4gQP6oaSRNUJYEyHYAQRrkBV50gAcKwopR5GFvuFrCDfZVEDjEwQsyKEcfD3ILBMTqGioxwQ1cGasojG8skdnTB9BjEsEJpATbyAMp8AGAEqghVqNASBKOcIACYKwgY/BAInSxQFn9wQrAuAQAPKAMXEnAWKsEgCMIkYADdGERLVEHProgK2LkQoxg6UAAGUA6CLFkWwxMyCRipf8CeBaECS7gxbBkhYkCoKwK4TRBH2LFAZmggJ2yamhZNJAme7LkVvlEiBZiRQKHpAFcN4vVCsogCY6uUgrjEGlNmIAJWSWgb47xpUBYMYk0uIwgPFjgMaaBEA+c4ABW8FRDWPCGWxVhIMf8RmKAFxZGLDABt7RJC3Lx0wM0QAY71EoHPsA144HEBMdcVkFMQL8DZCIhJIiVEB5irwP4AwAuCBYIYFGD+GUiViGAAU/cgMVYnSAcFlGHUOCkG69+BBcowxdBpLDQA2zyII7QmCUZMg+UDSBWCZjsy/gRK3K40SfgsF4IwnAVC4hGTCIBRKyQYAwa2CwHLCgIC8DlAA7/8PEgs9ibH8C5EEW8Q1YgoJUHllC1G/hTUiWw1sWG4olu0NIBVfCEQHgQgGakIAVAkIE4lJKB+FyGl700Wax8IZBKxCq2BqnBAkOgA4QwwZA92CJDapCF+w0EHD2o2gqOhQOIaTYodHBDNRUADxOkVVkImEVSSNOrAn6kGrEiwyA6scAAQCIYB0EBrJ6QECbAKgSfrYh6/YqDSXlgbwPQQ1KksAJQpiKtApCAjGO1haSQUVWrcvBHgIAyAxzAASfYRjz4QJASCOIAYGhCQlIKgsdW5B+SaGw9lEwmIzzCA3qAAR+xsLce3FYpcNiGBGKBWHkMhB0HkOhRHnDaM44E/4eySkQFcFgAfaiCIPj870CikbISY8QNEJvHCLU0Q1z1FRdSIUclB7ItNRuFNF3VcUdQECtDihUA0EgFrtwhCkanbBUJuVUI9EwQSPyAISYYhOdcoKUUHiAGUwkfHgbCiTQnJTcN9tpHrBGrIagiEuZKARp8QS4PMBO4JPiEB/AQq0DsASGSWGAUjjsLWYEBHQyJxRf8KgZHSAl5BCg2DWJ13KZAIVa0cMZlD0DavAiOEa6Od7wFsIw88EICZOjFQEPQBS8QgQOfsMEiaCkrKi+kBlU9QV2NZIMKrKAGyDsBQQ7wh6oMwWnJUEoHvgvekghuE057Rq1pcYIENINuAf+wmbxXLisyLLQdkBhFrCrhECkAK1ZLSKSOFOEBKFRWVnf1wcSZYZVqpOEQHEj6WpPCq8JKmiOecBqoF2KEGtxAubJKgQuSzvWkH8EbX7zDHA7AhYG01BsQYcENqimBUDSiRR5YARF84LRv+IMJBxBAsRNxAIlTZQ/DIMEUdCEDTAih3EG5MY4N25EaXC8cM170Q0oAjZXxkwcI0cMCTRirUKAgFrBy9EMgeoAz6LwGUDAEPRDRBgrhIQaDAKWyQuACD+TOaVeoinlRpotbt/mRITnZFwZCd1Ir5AUu0HSsAnAEOBjkjzIAwB1Q5gqK/MB69/ij+hpUgiD8opwoa0D/D45QixcchPSyOkJVLheAeZzAxzdLyggoEGlde0Ro18r/AW7BATcgPiF7UE0cxQHIQBCRkFaY8AQoA0MU4QGqdgLpcAAKMAhFFC6M4QFJlwqVYArc4GQHYQNG0FpQYHmyIgDvgAnK5nwN8QMwgAMtIF9T4QeSBwApBQVJQVilwXgcoQpOA38HwA4SYQIKqCxFAAUFKBDhEAWxkl+y4gUYUQyKECuPxTulkAtlgBgvkEI6RxAocARG4zT0cAiQIBOKMDszYQM/UAFRYAk8dgCAJRAt1W5HYVqWIhKx4DTmMAuWtgD24GcPQQWxogZwZgAIBAAYpSwdhRFJECu1kDEI/2YFbsAGhVE1J5ADtARDscABf6ByiHgD02B+NGGGMHEOHCABBIcr2zAQlyN6RLEBFMBxOrgR+EQEPGALAXBeAGAMUKAAsdIN/UBkDuECICAAQtAGmWAKBGcPcYUyiYgRPEYGrZALrtQDpfANBiUrDUAC3UADk+CHfBErciAQtRArnUB3uCIApkAFHKAF6JQRdPAIMGANeOABGIYU1XAD3eA0UxAFHHBZAnAGuFAJBkUFtxY4sagR+BQDFVAB6yYPHOBGjoANZeUDcohqC9RP4nQKlhArv+A0PYCQKPNZZaAFLvAwKAMGEnAEQpUXsdJ6ANAGsVJNBSABsnBqH3Fgsv+yANU3FHIQBk6kLAQQB9DgbQIhcyiTC0kBMjhWT6gTEofgNPOgMYlARzPAiTXWEB5gM1ZAEHKAL3AmK/uFEWOwkbLyTAXBBu0QAwMFSLQkAFUwZHYRKyoGAG3VBCgAiiERCU5jQj5hB++QApwYKw7wDdwgCQVxDgMRBFgADzIGBd2iF4ITD06jD2awe2CwBUkwXWfgV0rgPAthTGkzMQSRLAjQA+SAk8uwEVqAB2bQEOWTDU9wi8riDoFAA6KgV2/BArEyDBzADqYQK+1FEqr1B8VgAtAAiHyJEzawBzfgB1RTgkjgD2KwhQbBWxHBVG7xQ06jfgDQCs2AWWEJAEz/gE+G00ALAVJmuQaxgglghyvW8BI6wARpwAmnKCudsAIVoIJq0Vi4EgJvJxI/IAdoEH9UBHIh4A29QASAMBMlUAFPUIG4ogK4QF6oITjUcC8VQAjA5Tx8QAmymQPEJBA6UJWxYgjheRBwEEczCADmiDIpMBMvEAxKIAG8qCyDiQg7gJdlYQJYIAa20AXJkA0hhhEswAfoUJIylgCBmZyWJisKMAeMoKMoIQVrwEHKIgDdcAnodSMigU/rwAE0YEgnsDckAE51AH64AA4DAQMcUFUpkA2Id2IHQATgRGmy8n6yAmsCYZ0QUQE0EAeiwKcVsQiUkAilQAL1CQKmkAo3/8AKg4YQyZAK/OCZUoGTsnIHEgEJaEAJs0ADvUkCAhhvJ7AHP+ABWyA3SSAEgSCbzUQLSlAOLgQSNhALYRAFrJp3QFAKWoCbbNFxHpc6TuMGHgArlvBZkiABDRAr3CBYAyEJSCArUUChz2dSAGCpKHOiEuE6J7ClHOEBDscLgRkrlgAFLlCPAnELbahSUiGYDtCkeJMQLxAKmSABndADoeo0C5AAAyABLlABabAKJaBaKIMEBNEEK3CrBzAAnTAJHEEHl8ABWCcrhjAD0goX8EEyTQkSdqosKmYC2wZiA2EGUyAriDBWiBUrU2CYBmECsLICvylvNpkQ5cYDKGODI/9hDKV4BUMDBaJQBl95ACvpFFl4ADZ5hwfgZ+WwBhJACDSgBgiLMlxgD/QqAW4gqAXRni6lZ42ABSQgexEmCy5ZEGvgSldwAs4QBfY1EHvgBhIQrlewAuFoFyJgARQwPBYFEmXgNKCwZ2mzcAIhBzOEBC4gRjiABWVFApPAqwIBB7vwCIBEK2aQVmfADgTXjAhhtdV6AGTABNfgY32AEougDzMwDqcISkKQBDywN1EQFbp5AJIIADgQK1cABvGGAMfwBN7AAXWgBSYQsxRhBNiJEHygBXGwbbjSC6WQCC45BimEBoXgCltgCqGqACSACpMwl3tBJ+EVEnoQKzGQCUP/YF4DQBAVgAAOIEQEcQ5xEysqSxB6MH29I4oAUAilNxDMRgZJYALfGStTFxH7o3MY9QNEpRIlgAbUEAPLs0VplZxOESvSRZe4YjMpcAJI8G+HMARJwK0tAQjCQJayQgBbYAaxkgyzwAFVECtegDJFQAZaEJx4MQJctTUHmRE/wC0CkY8MrL8H4AXw1AQQowKhUxDGAL8HwAlbyLwFEAoAYAdhdQAqIA+8A7ILcQ0VgAsnwAUVoLNhOYT9ILt5IAG/MAppoAePOhIQdgDYBgA6e1ZQ0bpYAAg7EAexkgVfxhNJgAUSIHtGOXEhdQBFIAEr4MJ78QEG+XQc8VMNowux/8IFfTBHA8EE+WUIdiBbpzCyB4AJk1wQMIBmsTIIWGAsQ4groBorKbBuzJDGAvEI0OAKHGAP9ZlmKjoIVaULrWDJKFMAKeAMRLAFR3ADolAIYbsR2yYAMtA5IBDMDew0WBMUOpALYeAGjRArMRsrNgADevCfLdHFEnhdfYAF//cTEDAB/THDGREGymIFotaOnraiA7EFNYqRBaEDl1BNR3VkyuIBqrAGvIAywFABTtCk57gMMbALRGYGcJZ7AyFwDjcPzhCut6wMEjADQ0BFGgwRL0AGOem3UOE0IJAUsfI/dBBCB1DGLnFBKLO3SCECv0fOFwGTSGaOINAIK5A2wP84EDR7ADdwEIpAA1STAlSQLQXxCnXAAQj0U2QQCFTgStEgEDAQPq6WAM7gBKeABphbDtFABTzArApRAh6wC7ZwBIRQCSQwAF6rLAFAAlFQm2LgBk3guwgBDbISfVMRKygAA49gzn5nFC2QQm7dEjIYA1owChzgY5hwFFrzGTJsyBohxwJAMKIQK9AAAMkCNQVRA4bEwANhAnKcdzmNEAOa1+OWB/iwma6GCJGNEiUwBAsZBVUVbyDgB4MgAdQwChWQO3KwlvEXFcUQKwNRw7yQFK6jQi1hBihQCJdQARywQFkwEGM3PUYBOLmWsR/BDbkNAIbEDIkgBRz0XyawQIT/gJgHAQNW6gNRVWoH0AwDoWp5wGexQgAxEATaoizmcA3BmxKxBQND0A4SQAzJKm8DAA0/+wlR8QbXMxCrECuzVhLGIAEkcAK8gASIcGca8QLTsDSbIKUioQNBIAzaUA+AmUKWNHbGFxeCI8cFcAm1QAS4wg12sDedpslpBQSKWxB1QAuxAgRCgM0CQVwksA9DWGMl8GwFocgoYwXaULEFkZknwQfT4AGycAMcsAVEAAQpADHPegAK1gQLhdlLgTwgMATk0jTEogbl7REbhTKUzRM2UAOy0A4c8AQkQAJXLm+ySQSQcGX0w2pI8QDS4oosbRGxqyxR0N0HcAzL6MgF/3EDs5IQr7ACagTUArHbEfp/eNSfRHDaxSQBtygAiPDNJcEGY+DSLmnPUREM8iYAfoCtG6Fa6cABo3AI3eSEG2EDY4gRRpDflaALPVDWTsMMSADGHGALHoACNmmtsVKRRMHnE6AqsPHnFlEBnAgCbrQDhuQFx+QHCLHZSG4QKp4yMxBiPKBycq0QUSdvqQkA6HcAqxsTga4srMgUy+NNdIAO1B0rCrACWq0Rt6LnACAEB5AKGmEEnYMrCIDoW10BvyAB5ODBruYAZHAELrAJAlHRBaF9uFIHSBE4CWJ/HwEHPJAJ1UAJzbAPALADaVVVKG0QmbBAMfB/JeAEoJSKA/9RDPWdEOFwAPRg47JCBGGAjAegCeVeCRzgRQig5DBRVrjymFLxD03OBGXsCTegM8vwDDP+ECgwCRyQCoKQDLey1AJxK0/wwBdxiLgiUWMADZQgD55aCpxgCACNK7icAvRAChxwCh6ABqdSEVyNBzxQB2qKFBFgKN8FfCbxRyjd2uyc2etV9QWhB1bqRr9gCT7QDUOaEHBADwewD8rSA240ya5wALADAIuYUSzBCsIwCxuLK+bpFYtwA00KCgvaEJtQxWXdA7ciCAMh5tVdEbfyVkFwCbbDARXQV652Bb8exqtASm4RAWZE+CIh4QDABvklASbQX7hSbuKdNpV/ENf/YA0G3Z/bn2Es43jKcggC8fkhsA2ogAix8gUNsASoLBJ2IAfUsAU/1/6dJWM/FQJjARDQaB0gyEuYIwAJFQJA92xJAoIRA+SLcYgFngMLjp0IQfBYxxkLRY4kCaDCgTUK2x245yAiwQBLCG2rkORFSZw5de7k2dPnT50PGEzAsAHoUZwMkP4sMUfAgRNZEso4AMJDiSUR3eEs4aSqB57ZDjiQQIJgjzc8CR2IsSMFVDIE75TY8TKihxMRyQlZWhJHGg5KjkG0q8wUDWsEN009kC6nqr6RJU9m8wsEQQTennHg0M3Z05c97GkrJxIF6JdCSgA5wA+pjh0AYhywpVDb/4FDQSZpKWZk8m/gwX9nwHCBAQMKwn0qVb7QRseXFRK6ISgBQJWIT3KGI0hjJ0FrCWcf8Gm2QhMuUFcQLCDEbsaErBChPuMLaYshM9IteE8wgQQXcLgpoVc6ImWaGwjapjkGG9Qplv4IMgCXS1jQSQdraqhAGhTKSKiEjrzxKZg1ciBonGMOGIfDQjr6xEEYY2wwgg+Ok5Ek5hrMhaBSiOioAEUSOukACcp4JyLpcFKCIKlyIig2AFwgCCGeUDiAADg8SU8CE0jhZ8iXHBBJkjmgEyAGdHSSogJQTOwPBD+gaAeQnGSxK4RHbrxRB5KaqOAeDqgQR5OczPBAiEpQe/9Pn1cmq6GAA5IsyQghjsjrJUTWeo8DPTv11CcNKGDgggcy+DShHBmEAqWEIiEoCIX2yMqQIMSIaI+cNGGtixZwKuKAJaSRxhKCLOxpiwMCAaAEs5xQx6QDnGCEhxr4k4SKI/A4ZBoYzEDGCwIIKqKKCm4yAw8sCHkHjPdSIIEQGuRJ4qdE3PQillM9baS/OxbSo5B7EHHzJSCUEIeNcjhglyAZKui1LxhY40EkOLI4Ap4GXgpABmGaWDarl0AoJl+SSxbqAgxMzTfV5qh6JqEkFDM2oUIQOICUBKsyI6cSAjjACpxWeQ8boCQ4wA4AWFDmABIAQNauBZCJ0AFFCeL/76UGLJGAgyDKmLlksH+CgSBlaOnjajuIMMQlu8AgYRZCSdphipdk4HMpEFlVRRR33jtjFhNKGnDAsAvXswMRIEBuZRjjOKC9NKAjCAR6SqGmgvFIoJvInUAhMnCSxLhaATGOagSEEG4yIS8VvLJrKxO0IWIQsyLsz4dD0mjCBsN77wmSA0JQSOj+DIhBiFZ6QiGfl5aYhiQP/uQMlfBEuiZCAaBA5m7fuyd5hA2Ks/FUlpVzZOmXXKiij6r746YNnUqpaoiSIllDloePeoZpPpat/b1B8CEI26CCGqpGABI8YR2BAEIKBhChAaQgB4KYww14QAkPPAIGcODJIvgR/4IvUKEE3lNOMKqiEDkQJBBL4MANPMA9oOggF4Kw2QEQQAgtKOR67yFEQnBQASg8MCLEoAINPEA4EibRU0IZSsoY5yApSO4ARVgIHyRRgSNIQAL0gNR7HACCOwBoCCiwSUJk4RJJCYcFv1pBQlhwBdvZ5Q9zEIcRkCgSV3whjl68kgSiQINRjBEFIwQA8SISAg8pcTJjI09CPECQ5kyihgTBxSZOsgAtSqAjZ5iBz/oDFkWG0lMaEEEHwFY+4UjJLmkMnQH2GBECSGAbnajOGJpjghAgYEBjIIgAiHAkgqhBAvAQwy2OcgN6vMQeQoiGBGiBhFeKCwsdAUE+7kCQNv+Ksi84IAgolMAPFUCSQTUwx0vCKQiFgKmXEnCDFAAwjS+CTpvzdBDiSkUyVAbHCmwpQzx6cABE7IQF7HjJILRwikAgggSaixAYgHEEDjyDEfmLTBMOsBUA6GAsxkgILQ3wm1aIAWRMQwUOFKKKPUhiEragQVlIQIsuRmQXCSEFVOh5n/4UAEaUyIQfGvArL6TzAAL4whbsIxIPfBGUN2XqcER1HA34ZAQaeIAGRjCSDDygqjzJJ3DYBQkhHeAKPSlETL0zkjeM4RASmMdb+sMFMkRhFhzQxnnS8pNydoEDv3LAGoSBCugI5wVCiGkAqpAnnFjoBYUQJwCWpIKmAuX/EkTQIi20WAM9WYkTQkUnTqhzgKVGVrRAscAFNhABCySnJ8ZR3AVGcpzjYGAnXf1NHw6QTUEc4BjPKM1OTECMiGDBt0Y7ABn6FsccxKCujIjESErQCmtUQBevDACDTHCGyxDEB8jYCd34sgm6ZWK02kTDULWYjY4ENSdr6UGjxvvenUDgAQmJAG0XsgEGWAAAFmCAURYS1QyMLyf2lQwsCAIETyoBIidQwtdI0oIlEeQePFnHAeqBguxGRAKpIMHAXkIAZSyUBP+MkBMu9ZKxOqgCZwANCKBwCd+QpA52QcDI4KvEMvTHCTvhwM8IeWMgLwQDFMDAAybgWp4IZb5K/yZJB4YyWxit5iUiYgNVDuAHPewEHIRp2k6MUIZrnkAC4UyWQnCwC1NE8z1USA/UZEQHSjzhJenIBZUWIkXrBDmJaEAFZwLFiJ70OAA/1vONR2Ac5KhsJ0xm8kj4618AMBG2k45RPF6CC4WI4lJEYINOPqFhnhiBIKBUw1ArEIZS9ycEEpBBKrqAhBMI8SXMOwAWKlABOYtJTyaggg8i4ks8KGQ9dslyoYNstC6TMK06KUEobl0BkxY6AxH4iQgYIFsMMEAEIhmB4qIKZQe1IcME2cJCxNGLoT7hBzkhLtNgoBPgHQAFCQnEewSABFTMwgOLwIkN9nANN3BgYg88A/8JJHCpOCSvUx5IBmsw4wIzYAYWcLSpsYPsB6Y1IrItGLcNuwBkoRzFyROIwAQYYEoGQAAAHWCtVk05YBhhJwSaaIHRBDCSW1yKBPMuCTkiAoZ55aQjJKDEGiBCgBhUYAWd7ovjIhQAfFxIOShYQbhc0IYIWXwnzZ2nWUJAaADY4K5KtEOECnHj+iJFAyafwLdTDoD6TpraMHfQPjGbEILkcCQziEhKSJKEDHNBniQZ9kuM+Rt1EoQEFfjVAVIR7VPZICJX8HVjtQ7fvPWLqXs4gAosZILxMOHGoboABEz/xAbtkwphPQAUFuPcObjED9wdyRAI4pIQQCMnLnDlAcD/EFrJRNjKNpQGDIiAGQnUIZGdeoXV/GDbYl0eyMHYJyzoyQIWJOYbCqkLAkA+aQIzKPx90QdBOnFigiCCTiThO0EwsfcDDAM62cRJLWz5GxPI4A7tsx0IEjH4hHiWydgEGEABcLiECtCEsusPB5O+0XoBuskzEmoFPOAECciupxiA4bE8B5SR8VsKRyAzglAADsiDiEAFnhOJXbiUfLg7hfiGA2ACPSISsGsOHQgDggiByrOLVKgH2/kDCUAFLMAGD0CBYCgJNECBYrg1WciCU8CDOdCiHPAB/juAXXgJwhCeDryxHXAlTjEcBDwCE4yjOiiGH6ACDhytCNAqNoS0/075QLz5BFggAWBYNwAIgjnILnNYBegBmW6AvGIQAKuwsikAvuBgAycIgQZoAEIoAeA6gSE4hcvQQB+SBnHwB8KIIwMoAkvYHDUbC8wgAQGgBV2ohBbYh/fwuy2ELw+4jC/0FBaIBEo4BUFYhkmKCAVoBiCIhlMQhRnrj+8Dv/nyFDhsjiyAjhCoAI0TiTQgMy+oBkciiBJotzlYiiP8O+ywoRlYRtaRgC8gs4P7RHGMiHaogFVAA53whPc4q1WEL0BwiYCSEVbAnJiyCzjphNxgvyVos6EKA5D7gAiIAAyAgNT6lGJkkHC4FC6YBACMkuBKCKMhBQBovwPghjHhBv8J0AagKIGnuagUBIAdfAnJaYYTcAZWqwIOiAMv6IJM7AVh+IRbo4FssMCriRAxC4c1yIIKuIZBWoiTAIEnAIZyOoA7akfRGpJXFA5kwIZRkIBbfAkS4ARbgDyeGAPeCTIIkC24Y4C0I0bDOQdjGL5BKDaFKIMVYJcTyIZzMEEXAAAeiIg/sA9F4ISQ+cjE0oa3cABhqEEftAskAIBrzIkW6Afi6oMVKEoAaAEP8AVZ4IFnGIYCYJv+mIJlGIc9uCYoWAQ6gJADCDqjfK9LOIAUSIixQ0ydiAQPyAQ16IGqcYACGAYOcANX2IMY+0ySqJEimwAK6Mo39J4tcBMfYCX/OOAASAmB9pMOdcICKwsjgoCsnMg//kAAfyQJNPDEiHBOn2iDbhjBI7AznbABFJCDU5MAP4CmiKABD4uI17PN8SoEDxg+UNMJE6gANwgE/usBXZgBj2HPnugAk4MqDfgAg0wiDoCOHNgCGHqFLhDJdwOT2lmHhOixRiqJGkCfPLBLNigFEXwPS0AKTSMILjjMvmiFIagAOPi09zgH/nyvH4gQxFKIF6iALAgDCRhDuyCAPOiCOli/FQWKgLwq1CMhXAPRKgAHFU2IGuAE0LCHhDCGy1iVAxAHGAgCUUhDIeGFqjgCyFOFWwCGesiYAwgAUnCJfdiBWsgL7UAKdfCA/1IIFxAIhHeLDAm1ix4drxY9AEYQh2SIggPwAQCoBRfgBnIwhJokCAI4gy+YA2pgBH6r09E6yE9BgUDILhCAkoTQBDJzh8AJgrco1BysAi3SyQq4AWpih9rEg0HIsADghLtLvCiVjBLIxgMggjjdiejJAlAtgpx5j39w1Mh6JMeIxgPwgv6ghWFIBtHzVSCD1FOBgRmADmKghoVwhfQIAY4ygURIhPdQANvxAVDggEqQgHoEBdpbiPfgC0fJLgTwgoYEAGRABU7Y0FdS1qaShgPgBYWwkgP4JxDgBSrYBTm4P3oNMmbNFzrAhi+AlBSYA3QEgD1gBoIwBA4wAxoQzf9T+ISlKQIU8ABiiSYE6AUOcIVaCIVQUNE1qIp3WAd2MQTgeAUOSNiq4AAPyAViIYCnNAASUIIpcAZ8MAMYfI92HdgkGpsUAAQYsIMrPAA6MIOrFFrhWMOwKdiSSYLxOIAZEL0a6I+2BIAUOgAlcBNlyIRxiyVe6LiXEIB0eJWEsLQF+I0S2NhPQD+o8YJ+AKt83TEAoKX3MESnJSF77Y9a7dvgsLaoHa0aCIPsWoJEaL8qtJ0YwAZ3UggjQIEhyAIJ6Eu7qIWEMAEr5YkmoAJQaJNX+gaFY7eqyIb/iVzBVaT0FM3VVY4MoIDTCsgg3bgtmMGIyIZJMFu7+IIqiAX/99oJOwiCUGADW6gKEugFSMkBZyABMhAGD4DGkWCCWlgDMfACXqiaAugFFhKCkUWBIOCBJXiKPogD6S0JaBIAW7AFiJ3Qn6Co1620WvAAOaDf+BUOSRMwr7yxchiE9KEmYCCzKQCGKLgBplsKdbQLQbCHTDwAA5gCeOCAaCCH9rULIJAAUviEF8WJswymchUJirML07xfEr68NWTDYRzQIGsB14mIrR0POviNcngPXQAAO2iGV0oHfZDRpvUJFKip5oybhaDIiLC+Ej5iJI4MqU2iEuCBa4oIKnwc4EiRQ/AEJpgNASDWiECAFAgBErACH+BWgkCCKEgGRpiGZQSK/03ggHBhmlzIH0Vwq8mBnySu40LDAA3QANPb49oNsn15jxtAYBldBwkIAoJYvx1xgBrAhKTzgB4GADiog0r4A7uYgnsYgkfGCchQCCFoMwSYAd7BpZcwBTsuZazUKvDrYyAzZCLJgvbVPZ5gAw/AAkEQV7tIB0iJAQBAAWryCTtYsd4boi4Qg03uiRKgAdAQgAoYBoJoht5LVlOOZmleYiV6JAJIi3WAlK1VCDYIBQ/wgCOYQyAAU7sogi9ehxLwgKcQADF2A6R4BFwlAX4sACvwhgqi4yoaCSmYBEpmm9Ipg7j4BWkeaNEagQ/YY5UjH617pI9KiLyYBBm1hbiwHf8V8KM4cIUDXgh9QMZ++A0mwDV0ewliiIZRODydsLQDuBtU/EuCbml6yjZKU2iL09cuqICJjpD/0AYxOI/vHDtJ2M/mSIYYkFsQyINMCIJMVghXmgFUCIfLkECXjmolgoCDjgA9VmUgq9rqKEF4mINToN+dCaUW2AEqIIHGw4wzkAEh8ACB/YeQfok6kGq5TiL5+oAHwC+sBrIaOINYmykguwQlWIaqAQEvqIASEOOXYIW5XmzfOWgNOA7VUmHGdpCxVgI5JghtvZIB6EtWmmzP9pQOoLaBVLT9/WwYcQQ0wAZQcAFXmKKHWVCBNm3ZNkpqnu2eAASC4Do4gmrb7m3/2P1P/e1N344RA0sBCWhjSx1u5Z4M/iq905Pp5WaQafy12ohu6+6L0irc62YQUdiFLKjB7Q5vndiACdBu8d4JATxv9f4NxQG/2j6K957r/llv+m6OgUTo55ZsX4Xf+u7vuY5v/w5wAS8ZAB9wAz/wGClwBF9w29aAuTNvBo9wA5evB0hoApdwDB/w1NJNhM7rDP/w684A4IYtDwdxE19uDdDKCz9xFj/vaVvxFo/x5T40yCZt4ZZxHO/tDyAyIytv6M5xIP9s+aIvBeeqID9yz/4A00ItH9fvnoAhJI9ywY1d2Po2J5dyrfNOnZhvLF8Ke7LxG+9yMcfwIh9zMzft/zI/czVf7DRfczfXswjogAx4uSt/czv3VSp/gOIo8Tvvc6PccfnizdL2c0LnTwq/6zZPikJfdPZU8g9QciSrc0afdK3rgKfqLz6ndE2Hry/Hp03/dItLcfrSrx8HdVMfLxq5gIAMuVI/dVdnKvdu8kF/dVqfpwqfADak81mvdV5XJDmH8F4PdhIy6A5vdWE/9sKBaRI3dmRv9nyhagiwagvfdWevdk+pa0TPdGvfduVwbMjWdm4P98kIbQAYbXAXd3SfDCun9nRv98jYAKoeAYNO9JKgd3dv9hGArQswuchm93v/956orw2wtpTT9TAHeIQPeOa4NhhPeIfXibhLZf9mf3iKJ3L3PveKz3hJ13iOb/iO/3iPB3mR9/eRL/kGsXeTT3mUT/mSX3mWF3mXf/mPj3mZ53iar/mMv3mcp3id33mH73mfR3igD/p/H3qid3ejP/p0T3qlF3emb3puf3qot3apn3pnr3qrR3asz3ph33qu73Wv//paD3uxf/MNeIBS6gmyL3s1z7YLoAAKMPh6Z3uQz/fksDYVpzu65/j6Urm+X4j8nbR+3/uK//u/J3ycDzDXwi9SR/yaN7kN4K91d3yWzwDjIDLKz3zlaG/37nzP/3zQD33RH33SL33TP33wk/Ut5HzUb33Xf33Yj/3WV331Xnsjhy/bF47c14n/3dd7+u59Rcf9zwT+uRf+/iZ+HLkx5Fdi5W/+43f+91r+vpD+haB+hbD+DsR+ANB+7f8J7of+3wf/Rx1+8Ret7r+87zf+dkz/6Pdv9h+v81f78o+s+Le49x9/2p7/pqp/YwMIBgAGEixo8CDChAoXMjwosCHEiBInAnhI8SLGjA0tauzokSDHjyIxhhxp8iTKlAlLqmwJ0iVMgyxj0lw4s6bJmzhF6tzp86dHCEBTCh16sqhRoEiTflzKtKPTp1KnUq1q9SrWrFq3cu3q9SvYsGLHki1r9izatGrXst06QsMDDSPOdhARl2yEDATrPhAxt63Bt3H/lt3w4EGHsXn3/9r1CzjtBQYQGFwwq4EBBQgWxGZ4IJngZAaUHxeMPLky2RGRL1yIELbz54GhR5MuzGCzBQYbyHZgMIFw2NBIN4wYMYGBa9IbbgPIvXvsBwYiyAonSNw48tpkPT8AwJ2sCMoUpCuOXfB4YtLfv48dfzo92AjmCaLXPnY9g+73GXzYMB7+V/I5FR4G2uGnn1iiRRDdB2IJaBCB9o0VIQbkTZgfAJMlF998FTaoHYUWijUeAA+GZeJAHko4Vm8TRFAfi775RwFwXWUQXmtz5TbBYRsC1uKLDAAIVnQPFPkajhHo6FuPK4alwXETaGBZlHoFJ5qCFWGJYW1Q+jZlarkxUP/glVi6tiWXTqq5JpttuvkmnHHKOSedddp5J5556rknn336+SeggQo6KKGFGnooookquiijjTr6KKSRSjoppZVaeimmmWq6KaedevopqKGKOiqppZp6Kqqpqroqq626mlIGEcgqawYaQGClVRhE9Sqvr84mGgQRIEZVbJP1emyvsTKYl7CJwbUBBBiM8MGtA0VgQbQ1EiTsBhZYMMIDEICZAbXSAtDBAxvo2t1lPHYwWbcWWCkCBNEOiSy+n7LnmWuTTXBcZr4BsJwFFW6GkGcURKbwfx0o/IDCJQI7ngYVZpaBv5FNAEB0GDzQWr4hg7pvdsbK152xuR12XEL8ViT/FL/h7VZhrBgu112xD0XW3G0P+Cgy0JmS3K9AJ2co0GSHHdZydp/x6zK/Rhuds2wCTRuZbkFrjenQR0uMskDhWRDBBg2G56PLTiOXwW0vUvA13L5F8O5Dxn4gQgQVTrc135N2bTKGxnp3HHMWbFxQ2jBn5+UFekmNoWcMYFy3QBBjRmbfmadKAZiae/45RR0cDDrppZt+Ouqpq7466627/jrsscs+O+2123477rnrvjvvvZMa61wjzG3tz5ZVC1G0ByV/ka24AoBx5wxBD6jwVgKf1PS+R1Qhu8zJhxpM801kNEMuQ3SX+eIvJLj5A6FbfELk+2mihgkJTtKuBsmv/z1DywkV3ds8U6AR6OoDVnpWtqhlpWtlyzsaoNcHgNMuxMClLs6q1950BQEDckwy3QGXZp6TAWzVz1oP0AtcAACuKcWFbh+YkmQgWCMGSitIPvOMCKi1m/cB4FneysAKz5Wu/fGJfshBl7og0B0byuqEGnANDefCQAhMZ4KJiaIKqaUyxE2Hh4ZJDL0s8BwESkuB7qMWB30or89hBgAKk1z9LkCBj1EgMf4CmL8GdhuDaekCx/lQijBzq8mMJ29jys10eIQBCmxMY0KR48ck57A5lvB5YwLAcTKwnOlIJgPHuUCBRONH/hSEYAbTgHvgIkjRdMBoGRPYBN4Wniemqf9PRpTVxBigAVRKRpXjSdcemWOkcOnSYrcyJXMig4EjESQ3b0nm2yqEAecc7V+r3JjDLgCxt73ycJqbzGU2SSK2FWiTXnOlQFT2AJZ9ZgTiy9lfGHmYz+QNAiQyGtuUWKRZeic79GkcZR5QocSoLTntnI86Wca+7FQIl2AbyM48swE5wu1PtzTazbzWz+ck1GoisEBkcFaUjrKtQfsLJ0gZ4M4GRcydmwHcQ8PzAWJGQHA781x4WDbKzTzuoeg8mtJEOpB3FuV+TDqMBgg20aJhSEBKE1Z22tdBDICSNagp6FCLMp+kKU2jUEPOT73WG2VWdH45cyjcFpocri5NjiL/CI9QgfrUptayNxW6THR2E5vPwNRrnpnpYehWtc+xTZii2RsjryW5cwYubG0r28uyKhMXCXYgKosAXLizAZbJR4xu5FwEREDLsVVSj9KRzyUjy50zaXUpYiNbg+AFG9dErbGDPdpiibinEYxnA8uhUU+PtoHZDuS1kJUb9ypCWeNGMLHJLU0bQ7Mkw5Cnr8Zi2wU2kLfJ3dZz45lOYa2nMTBZ9yHrFM1m9uqUyHF3INMazxxV4xuWHe1tIxTNBGaGmcj8bDx68a9kO3Cc9LbWIOdljn+k81W0Ck5wl0GNbveUAaw1Dm4Y/W77DryZy0gGcqLRi4Z76J5aAkBsJWaO/wpzQwEylXcgS6VMZe/HP0TddcY2lhQFaHTjHfO4xz7+MZBToqseHs8g2cvIkBHSPK0sL8i2kyryijasg0RYIjJGnD9xor6V5M/JoOsAGudVLwzUlD8s1EBnAKBBDg5MM5wdFgE36DgSrxmF6fqhi90ckhHWKztglnNxx5yYblGRIOHyGJhsVejnaXGXTGqlE6GILXNt2cufy+Y2p/oxEXwylOMRiCIZqUdtssxlkJRjK0kc6o11c9TnLcgkaYrpHGu6NcgskME8IxRpInKsRiqYIGHzS2QS2NKokylNc2MBn/XToOCrJ4lyY8fKre2SmyQitJGms3QKSaPF1WWzkf+tIWUz25kAoKjAIitPXbNtAhhwTGwkatn8vLrSxs7cX5XWgauJhroGLYpSd9ZgaqP1ZPsLuLYHO3As0xY5+Q4sv3WzcPUqV2lTgtZ4KhNvf7I1rvcmHXa1iwFy4U1vq41sP9NV6vxsluBudFFuaoaglLdco8bSLH2t1TYNhXy7dzPkW1meTN1cRiiXhcuCtEtruaHLn8xF+cdJ9+ILoAu+BRIwc2IjX2uq8I4un/CXyqpCjSmUcl2fb0gsxt+BUbjql0vReL71vONMRijvxQxiKAziD2eYcMWOOuC3QjaoYi7whl8RhykQwcMzvvGOfzzkIy/5yVO+8pa/POYzr/kkzXO+857/POhDL/rRk770pj896lOv+tWzvvWufz3sYy/70gcEADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Changes in hair growth rates, determined by photography, in hirsute women treated with ethinyl estradiol 30 g and desogestrel 0.15 mg (left panel) or not treated (right panel). The rate of hair growth was stable in untreated women but slowed by about 25 percent with oral contraceptive therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Dewis P, Petsos P, Newman M, Anderson DC. The treatment of hirsutism with a combination of desogestrel and ethinyl oestradiol. Clin Endocrinol (Oxf) 1985; 22:29.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_25_24991=[""].join("\n");
var outline_f24_25_24991=null;
